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Summary	
The	 intestinal	 tract	 is	 exposed	 to	 a	 large	 variety	 of	 antigens	 such	 as	 food	 proteins,	commensal	 bacteria	 and	 pathogens	 and	 contains	 one	 of	 the	 largest	 arms	 of	 the	immune	 system.	 	 The	 intestinal	 immune	 system	 has	 to	 discriminate	 between	harmless	 and	harmful	 antigens,	 inducing	 tolerance	 to	 harmless	 antigens	 and	 active	immunity	towards	pathogens	and	other	harmful	materials.		Dendritic	cells	(DC)	in	the	mucosal	lamina	propria	(LP)	are	central	to	this	process,	as	they	sample	bacteria	from	the	 local	 environment	 and	 constitutively	migrate	 to	 the	draining	mesenteric	 lymph	nodes	 (MLN),	 where	 they	 present	 antigen	 to	 naïve	 T	 cells	 in	 order	 to	 direct	 an	appropriate	immune	response.		Despite	their	crucial	role,	understanding	the	function	and	phenotype	of	LP	DC	has	been	hampered	by	 the	 fact	 that	 they	share	phenotypic	markers	with	macrophages	(mφ),	which	are	the	dominant	population	of	mononuclear	phagocyte	 (MP)	 in	 the	 LP.	 	 Recent	 work	 in	 our	 own	 and	 other	 laboratories	 has	established	 gating	 strategies	 and	 phenotyping	 panels	 that	 allow	 precise	discrimination	between	intestinal	DC	and	mφ	using	the	mφ	specific	markers	CD64	and	F4/80.	 	 In	 this	 way	 four	 bona	 fide	 DC	 subsets	 with	 distinct	 functions	 have	 been	identified	in	adult	LP	based	on	their	expression	of	CD11b	and	CD103	and	a	major	aim	of	my	 project	was	 to	 understand	 how	 these	 subsets	might	 develop	 in	 the	 neonatal	intestine.			
At	the	beginning	of	my	PhD,	the	laboratory	had	used	these	new	methods	to	show	that	signal	 regulatory	 protein	 α (SIRPα),	 an	 inhibitory	 receptor	 expressed	 by	 myeloid	cells,	was	expressed	by	mφ	and	most	DC	in	the	intestine,	except	for	those	expressing	CD103	 alone.	 	 In	 addition,	 mice	 carrying	 a	 non-signalling	 mutation	 in	 SIRPα	(SIRPα mt)	had	a	selective	reduction	in	CD103+CD11b+	DC,	a	subset	which	is	unique	to	 the	 intestinal	 LP.  This	 was	 the	 basis	 for	 the	 initial	 experiments	 of	 my	 project,	described	in	Chapter	3,	where	I	investigated	if	the	phenotype	in	SIRPα	mt	mice	was	intrinsic	 to	 haematopoietic	 cells	 or	 not.	 	 To	 explore	 this,	 I	 generated	 bone	marrow	(BM)	 chimeric	 mice	 by	 reconstituting	 irradiated	 WT	 mice	 with	 SIRPα	 mt	 BM,	 or	SIRPα	 mt	 animals	 with	 WT	 BM.	 	 These	 experiments	 suggested	 that	 the	 defect	 in	CD103+CD11b+	 DC	 was	 not	 replicated	 in	 DC	 derived	 from	 BM	 of	 SIRPα	 origin.	However	as	this	seemed	inconsistent	with	other	data,	I	considered	the	possibility	that	
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the	 phenotype	 may	 have	 been	 lost	 with	 age,	 as	 the	 BM	 chimeric	 mice	 were	considerably	 older	 than	 those	 used	 in	 the	 original	 studies	 of	 SIRPα	 function.		However	 a	 comparison	of	DC	 subsets	 in	 the	 intestine	of	WT	and	SIRPα	mt	mice	 as	they	aged	provided	no	conclusive	evidence	to	support	this	idea.			
As	these	experiments	did	show	age-dependent	effects	on	DC	subsets,	 in	Chapter	4,	I	went	on	 to	 investigate	how	the	DC	populations	appeared	 in	 the	 intestine	and	other	tissues	 in	 the	 neonatal	 period.	 	 These	 experiments	 showed	 there	 were	 few	CD103+CD11b+	DC	present	 in	 the	LP	and	migratory	DC	compartment	of	 the	MLN	 in	the	neonate	and	 that	as	 this	population	gradually	 increased	 in	proportion	with	age,	there	 was	 a	 reciprocal	 decrease	 in	 the	 relative	 proportion	 of	 CD103-CD11b+	 DC.	Interestingly,	most	of	the	changes	in	DC	numbers	in	the	intestine	were	found	during	the	 second	 or	 third	week	 of	 life	 when	 the	weaning	 process	 began.	 To	 validate	my	findings	that	there	were	few	CD103+CD11b+	DC	in	the	neonate	and	that	this	was	not	merely	an	absence	of	CD103	upregulation,	 I	examined	the	expression	of	CD101	and	Trem-1,	markers	that	other	work	in	the	laboratory	had	suggested	were	specific	to	the	CD103+CD11b+	 DC	 lineage.	 My	 work	 showed	 that	 CD101	 and	 Trem-1	 were	 co-expressed	 by	most	 CD103+CD11b+	DC	 in	 small	 intestine	 (SI)	 LP,	 as	well	 as	 a	 small	subset	of	CD103-CD11b+	DC	in	this	tissue.		Interestingly,	Trem-1	was	highly	specific	to	the	SI	LP	and	migratory	DC	in	the	MLN,	but	absent	from	the	colon	and	other	tissues.	CD101	expression	was	also	only	 found	on	CD11b+	DC,	but	 showed	a	 less	 restricted	pattern	of	distribution,	being	found	in	several	tissues	as	well	as	the	SI	LP.	
The	 relative	 timing	 of	 their	 development	 suggested	 there	 might	 be	 a	 relationship	between	 CD103+CD11b+	 and	 CD103-CD11b+	 DC	 and	 this	 was	 supported	 by	microarray	 analysis.	 	 I	 hypothesised	 that	 the	 CD103-CD11b+	 DC	 that	 co-expressed	CD101	 and	 Trem-1	 may	 be	 the	 cells	 that	 developed	 into	 CD103+CD11b+	 DC.	 	 To	investigate	 this	 I	 analysed	 how	 CD101	 and	 Trem-1	 expression	 changed	 with	 age	amongst	 the	 DC	 subsets	 in	 SI	 LP,	 colonic	 LP	 (CLP)	 and	 MLN.	 	 The	 proportion	 of	CD101+Trem-1+	 cells	 increased	 amongst	 CD103+CD11b+	 DC	 in	 the	 SI	 LP	 and	 MLN	with	age,	while	amongst	CD103+CD11b+	DC	in	the	CLP	this	decreased.	 	This	was	not	the	 same	 in	 CD103-CD11b+	 DC,	 where	 CD101	 and	 Trem-1	 expression	 was	 more	varied	with	 age	 in	 all	 tissues.	 	 CD101	and	Trem-1	were	not	 expressed	 to	 any	great	extent	on	CD103+CD11b-	or	CD103-CD11b-	DC.	 	The	phenotypic	development	of	 the	
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intestinal	 DC	 subsets	 was	 paralleled	 by	 the	 gradual	 upregulation	 of	 CD103	expression,	while	the	production	of	retinoic	acid	(RA),	as	assessed	by	the	AldefluorTM	assay,	was	low	early	in	life	and	did	not	attain	adult	levels	until	after	weaning.	 	Thus	DC	in	the	neonatal	intestine	take	some	time	to	acquire	the	adult	pattern	of	phenotypic	subsets	and	are	functionally	immature	compared	with	their	adult	counterparts.			
In	 Chapter	 5,	 I	 used	 CD101	 and	 Trem-1	 to	 explore	 the	 ontogeny	 of	 intestinal	 DC	subsets	 in	 CCR2-/-	 and	 SIRPα	mt	mice,	 both	 of	which	 have	 selective	 defects	 in	 one	particular	group	of	DC.		The	selective	defect	seen	amongst	CD103+CD11b+	DC	in	adult	SIRPα	mt	mice	was	more	profound	 in	mice	at	D7	and	D14	of	age,	 indicating	 that	 it	may	 be	 intrinsic	 to	 this	 population	 and	 not	 highly	 dependent	 on	 environmental	factors	 that	 change	 after	 birth.	 The	 expression	 of	 CD101	 and	 Trem-1	 by	 both	CD103+CD11b+	 and	 CD103-CD11b+	 DC	 was	 reduced	 in	 SIRPα	 mt	 mice,	 again	indicating	 that	 this	 entire	 lineage	 was	 affected	 by	 the	 lack	 of	 SIRPα	 signalling.	However	there	was	also	a	generalised	defect	in	the	numbers	of	all	DC	subsets	in	many	tissues	 from	 early	 in	 life,	 suggesting	 there	 was	 compromised	 development,	recruitment	or	survival	of	DC	 in	 the	absence	of	SIRPα	 signalling.	 	 In	contrast	 to	 the	findings	in	SIRPα	mt	mice,	more	CD103+CD11b+	DC	co-expressed	CD101	and	Trem-1	in	CCR2-/-	mice,	while	there	were	no	differences	in	the	expression	of	these	molecules	amongst	CD103-CD11b+	DC.		This	may	suggest	that	CCR2+	CD103-CD11b+	DC	are	not	the	 cells	 that	 express	 CD101	 and	 Trem-1	 that	 are	 predicted	 to	 be	 the	 direct	precursors	of	CD103+CD11b+	DC.		I	also	examined	the	expression	of	DC	growth	factor	receptors	 on	 DC	 subsets	 from	 mice	 of	 different	 ages,	 but	 no	 clear	 age	 or	 subset-related	patterns	of	the	expression	of	mRNA	for	Csf2ra,	Irf4,	Tgfbr1	and	Rara	could	be	observed.	 	Next,	 I	 investigated	whether	Trem-1	played	any	role	 in	DC	development.	Preliminary	experiments	 in	Trem-1-/-	mice	 show	no	differences	between	any	of	 the	DC	 subsets,	 nor	 were	 there	 any	 selective	 effects	 on	 individual	 subsets	 when	 DC	development	from	Trem-1-/-	KO	and	WT	BM	was	compared	in	competitive	chimeras.	However	these	experiments	were	difficult	to	interpret	due	to	viability	problems	and	because	I	found	an	unexpected	defect	in	the	ability	of	Trem-1-/-	BM	to	generate	all	DC,	irrespective	of	whether	they	expressed	Trem-1	or	not.	
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The	 final	 experiments	 I	 carried	 out	 were	 to	 examine	 the	 role	 of	 the	microbiota	 in	driving	the	differentiation	of	intestinal	DC	subsets,	based	on	the	hypothesis	that	this	could	 be	 one	 of	 the	 environmental	 factors	 that	 might	 influence	 events	 in	 the	developing	intestine.	To	this	end	I	performed	experiments	in	both	antibiotic	treated	and	germ	free	adult	mice,	both	of	which	showed	no	significant	phenotypic	differences	amongst	 any	 of	 the	 DC	 subsets.	 However	 the	 study	 of	 germ	 free	 mice	 was	compromised	by	recent	contamination	of	 the	colony	and	may	not	be	 the	conclusive	answer.	
Together	the	data	in	this	thesis	have	shown	that	the	population	of	CD103+CD11b+	DC,	which	is	unique	to	the	intestine,	is	not	present	at	birth.		These	cells	gradually	increase	in	 frequency	 over	 time	 and	 as	 this	 occurs	 there	 is	 a	 reciprocal	 decrease	 in	 the	frequency	of	CD103-CD11b+	DC.	 	Along	with	other	results,	this	leads	to	the	idea	that	there	 may	 be	 a	 linear	 developmental	 pathway	 from	 CD103-CD11b+	 DC	 to	CD103+CD11b+	 DC	 that	 is	 driven	 by	 non-microbial	 factors	 that	 are	 located	preferentially	in	the	small	intestine.		My	project	indicates	that	markers	such	as	CD101	and	Trem-1	may	assist	the	dissection	of	this	process	and	highlights	the	importance	of	the	neonatal	period	for	these	events.	
  	
	
	
	
	
1 Chapter	1	
General	Introduction	
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1.1 Introduction	
From	the	beginning	of	time,	selective	pressures	such	as	competition	for	nutrients	and	space	have	allowed	for	the	evolution	of	systems	of	protection	and	survival.	 	Even	as	early	as	the	sponge,	there	is	evidence	of	cell	specialisation	and	pattern	recognition,	as	well	 as	 recognition	 of	 self	 and	 non-self,	 elements	 we	 associate	 with	 the	 immune	system.	 	 Fast-forward	 several	 hundred	million	 years	 and	mammals	 have	 evolved	 a	complex	system	of	discrimination	between	harmful	materials	such	as	pathogens	and	innocuous	agents	such	as	‘self’	tissues,	commensal	bacteria	or	food	proteins.		Harmful	or	 infectious	 organisms	 must	 be	 eradicated,	 and	 the	 immune	 system	 does	 this	efficiently	via	two	lines	of	defence,	namely	innate	and	adaptive	immunity.		The	innate	immune	system	acts	rapidly,	but	 is	hard	wired,	 is	not	antigen	specific	and	does	not	show	memory.	 	 In	 contrast,	 adaptive	 immunity	 takes	 longer	 to	develop,	 needing	 to	expand	antigen	 specific	 cells,	but	 is	 long-lived	and	generates	 faster	 responses	upon	re-encounter	of	the	same	antigen	(memory).		As	well	as	generating	active	responses,	the	immune	system	must	also	tolerate	the	presence	of	commensal	organisms,	dietary	proteins	 and	 other	 harmless	 environmental	 antigens.	 	 As	 the	 intestinal	 immune	system	encounters	more	 foreign	antigens	 than	any	other	part	of	 the	body	 from	 the	moment	 of	 birth,	 it	 is	 particularly	 crucial	 that	 immune	 responses	 in	 this	 tissue	 are	highly	 regulated.	 	 Dendritic	 cells	 (DC)	 are	 crucial	 for	 surveying	 the	 intestinal	environment,	migrating	to	the	draining	mesenteric	lymph	nodes	(MLN)	with	sampled	antigen,	 and	 presenting	 this	 to	 naïve	 T	 cells.	 	 The	 T	 cells	 then	 proliferate	 and	differentiate	accordingly	 into	gut	homing	effector	or	regulatory	T	cells,	allowing	 for	active	immunity	or	tolerance	to	be	induced.		
1.1.1 The gastrointestinal tract 
The	 gastrointestinal	 (GI)	 tract	 is	 made	 up	 of	 several	 “systems”	 with	 different	biological	 functions,	 which	 have	 evolved	 alongside	 one	 another	 to	 create	 an	integrated	efficient	organ.	 	The	GI	 tract	consists	of	 the	stomach,	 small	 intestine	and	large	intestine	and	develops	from	the	embryological	midgut	(stomach,	small	intestine	(SI))	and	hindgut	(caecum,	large	intestine/colon,	rectum).		An	enteric	nervous	system	develops	 in	 parallel,	 providing	 sensory	 and	motor	 activities	 essential	 for	 intestinal	function.	 	 Local	 neuroendocrine	 cells	 also	 develop	 in	 the	 intestine,	 releasing	
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hormones	 to	help	 regulate	digestion.	 	The	GI	 tract	has	 several	 layers	with	different	functions.		The	outermost	layer	is	the	mucosa,	made	up	of	the	surface	epithelium,	the	underlying	 lamina	propria	 (LP)	 and	 the	muscularis	mucosae.	 	Under	 the	mucosa	 is	the	submucosa,	a	dense	layer	of	connective	tissue	containing	vasculature,	lymphatics	and	 nerves.	 	 The	 muscularis	 externa	 is	 the	 outer	 muscle	 layer	 responsible	 for	peristalsis.		Lastly	there	are	the	adventitia	and	serosa,	which	are	the	outermost	layers	of	the	GI	tract	and	are	made	up	of	connective	tissue	separating	the	intestinal	tissues	from	 the	peritoneal	 cavity.	 	 This	 also	 contains	 the	mesentery	 that	houses	 the	 veins	and	 arteries	 that	 supply	 the	 intestine,	 as	well	 as	 the	 lymphatics	 draining	 from	 the	intestinal	wall	to	the	MLN.				
The	 primary	 function	 of	 the	 GI	 tract	 is	 to	 move	 and	 process	 foodstuffs,	 absorbing	essential	nutrients	and	water	from	the	small	intestine	and	colon	respectively.		It	does	this	via	a	single	epithelial	layer	that	is	the	largest	mucosal	surface	of	the	body	and	is	bombarded	 constantly	 by	 antigens	 and	 other	 external	 agents.	 	 As	 a	 result,	 it	 has	evolved	 an	 enormous	 and	 elaborate	 immune	 system.	 	 The	 size	 and	 fragility	 of	 the	epithelium	means	there	is	a	high	risk	of	 invasion	by	pathogens.	 	Meanwhile,	the	gut	also	provides	a	home	to	 trillions	of	symbiotic	commensals	and	 is	 in	regular	contact	with	dietary	antigen,	both	of	which	require	immunological	hyporesponsiveness	to	be	maintained	 to	 prevent	 inflammatory	 disorders	 such	 as	 coeliac	 disease	 and	inflammatory	bowel	disease	(IBD)	(A.	Mowat,	2003).	 	The	immune	apparatus	of	the	intestine	 consists	 of	 organised	 lymphoid	 tissues	 such	 as	 the	 Peyer’s	 patches	 (PPs),	isolated	 lymphoid	 follicles	 (ILFs),	appendix	and	 the	MLN,	where	 immune	responses	are	initiated	(Chirdo	et	al.,	2005;	A.	Mowat,	2003).		Many	immune	cells	are	also	found	scattered	 throughout	 the	 wall	 of	 the	 intestine,	 where	 lymphocytes,	 plasma	 cells,	macrophages	(mφ),	DC,	innate	lymphoid	cells	(ILCs)	and	eosinophils	form	the	effector	arm	of	the	local	immune	system.			
1.1.2 The intestinal immune system 
The	SI	and	colon	form	a	continuous	tube	from	the	outlet	of	the	stomach	to	the	rectum.		The	 SI	 is	made	up	of	 three	 segments,	 the	duodenum,	 jejunum	and	 ileum,	while	 the	colon	comprises	the	ascending,	transverse	and	descending	colon.		The	caecum	forms	the	first	part	of	the	large	intestine	separated	from	the	ileum	by	the	ileocaecal	valve.		
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Along	 the	 length	 of	 the	 SI,	 the	 surface	 area	 of	 the	 already	 extensive	 structure	 is	increased	by	the	presence	of	finger-like	projections	known	as	villi	that	extend	into	the	lumen.	 	 These	 are	 longest	 in	 the	 duodenum	 and	 jejunum	 becoming	 shorter	 as	 the	ileum	 is	 reached.	 	 The	 caecum	 and	 colon	 have	 a	 flat	 luminal	 surface	 due	 to	 the	absence	of	the	villi.		The	function	of	the	SI	is	to	digest	and	absorb	nutrients	from	food,	whereas	the	colon	is	designed	to	reabsorb	water,	remove	undigested	foodstuffs	and	provide	a	home	to	a	huge	array	of	different	commensal	bacteria.		The	immune	system	in	these	sites	reflects	these	anatomical	and	physiological	differences.			
1.1.3 Peyer’s patches and isolated lymphoid follicles 
In	1677,	 Johann	Conrad	Peyer	described	 lymphoid	aggregates	 found	along	 the	anti-mesenteric	axis	of	 the	SI,	 after	which	 they	were	known	as	Peyer’s	patches	 (PP).	 	 In	mice,	the	development	of	PP	begins	before	birth	with	colonisation	by	lymphoid	tissue	inducer	(LTi)	cells	that	aggregate	to	form	primordial	PP	around	embryonic	day	16.5	(E16.5)	 (Veiga-Fernandes	 et	 al.,	 2007).	 	 By	 two	 days	post	partum,	 CD11c+	 cells	 are	present	 in	 the	 periphery	 of	 the	 PP	 anlagen	 and	 these	 are	 thought	 to	 help	 the	structural	 compartmentalisation	 of	 the	 PP	 (Hashi	 et	 al.,	 2001).	 	 It	 is	 still	 to	 be	established	whether	these	are	bona	fide	DC	or	mφ.		The	general	structure	of	PP	is	that	of	 large	 B	 cell	 follicles	 with	 intervening	 T	 cell	 areas,	 together	 with	 an	 overlying	subepithelial	dome	(SED)	region,	which	is	rich	in	a	variety	of	immune	cells	including	DC.		Overlying	the	PP	is	a	single	layer	of	columnar	epithelial	cells	that	have	only	low	levels	of	the	brush	border	found	on	other	intestinal	epithelial	cells,	and	is	known	as	the	 follicle	 associated	 epithelium	 (FAE)	 (A.	 Mowat,	 2003).	 	 This	 differs	 from	 the	conventional	 villus	 epithelium	 in	 that	 it	 contains	 microfold	 (M)	 cells	 which	 are	specialised	enterocytes	lacking	surface	microvilli	and	the	thick	layer	of	mucus	found	elsewhere	 in	 the	 intestine	 (Hamada	 et	 al.,	 2002).	 	 M	 cells	 have	 distinct	oligosaccharides	on	their	surface	allowing	for	the	adhesion	and	invasion	of	pathogens	(Neutra	et	al.,	1996).	 	Microbes	and	other	particulate	materials	 taken	up	by	M	cells	are	transported	to	neighbouring	DC	in	the	SED	for	presentation	to	local	T	and	B	cells	(Newberry	and	Lorenz,	2005).	 	Recent	evidence	suggests	 that	some	of	 these	DC	are	also	 capable	 of	 migrating	 to	 the	 draining	 MLN	 to	 present	 antigen	 (Houston	 et	 al.,	2015).		The	exact	role	of	PP	in	the	intestinal	immune	response	remains	ambiguous,	as	some	reports	have	shown	normal	tolerance	to	fed	proteins	in	mice	lacking	PP	and	M	
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cells,	while	 others	have	 shown	opposite	 results	 (Alpan	 et	 al.,	 2001;	 Fujihashi	 et	 al.,	2001).	
ILFs	are	found	throughout	the	length	of	both	the	SI	and	colon.		They	are	microscopic	lymphoid	 aggregates	 and	 are	 similar	 to	 PP	 in	 that	 they	 have	 FAE	 and	M	 cells	 but	consist	of	a	single	B	cell	 follicle	with	a	 few	T	cells	and	DC.	 	The	 ILFs	are	 thought	 to	contribute	 to	 the	 regulation	 of	 bacterial	 colonisation	 in	 the	 intestine	 via	 the	production	 of	 immunoglobulin	A	 (IgA)	 (Eberl	 and	 Lochner,	 2009).	 	 Unlike	 PP,	 ILFs	develop	 postnatally	 in	 response	 to	 factors	 produced	 by	 the	 microbiota	 (Eberl	 and	Lochner,	2009).			
1.1.4 Mesenteric lymph nodes 
The	MLN	are	a	chain	of	lymph	nodes	that	drain	the	SI	and	colon.		Consistent	with	the	antigenic	load	in	the	intestine,	the	MLN	are	the	largest	lymph	nodes	in	the	body	and	are	thought	to	be	the	principal	site	for	induction	of	most	immune	responses	in	the	gut.		Although	the	MLN	consists	of	linked	nodes,	each	of	these	drains	anatomically	distinct	parts	of	the	SI	or	colon.		This	compartmentalisation	was	first	described	over	40	years	ago	 (Carter	 and	 Collins,	 1974;	 Tilney,	 1971),	 but	 has	 been	 largely	 forgotten	 until	recently,	 when	 two	 studies	 showed	 that	 not	 only	 are	 there	 anatomically	 distinct	drainage	 routes	 (Houston	 et	 al.,	 2015;	 Van	 den	 Broeck	 et	 al.,	 2006),	 but	 that	 the	characteristics	of	the	T	cells	primed	in	either	the	SI	draining	lymph	node	(sMLN)	or	the	colonic	draining	lymph	node	(cMLN)	are	distinct	(Houston	et	al.,	2015).		The	MLN	are	compartmentalised	in	the	same	way	as	other	secondary	lymphoid	tissues,	with	B	cell	follicles	in	the	outer	cortex	surrounding	T	cell	zones	in	the	paracortical	region.		It	is	 this	 highly	 organised	 structure	 of	 the	 lymph	 nodes	 that	 allows	 for	 the	 efficient	priming	 of	 T	 cells	 (Sainte-Marie,	 2010)	 by	migrating	DC,	which	 I	will	 discuss	 later.		During	my	project,	I	investigated	whether	or	not	the	DC	populations	migrating	to	the	segments	of	the	MLN	draining	either	the	SI	or	the	colon	were	phenotypically	similar.		
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1.1.5 Intestinal epithelial cells 
Epithelial	 cells	 in	 the	 intestine	 are	 highly	 specialised,	 consisting	 of	 a	 number	 of	different	 cell	 types	 including	 absorptive	 enterocytes,	 enteroendocrine	 cells,	 mucus	secreting	goblet	cells	and	antimicrobial	peptide	(AMP)	secreting	Paneth	cells,	each	of	which	 has	 a	 distinct	 role	 in	 the	 function	 of	 the	 epithelium.	 	 The	 epithelial	 layer	 is	constantly	renewed	by	fresh	cells	that	are	transported	in	a	conveyor	belt-like	process	from	the	crypts	where	 they	divide,	 to	 the	 tips	of	 the	villi	 from	where	 they	are	shed	every	4-5	days	(A.	Mowat,	2003).		The	microvilli	on	the	luminal	surface	of	SI	epithelial	cells	(brush	border)	are	embedded	with	nutrient	transporters	and	enzymes	required	for	 the	 digestion	 of	 dietary	 components.	 	 The	 long	 length	 of	 the	 duodenal	 villi	enhances	 this	 absorptive	 effect	 and,	 as	 the	 length	 of	 the	 villi	 shortens	 towards	 the	ileum,	 so	 do	 the	 levels	 of	 brush	 border	 enzymes	 (A.	 M.	 Mowat	 and	 Agace,	 2014;	Sansonetti,	 2004;	 Turner	 et	 al.,	 1997).	 	 The	 colon	 lacks	 villi	 and	 a	 brush	 border,	consistent	with	its	role	in	water	reabsorption	rather	than	digestion.			
Although	there	are	regional	differences	between	the	epithelial	layer	of	the	SI	and	the	colon,	 throughout	 its	 length	 it	 acts	 as	 a	 physical	 barrier	 against	 penetration	 of	microorganisms,	 and	 it	 is	 an	 important	 first	 line	 component	 of	 the	 innate	 immune	system.		Epithelial	cells	are	connected	by	tight	junctions	that	contain	proteins	such	as	occludins	and	claudins,	as	well	as	other	junctional	adherence	proteins,	that	keep	the	cells	firmly	attached	to	one	another	and	maintain	the	polarity	of	the	epithelial	layer;	this	 creates	 an	 highly	 effective	 barrier	 (M.	 E.	 Delgado	 et	 al.,	 2015).	 	 Conventional	epithelial	 cells	 express	 pattern	 recognition	 receptors	 (PRRs),	 thus	 allowing	 innate	responses	 via	 Toll-like	 receptors	 (TLRs)	 and	 the	 resulting	 production	 of	 cytokines	and	chemokines.			
Paneth	cells	are	found	in	the	SI,	mostly	in	the	ileum	and	they	are	found	at	the	base	of	the	crypts,	where	they	produce	AMPs	and	maintain	crypt	stem	cell	activity.		They	are	not	 present	 in	 the	 colon,	 where	 large	 numbers	 of	 goblet	 cells	 are	 present	 instead.		Goblet	 cells	 produce	 mucus	 that	 coats	 the	 mucosa	 with	 a	 layer	 known	 as	 the	glycocalyx,	 thickest	 in	 the	 colon,	 where	 it	 consists	 of	 an	 inner	 dense	 layer	 and	 an	
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outer	loose	layer	(also	found	in	the	SI).	 	Although	bacteria	can	be	found	in	the	outer	layer	 of	mucus,	 the	 inner	 layer	 is	 impenetrable	 to	 bacteria	 (Johansson	 et	 al.,	 2011;	2008).	 	 Mucus	 production	 is	 controlled	 by	 immune	mediators	 such	 as	 interferon-γ	(IFNγ),	IL-9	and	IL-13	(Bancroft	et	al.,	1998;	Steenwinckel	et	al.,	2009),	and	it	plays	an	important	 antimicrobial	 role	 by	 forming	 a	 highly	 charged	 gel	 layer	 that	 acts	 as	 a	physical	barrier.	 	Mucin	glycoproteins	are	directly	microbicidal,	and	 the	mucus	also	provides	a	scaffolding	 for	secreted	antibodies	and	AMPs	 to	adhere	 to	 (Johansson	et	al.,	2011).	
A	 number	 of	 immune	 cells	 including	 intra	 epithelial	 lymphocytes	 (IELs),	 DC	 and	mφ are	also	present	whithin	the epithelium,	 or	 in	 close	 proximity	 to	 it.		 IELs	 are	mostly	CD8+	T	cells	 that	express	CD103,	 the	αE	chain	of	αEβ7	 integrin.	 	They	can	be	divided	into	two	major	groups.	 	So-called	“natural”	IELs	can	express	either	an	αβ	or	
γδ TCR	 together	 with	 a	 CD8αα	 homodimer.	 	 These	 IELs	 are	 believed	 to	 leave	 the	thymus	 early	 in	 development	 and	 undergo	 a	 terminal	 selection	 process	 in	 the	epithelium	 itself.	 	 “Induced”	 IELs	 are	 conventional	 TCRαβ+	 CD8αβ+	 T	 cells	 that	 are	primed	by	 cognate	 antigen	 in	 the	PP	or	MLN	and	have	 returned	 to	 the	 intestine	 as	effector	 cells,	 where	 they	 act	 as	 cytotoxic	 T	 lymphocytes	 (CTLs)	 or	 produce	 IFNγ	(Gangadharan	et	al.,	2006;	Hayday	and	Gibbons,	2008;	Steege	and	Buurman,	1997).	
1.1.6 Lamina Propria 
The	 LP	 is	 made	 up	 of	 loosely	 packed	 connective	 tissue	 immediately	 beneath	 the	epithelium	and	 contains	blood	vessels,	 lymphatics	 and	nerve	 cells,	 as	well	 as	many	immune	cells.		The	LP	is	connected	to	the	draining	MLN	via	afferent	lymphatics	and	is	one	 of	 most	 varied	 of	 any	 immune	 site,	 containing	 lymphocytes,	 mononuclear	phagocytes	(DC	and	mφ),	eosinophils	and	ILCs.		Along	with	classical	TCRαβ	CD4+	and	CD8+	 T	 cells,	 there	 are	 γδ	 T	 cells,	 NKT	 cells	 and	 plasma	 cells	 which	 produce	 vast	quantities	 of	 immunoglobulin	 A	 (IgA)	 (Mayrhofer	 et	 al.,	 1983).	 	 IgA	 is	 the	 most	abundant	 immunoglobulin	 isotype	 in	 the	 body,	 being	 secreted	 as	 a	 J	 chain-linked	dimer	by	LP	plasma	cells,	from	where	it	is	transferred	into	the	lumen	after	binding	to	polymeric	 Ig	 receptors	 (pIgR)	on	 the	basolateral	 surface	of	 the	epithelial	 cells.	 	The	complex	is	then	transported	across	the	cell	and	released	into	the	lumen	as	secretory	
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IgA	(SIgA),	where	it	binds	to	the	mucus	layer.	 	SIgA	contributes	to	the	local	immune	system	by	 trapping	and	neutralising	microorganisms	and	can	help	 to	keep	 in	check	the	bacterial	communities	of	the	intestine	(Cerutti	and	Rescigno,	2008).		
The	 T	 cells	 of	 the	 LP	 are	mostly	 effector/memory	 type	 cells	 and	 are	 derived	 from	naïve	T	cells	that	have	migrated	to	the	LP	after	activation	in	the	PP	or	MLN	(van	Wijk	and	 Cheroutre,	 2009).	 	 TCRαβ+	 CD4+	 cells	 in	 the	 LP	 consist	 of	 a	 mixture	 of	 IFNγ-producing	 Th1,	 IL-17/IL-22	 producing	 Th17	 cells	 and	 FoxP3+	 Tregs,	 although	 the	relative	 proportions	 of	 the	 different	 subsets	 vary	 along	 the	 length	 of	 the	 GI	 tract	(Denning	et	al.,	2011).	 	Th17	cells	are	most	predominant	 in	 the	SI,	whilst	Tregs	are	increasingly	 frequent	 towards	 the	 colon.	 	 The	 composition	 of	 the	 CD4+	 T	 cell	population	of	the	LP	is	also	highly	dependent	on	the	presence	of	the	microbiota,	with	Th17	cells	being	decreased	in	germ	free	(GF)	mice	or	after	treatment	with	antibiotics,	despite	no	overall	difference	in	the	total	number	of	CD4	T	cells	(Ivanov	et	al.,	2008).		Segmented	filamentous	bacteria	(SFB)	are	particularly	associated	with	the	generation	of	Th17	cells	 in	 the	SI	 (Ivanov	et	 al.,	 2009).	 	Th17	cells	produce	 IL-17A	and	 IL-17F	along	with	 IL-22,	which	 together	play	 important	 role	 in	 intestinal	homeostasis.	 	 IL-17A	and	IL-17F	are	both	capable	of	inducing	production	of	the	antimicrobial	peptide	(AMP),	β-defensin,	by	epithelial	cells,	while	 IL-22	induces	the	production	of	 the	Reg	family	of	AMPs	and	also	enhances	tight	junction	formation	between	epithelial	cells	(A.	M.	Mowat	and	Agace,	2014).	
Potentially	 damaging	 immune	 responses	 to	 harmless	 dietary	 and	 commensal	antigens	are	normally	prevented	by	regulatory	T	cells	(Tregs)	(Asseman	et	al.,	2003).		Tregs	are	divisible	into	FoxP3+	natural	Tregs	(nTregs)	that	are	thymically	derived	and	recognise	self	antigens,	together	with	two	populations	of	inducible	Tregs	(iTregs)	that,	as	 their	 name	 suggests	 are	 induced	 in	 response	 to	 self	 and	 foreign	 antigen	 in	 the	periphery.	 	 These	 can	 be	 FoxP3+	 or	 FoxP3-,	 with	 the	 FoxP3-	 subset	 being	characterised	by	the	production	of	IL-10	(Barnes	and	Powrie,	2010;	Kamanaka	et	al.,	2006;	Maynard	et	al.,	2007).			
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1.1.7 Intestinal microbiota 
Normal	intestinal	function	and	immune	responses	are	dependent	on	the	presence	of	a	large	and	diverse	microbiota	that	lives	in	close	symbiosis	with	the	host,	exploiting	the	nutrient	rich	niche	of	the	intestine.	 	This	has	been	shown	in	experiments	with	germ	free	(GF)	mice,	which	have	very	poor	immune	responses	and	smaller	LNs	than	their	SPF	 counterparts	 (Hooper	 and	 Macpherson,	 2010;	 Hooper	 et	 al.,	 2001).	 	 The	 two	main	phyla	found	in	the	intestine	are	Bacteroidetes	(~16%)	and	Firmicutes	(~66%)	(Ley	 et	 al.,	 2008).	 	 One	 of	 the	 major	 roles	 of	 intestinal	 bacteria	 is	 to	 break	 down	complex	dietary	polysaccharides	that	escape	digestion	in	the	SI	and	it	is	this	function	that	 is	 thought	 to	 have	 driven	 such	 close	 evolution	 of	 the	 host	 and	 its	microbiota.		Short-chain	 fatty	 acids	 such	 as	 butyrate,	 acetate	 and	 palmyrate	 produced	 by	 this	digestion	 are	 essential	 for	 epithelial	 cell	 renewal	 (Maslowski et al., 2009)	 and	stimulation	 of	 AMP	 production	 by	 Paneth	 cells	 (Hooper	 and	 Macpherson,	 2010;	Sonnenburg	et	 al.,	 2005).	 	Butyrate	also	drives	Tregs	via	HDAC	and	modification	of	the	FoxP3	locus(Barbi	et	al.,	2014).	 	The	microbiota	can	also	influence	other	aspects	of	intestinal	physiology	such	as	angiogenesis	(Hooper	et	al.,	2003;	Stappenbeck	et	al.,	2002).			
A	 further	 crucial	 property	 of	 commensal	 bacteria	 is	 that	 they	 are	 essential	 for	protection	against	harmful	pathogens.		This	partly	reflects	their	ability	to	compete	for	nutrients	and	space,	as	well	as	modulation	of	the	host	immune	response.		An	example	of	this	is	during	Salmonella	typhimurium	infection	which	is	limited	by	the	activation	of	TLRs	by	 the	commensals	on	host	 immune	cells	 (Stecher	et	al.,	2005).	 	This	effect	extends	to	more	complex	pathogens	such	as	Toxoplasma	gondii,	where	activation	of	DC	 by	 commensals	 induces	 the	 production	 of	 protective	 pathways	 (Benson	 et	 al.,	2009).	 Similarly,	 the	ability	of	 certain	 families	of	bacteria,	 such	as	SFB,	 to	 skew	 the	CD4	 T	 cell	 repertoire	 towards	 Il-17	 production	 can	 provide	 protection	 from	
Citrobacter	rodentium	infection	(Ivanov	et	al.,	2009).			
1.1.8 Active immunity versus tolerance in the intestine 
Pathogens	have	evolved	 to	gain	entry	 to	 the	LP	where	 they	 come	 into	 contact	with	many	 innate	 immune	 cells	 including	 the	 largest	 population	 of	
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mφ	in	the	body,	as	well	as	eosinophils	 and	 ILCs;	 neutrophils	 are	 recruited	 readily	 in	response	 to	 infection.	 	Granulocytes	and	mφ	engulf	and	kill	 invading	organisms	and	produce	pro-inflammatory	cytokines.		ILCs	can	produce	cytokines	such	as	IL-22	that	further	drives	the	release	of	AMPs	and	strengthens	the	epithelial	barrier	(Cella	et	al.,	2008;	Sanos	et	al.,	2009;	Sonnenberg	et	al.,	2011).		The	LP	and	PP/ILF	are	also	rich	in	DC,	 which	 can	 acquire	 microbes,	 process	 the	 associated	 antigens	 and	 present	 the	peptides	to	T	and	B	cells	in	the	PPs	and	MLN.		This	begins	the	cascade	of	the	antigen	specific	adaptive	immune	response,	discussed	in	more	detail	below.			
As	discussed	above,	the	intestinal	immune	system	is	exposed	to	many	other	antigens	that	 are	 not	 pathogenic,	 but	 are	 not	 “self”	 either.	 	 These	 are	 dietary	 proteins	 and	antigens	from	commensal	organisms,	all	of	which	are	continuously	sampled	from	the	lumen	by	mφ	and	DC.		Under	normal	conditions,	the	consequence	of	exposure	to	these	materials	 is	 the	 induction	 of	 antigen-specific	 tolerance.	 	 “Oral	 tolerance”	 is	 the	phenomenon	 by	which	 dietary	 proteins	 induce	 tolerance	 of	 both	 the	 systemic	 and	local	immune	systems	(Pabst	and	A.	M.	Mowat,	2012).		This	is	believed	to	reflect	the	generation	of	Tregs	in	the	MLN	(Thomson	and	Knolle,	2010).		In	contrast,	tolerance	to	commensal	 bacteria	 is	 restricted	 to	 the	mucosal	 immune	 system,	 as	 these	 antigens	normally	do	not	spread	beyond	the	MLN	and	the	systemic	 immune	system	remains	ignorant	 of	 their	presence.	 	 Furthermore	 substantial	 amounts	of	 intestinal	 sIgA	are	generated	against	commensal	bacteria,	but	not	food	proteins	(Pabst	and	A.	M.	Mowat,	2012).			
When	 there	 is	 a	 failure	 to	 induce	 tolerance,	 inappropriate	 immune	 responses	generated	 against	 both	 dietary	 and	 commensal	 antigens	 can	 lead	 to	 intestinal	pathology	such	as	food	allergies,	coeliac	disease	and	the	inflammatory	bowel	diseases,	ulcerative	colitis	(UC)	and	Crohn’s	disease	(CD).		It	remains	unclear	what	factors	lead	to	 a	breakdown	 in	 these	 tolerance	mechanisms,	but	 it	 seems	 reasonable	 to	 suggest	that	it	may	involve	the	way	antigens	are	presented	to	naïve	T	cells	by	local	DC,	as	they	are	the	principal	cells	that	can	discriminate	between	innocuous	and	harmful	antigen.		Thus,	 there	 is	 considerable	 interest	 in	 understanding	 the	 nature	 and	 functions	 of	intestinal	DC	and	their	subsets,	which	is	the	main	focus	of	this	thesis.			
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1.2 The	neonatal	intestine	
At	 the	 moment	 of	 birth,	 the	 embryonic	 intestine	 is	 introduced	 to	 the	 non-sterile	outside	world,	 ingesting	 a	 large	 amount	 of	 bacteria	 during	 passage	 along	 the	 birth	canal	 and	 with	 this,	 a	 new	 microbial	 eco-system	 is	 born.	 	 Shortly	 afterwards	 the	newborn	 mammal	 begins	 to	 ingest	 food	 in	 the	 form	 of	 the	 mother’s	 milk	 and	 at	around	14	days	in	mice,	this	is	supplemented	with	solid	food,	before	becoming	fully	weaned	around	20-21	days.	
The	GI	tract	expands	in	size	from	the	neonatal	period	into	adulthood,	with	the	mature	villus-crypt	 architecture	 developing	 slowly	 during	 the	 first	 three	 weeks	 of	 life.			Epithelial	cell	turnover	is	low	until	the	time	of	weaning	(Clevers,	2013),	when	there	are	 marked	 increases	 in	 crypt	 length	 and	 decreases	 in	 villus	 length	 (Mowat,	unpublished	data).		In	parallel	the	epithelial	layer	is	much	less	well	developed	in	the	neonate	than	in	the	adult	with	low	levels	of	digestive	enzymes,	as	well	as	few	Paneth	cells	(Bry	et	al.,	1994),	explaining	the	very	low	amounts	of	AMPs	that	are	found	until	around	D9	after	birth	(Hornef	and	Fulde,	2014).		Epithelial	cell	expression	of	PRR	also	changes	 during	 neonatal	 development,	with	most	 TLR	 being	 found	 at	 low	 levels	 at	birth,	increasing	thereafter.		It	has	been	suggested	that	this	may	be	a	strategy	aimed	at	allowing	efficient	colonisation	by	the	arriving	microbiota	(Hornef	and	Fulde,	2014;	Pott	et	al.,	2012).		In	contrast,	Nod1/2	and	components	of	the	inflammasome	do	not	change	 (Gribar	 et	 al.,	 2009).	 	 Goblet	 cells	 are	 also	 reduced	 in	 the	neonatal	GI	 tract,	resulting	 in	 a	 reduced	 thickness	 in	 mucus	 layer	 compared	 with	 the	 adult	(Birchenough	et	al.,	2013;	Kim	and	Ho,	2010).			
As	already	mentioned,	in	mice	PP	are	present	from	as	early	as	E15.5.		Around	E17.5,	lymphoid	tissue	inducer	cells	are	recruited	in	a	VCAM-1	dependent	manner	(Hashi	et	al.,	2001;	Jung	et	al.,	2010)	and	this	leads	to	recruitment	of	mature	lymphocytes	to	the	PP	anlagen	within	the	first	few	days	of	postnatal	life.		As	a	result	PP	are	almost	fully	formed	in	the	early	postnatal	period.		ILF	on	the	other	hand,	are	not	present	at	birth	and	 require	 interaction	with	 commensal	 bacteria	 for	 their	 development	 (Eberl	 and	Lochner,	 2009;	Hamada	 et	 al.,	 2002).	 Like	 PP,	MLN	 appear	 in	 the	 embryo	 between	E10.5	 and	 E15.5,	 requiring	 the	 function	 of	 a	 specific	 subset	 of	 CD4+CD3-	 IL-7Rα+	lymphoid	 tissue	 inducer	 cells	 that	 are	 required	 for	 the	 development	 of	 the	 MLN	
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(Mebius	 et	 al.,	 1996).	 	 Another	 important	 mechanism	 of	 protection	 against	 the	onslaught	by	new	antigens	in	the	early	days	of	neonatal	development	is	that	a	large	amount	 of	 IgA	 is	 present	 in	 the	 infant	 GI	 tract.	 	 As	 the	 neonatal	 intestine	 has	 few	mature	B	cells	(Adkins	et	al.,	2004;	Torow	et	al.,	2015),	 this	IgA	is	derived	from	the	mother	 through	 ingestion	 of	 colostrum	 and	 milk	 (Macpherson	 et	 al.,	 2001).	 	 The	ability	 of	 this	 IgA	 to	 recognise	 commensal	 organisms	 is	 thought	 to	 help	 regulate	microbial	 colonisation	 of	 the	 neonatal	 intestine	 (Kramer	 and	 Cebra,	 1995)	(Macpherson	et	al.,	2001).	 	Maternal	IgA	also	seems	to	suppress	development	of	the	host	immune	response,	perhaps	because	it	 limits	access	to	the	microbiota,	and	mice	suckled	 for	 longer	 than	 usual	 are	 unable	 to	 generate	 IgA	 plasma	 cells	 efficiently	(Kramer	and	Cebra,	1995).		
CD4+	T	cells	accumulate	 in	 the	neonate	LP	within	 the	 first	 two	days	after	birth	and	then	 increase	 again	 after	 weaning.	 	 However	 those	 that	 are	 present	 early	 in	development	are	immature	and	unable	to	secrete	IL-17,	IFNγ,	IL-10	or	IL-22	(Torow	et	al.,	2015).		The	entry	of	immature	T	cells	into	PP,	MLN	and	LP	is	dependent	on	their	expression	of	β7	integrin,	which	recognises	mucosal	adressin	cell	adhesion	molecule	1	 (MAdCAM-1)	 on	 the	 vasculature	 of	 the	 LP,	 PP	 and	 MLN.	 	 The	 expression	 of	MAdCAM-1	 is	 partly	 driven	 by	 the	 microbiota.	 	 It	 has	 been	 suggested	 that	 the	immaturity	 of	 gut	 lymphocytes	 in	 the	 neonate	may	 reflect	 active	 suppression,	 and	that	this	provides	a	window	in	the	neonatal	period	that	favours	the	development	of	tolerance	again	commensals	(Torow	et	al.,	2015).			
Although	some	studies	have	described	an	increase	in	DC	in	the	neonate	intestine	(A.	M.	Williams	et	al.,	2006),	to	my	knowledge	no	work	has	been	carried	out	on	how	the	intestinal	 DC	 subsets	 develop	 in	 this	 early	 period,	 and	 thus	 a	 principal	 aim	 of	 my	thesis	was	to	understand	the	population	dynamics	of	DC	from	birth	until	adulthood.			
1.3 Dendritic	cells	
DC	are	specialised	antigen	presenting	cells	of	myeloid	origin	and	are	the	crucial	link	between	innate	and	adaptive	immunity.		They	were	first	described	by	Ralph	Steinman	and	 Zanvil	 Cohn	 in	 1973	 based	 on	 their	 morphology	 and	 appearance	 in	 lymphoid	organs	(Steinman	and	Cohn,	1973).		They	are	found	in	all	tissues	of	the	body,	and	in	
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non-lymphoid	 organs,	 DC	 sample	 large	 amounts	 of	 material	 from	 the	 local	environment	through	macropinocytosis,	endocytosis	and	phagocytosis.		After	uptake	of	antigen,	DC	process	the	protein,	present	the	resulting	peptides	on	the	cell	surface	with	class	I	or	 II	major	histocompatibility	complex	(MHC)	molecules	and	migrate	to	the	 draining	 lymph	 nodes,	 where	 they	 interact	 with	 naïve	 T	 cells.	 	 This	 induces	proliferation	 of	 antigen	 specific	 T	 cells,	 and	 depending	 on	 the	 circumstances,	 they	differentiate	 into	effector	or	regulatory	T	cells	and	are	 imprinted	with	the	ability	 to	home	back	to	the	tissue	from	where	the	DC	arrived.		Although	other	cells	such	as	mφ	and	 B	 cells	 can	 present	 antigen	 with	 MHC,	 DC	 are	 unique	 in	 their	 ability	 to	 carry	antigen	 to	 lymph	 nodes	 and	 to	 prime	 naïve	 T	 cells.	 	 This	 is	 particularly	 crucial	 for	MHC	 II-restricted	 presentation	 by	 DC;	 hence	 DC	 are	 essential	 for	 CD4+	 T	 cells	activation	and	consequently	most	adaptive	immune	responses.			
1.3.1 How to identify a DC 
DC	 are	 classified	 along	 with	 macrophages	 and	 monocytes	 as	 mononuclear	phagocytes.	 	The	mononuclear	phagocyte	system	(MPS)	was	 first	described	 in	1972	as	 a	 system	of	phagocytic	 cells	 located	 in	 reticular	 connective	 tissue	 arising	 from	a	common	 bone	 marrow	 (BM)	 progenitor	 via	 blood	 monocytes	 (Bain	 et	 al.,	 2014).		Although	 now	 known	 to	 be	 more	 complex	 than	 this,	 the	 concept	 of	 the	 MPS	 still	underpins	much	of	our	current	understanding	of	DC	and	mφ	ontogeny.			
Discriminating	between	DC	and	mφ has	been	a	problem	for	some	time,	because	of	the	overlap	in	their	phenotype	and	function.		Like	other	leucocytes,	DC	express	CD45,	but	lack	lineage	markers	found	on	B	and	T	cells,	erythrocytes,	granulocytes	and	NK	cells	(Merad	et	al.,	2013).		In	mice,	they	were	classically	defined	by	their	co-expression	of	MHC	 II	 and	 the	 integrin	 CD11c	 and	 usually	 this	 is	 sufficient	 to	 identify	 DC	 in	secondary	lymphoid	organs.		However	it	is	now	clear	that	this	is	not	suitable	in	non-lymphoid	tissues,	where	other	cells	such	as	mφ,	eosinophils	and	T	cells	can	express	CD11c	(Bain	et	al.,	2012;	Tamoutounour	et	al.,	2012).		This	is	a	particular	problem	in	the	 intestine,	 where	 all	mφ	 express	MHC	 II	 and	 CD11c	 (Schraml	 and	 Reis	 e	 Sousa,	2015)	and	therefore	more	specific	markers	have	to	be	used.		Previous	work	in	the	lab	had	 applied	 rigorous	 testing	 of	 several	 phenotypic	 markers	 (Table	 1.1)	 to	 the	intestine	for	the	first	time,	allowing	bona	fide	DC	to	be	identified.	 	In	line	with	this,	I	
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have	 used	 the	 expression	 of	 MHC	 II	 along	 with	 CD11c	 to	 identify	 all	 MP,	 before	differentiating	between	DC	and	mφ based	on	the	expression	of	CD64	or	F4/80.		This	approach	 has	 been	 validated	 by	 additional	 markers,	 including	 CD24	 and	 zbtb46	specifically	 in	DC	as	well	 as	MERTK	and	CD26	 in	mφ	 (Bain	et	 al.,	 2012;	 Scott	 et	 al.,	2014b).			
Table	1.1:	Phenotype	of	murine	MP	
Surface	Marker	 CD8α
+	DC	
cDC1	
CD11b+	DC	
cDC2	 pDC	 mφ 	CD45	 +	 +	 +	 +	MHC	II	 ++	 ++	 +	 +++	CD11c	 ++	 ++	 +	 +	CD64		 -	 -	 -	 +	F4/80	 -	 -	 -	 +	CD8a	 +	 -	 +/-	 +	CD4	 -	 +/-	 +	 +	CD11b	 -	 +	 -	 +	CD103	 +	 +/-	 -	 -	SIRPα	(CD172a)	 -	 +	 -	 +	Ly6C	 -	 -	 ++	 +	CD205	 ++	 +	 -	 -	CD209	 -	 +/-	 ++	 ND	Clec9a	(DNGR1)	 ++	 -	 +	 -	XCR1	 +	 -	 -	 -	CD24	 ++	 +/-	 ND	 -	CX3CR1	 -	 +/-	 -	 +++	MERTK	 -	 -	 -	 +	
-	Marker	not	expressed;	+	marker	expressed;	+/-	expressed	on	a	subset;		
ND	not	determined				
1.3.2 Dendritic cell subsets  
There	 are	 two	main	 lineages	 of	 DC	 –	 plasmacytoid	 (pDC)	 and	 conventional	 (cDC).		Although	 derived	 from	 the	 same	 precursor,	 these	 are	 quite	 distinct,	 with	 pDC	showing	little	APC	activity	and	producing	copious	amounts	of	type-1	IFNs.		cDC	were	traditionally	separated	 into	“myeloid”	and	“lymphoid”	derived	subsets,	although	we	now	 know	 that	 they	 are	 all	 generated	 from	 a	 myeloid	 progenitor	 (see	 below).		Nevertheless,	 there	 are	 clearly	 distinct	 subsets	 of	 cDC.	 	 DC	 subsets	 were	 first	identified	in	mouse	lymphoid	organs,	where	one	expressed	CD11b	or	CD4	and	lacked	
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the	expression	of	CD8α	(CD11b+	DC),	whereas	the	other	expressed	CD8α	but	lacked	CD4	or	CD11b	(CD8+	DC).		In	non-lymphoid	tissues,	CD8α	expression	largely	overlaps	with	 the	 expression	 of	 the	 aE	 integrin	 CD103	 (Ginhoux	 et	 al.,	 2009a),	 except	 in	 the	intestine,	where	a	large	population	expresses	both	CD103	and	CD11b	(Bogunovic	et	al.,	2009;	Denning	et	al.,	2011;	Varol	et	al.,	2009)(see	below).		Cd11b/CD8α	based	DC	subsets	also	differ	in	the	expression	of	other	surface	markers	(Table	1.1)	and	this	can	be	 useful	 in	 defining	 some	 functional	 properties	 of	 DC.	 	 Although	 the	 individual	surface	markers	vary,	 analogous	populations	exist	 in	other	 species,	 and	recently	an	attempt	 at	 consensus	 has	 been	 made	 based	 on	 common	 phenotypic	 markers,	dependence	on	 transcription	 factors,	 functions	and	anatomical	 localisation	 (Cerovic	et	 al.,	 2014a;	 Geissmann	 et	 al.,	 2010;	Miller	 et	 al.,	 2012;	 Schraml	 and	Reis	 e	 Sousa,	2015;	 Steinman	 and	 Idoyaga,	 2010).	 	 These	 have	 been	 labelled	 as	 cDC1	 and	 cDC2	(Guilliams	et	al.,	2014).			
1.3.2.1 cDC1  
Initially	described	as	CD11b-CD8α+(CD103+)	in	mice,	the	cDC1	subset	was	difficult	to	assign	in	other	species,	where	CD8	is	not	expressed	on	DC	and	CD103	expression	had	not	been	characterised	 fully.	 	However,	 recent	work	has	shown	 that	 the	chemokine	receptor	XCR1	and	DC	NK	 lectin	group	receptor-1	(DNGR1,	also	called	CLEC9A)	are	expressed	by	this	subset	in	all	species	(Bachem	et	al.,	2010;	2012;	Sancho	et	al.,	2009;	2008).	 	Resident	cDC1	 in	secondary	 lymphoid	organs	are	CD103-,	but	 those	 in	non-lymphoid	tissues,	or	those	that	have	migrated	from	there	to	lymphoid	tissues	express	CD103.	 	 In	humans,	 this	subset	can	also	be	 identified	by	expression	of	CD141.	 	This	subset	 of	 DC	 also	 expresses	 a	 unique	 set	 of	 transcription	 factors,	 including	 IRF8	(Edelson	 et	 al.,	 2010a;	Ginhoux	 et	 al.,	 2009b;	 Schraml	 and	Reis	 e	 Sousa,	 2015),	 the	basic	leucine	zipper	transcription	factor	ATF-like	3	(Batf3)	(Edelson	et	al.,	2010b)	and	inhibitor	of	DNA-binding	2	(Id2)	(Jackson	et	al.,	2011),	and	its	development	in	mice	is	dependent	 on	 these	 factors.	 	 Finally,	 the	 absence	 of	 the	 DC	 specific	 transcription	factor	 zDC	 skews	DC	development	 towards	CD103+	CD8+	DC	 (Meredith	 et	 al.,	 2012;	Satpathy	et	al.,	2012).		Although	cDC1	are	able	to	carry	out	all	classical	DC	functions,	they	have	the	unique	ability	to	cross-present	exogenous	antigen	to	CD8+	T	cells	in	the	context	of	MHC	I.			
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1.3.2.2 cDC2 
cDC2	are	CD11b+CD8α-	and	also	CD4+	in	mice,	but	again,	CD11b	is	not	a	useful	marker	in	other	species.		The	defining	feature	of	cDC2	is	the	expression	of	and	dependence	on	the	transcription	factor	interferon	regulatory	factor	4	(IRF4).		In	the	absence	of	IRF4	signalling	there	are	reduced	populations	of	CD11b+	DC	in	most	tissues,	including	the	spleen,	 lung	and	 intestine	(Persson	et	al.,	2013b;	Schlitzer	et	al.,	2013).	 	Although	 it	was	originally	thought	that	IRF4	was	involved	in	development	of	these	DC		(Suzuki	et	al.,	2004),	more	recent	work	suggests	 it	may	also	be	 important	 for	 their	survival	or	migration	from	tissues	to	LN	(Bajana	et	al.,	2012;	Persson	et	al.,	2013b).		
Other	 factors	 involved	 in	 cDC2	 development	 or	 maintenance	 include	 Notch2	signalling	 (Lewis	 et	 al.,	 2011),	 RelB	 and	 TRAF6	 (Kobayashi	 et	 al.,	 2003;	Wu	 et	 al.,	1998).	 	However,	 the	CD11b+	DC	subset	 in	mice	 is	 clearly	heterogeneous,	as	not	all	are	depleted	 in	 the	absence	of	 IRF4	or	Notch2	signalling	and	 there	 is	evidence	 that	ESAM+	DC	 in	 the	spleen	 (Lewis	et	al.,	2011)	and	CD103+CD11b+	DC	 in	 the	 intestine	(Satpathy	 et	 al.,	 2013)	 are	 more	 affected	 in	 these	 circumstances.	 	 Another	 factor	involved	in	cDC2	commitment	is	Kruppel-like	factor	4	(Klf4),	which	appears	to	induce	IRF4	expression	 in	DC	precursors,	and	the	absence	of	Klf4	 leads	to	reduced	CD11b+	DC	 in	 the	 skin	 and	 lung	 as	 well	 as	 reduced	 CD103+CD11b+	 DC	 the	 intestine	(Tussiwand	et	al.,	2015).				
Although	 cDC2	 may	 contribute	 to	 CD8	 T	 cell	 priming	 in	 some	 circumstances	(Fujimoto	et	al.,	2011),	their	main	role	appears	to	be	in	activation	of	CD4+	T	cells.		The	reduction	 of	 cDC2	 in	 IRF4	 KO	 mice	 is	 associated	 with	 a	 defect	 in	 Th2	 generation	(Vander	Lugt	et	al.,	2013;	J.	W.	Williams	et	al.,	2013),	although	as	described	later,	the	selective	 absence	 of	 CD103+CD11b+	 DC	 in	 the	 intestine	 leads	 to	 reduced	differentiation	of	Th17	cells	(Lewis	et	al.,	2011;	Persson	et	al.,	2013b;	Schlitzer	et	al.,	2013).	 	 The	 equivalent	 subset	 in	 humans	 can	 be	 identified	 as	 CD1c+	while	 SIRPα	appears	 to	be	a	conserved	marker	of	cDC2	 in	all	species (Barclay,	2009;	Saito	et	al.,	2010).			
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1.3.2.3 SIRPα expression on mononuclear phagocytes 
SIRPα	 (CD172a)	 is	a	 transmembrane	receptor	expressed	on	myeloid	cells	 including	cDC2	 and	 mφ.	 	 SIRPα	 has	 three	 extracellular	 immunoglobulin	 domains	 and	 an	intracellular	 region	 with	 two	 immunoreceptor	 tyrosine-based	 inhibitory	 motifs	(ITIMs).	 	 Recognition	 of	 its	 ubiquitously	 expressed	 ligand,	 CD47,	 results	 in	 ITIM	phosphorylation	 and	 recruitment	 of	 the	 phosphatases,	 SHP-1	 and	 SHP-2,	 which	inhibit	several	kinase	pathways	(Fortin	et	al.,	2009;	Sato-Hashimoto	et	al.,	2011).		The	role	 of	 the	 SIRPα/CD47	 pathway	 in	 the	 immune	 system	 is	 still	 poorly	 understood,	with	 both	 positive	 and	 inhibitory	 functions	 having	 been	 described	 (Matozaki	 et	 al.,	2009;	 Yrlid	 et	 al.,	 2006).	 	 Recognition	 of	 CD47	 on	 red	 blood	 cells	 or	 other	 cells	 by	SIRPα	 on	mφ	 inhibits	 phagocytosis,	 and	 acts	 as	 a	 “don’t	 eat	 me”	 signal	 (Ishikawa-Sekigami	et	al.,	2006).		In	addition,	ligation	of	SIRPα	has	been	shown	to	regulate	pro-inflammatory	cytokine	production	by	DC	(Latour	et	al.,	2012;	Smith,	2003),	stimulate	the	 migration	 of	 several	 cell	 types	 (Hagnerud	 et	 al.,	 2006;	 Ogura	 et	 al.,	 2012;	Stefanidakis	 et	 al.,	 2008)	and	promote	eosinophil	homeostasis	 (Verjan	Garcia	 et	 al.,	2011).		
1.3.2.4 Plasmacytoid DC 
pDC,	 although	 originating	 from	 a	 similar	 lineage	 to	 cDC	 are	 quite	 different.		Morphologically	 they	resemble	more	of	a	plasma	cell,	 as	 their	name	would	suggest.		Their	 surface	 phenotype	 also	 differs	 from	 that	 of	 cDC	 as	 they	 express	 B220,	 Ly6C,	CCR9	and	SIGLEC-H	along	with	lower	levels	of	CD11c	and	MHC	II	(Table	1.1)	(Nakano	et	 al.,	 2001).	 	 The	main	 function	of	 pDC	 is	 to	 respond	 to	 viral	 infections	by	 rapidly	producing	 type	 1	 IFN	 to	 viral	 nucleic	 acid	 and	 inducing	 cDC	 maturation	 by	 their	release	of	type	1	IFN	and	TNFα	(Fonteneau	et	al.,	2004;	Tang	et	al.,	2010).		However,	these	DC	are	not	the	focus	of	this	study	and	are	therefore	not	considered	further.			
1.3.3 Dendritic cell functions  
In	 non-lymphoid	 tissues	 such	 as	 the	 intestine,	 DC	 continuously	 sample	 their	 local	environment,	 take	 up	 antigens,	 and	 reconnoitre	 for	 danger	 and	 invasive	 organisms	using	 pattern	 recognition	 receptors	 such	 as	 Toll-like	 receptors	 (TLR).	 	 They	 then	
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migrate	 constitutively	 to	 local	 draining	 lymph	 nodes	where	 they	 interact	with	 and	cause	differentiation	of	recirculating	naive	T	cells.	
1.3.3.1 Antigen acquisition 
The	 cDC	 that	 arrive	 as	 precursors	 in	 non-lymphoid	 tissues	 are	 referred	 to	 as	immature	and	they	have	a	huge	capacity	for	the	uptake	of	antigen,	via	the	processes	of	phagocytosis,	receptor	mediated	endocytosis	or	fluid	phase	macropinocytosis.		The	volume	of	fluid	the	DC	can	take	up	via	the	latter	mechanism	is	estimated	to	be	1000	–	1500	mm3	per	hour,	similar	to	the	volume	of	the	cell	itself	(Sallusto	et	al.,	1995).		This	environmental	 sampling	 can	 go	on	 for	 several	 days	without	 affecting	DC	behaviour	markedly,	 but	 in	 the	 presence	 of	 a	 pathogen,	 tissue	 damage	 or	 an	 other	 source	 of	inflammation,	 the	 DC	 undergo	 maturation.	 	 This	 is	 driven	 by	 families	 of	 innate	immune	 receptors	 on	 the	DC	 (PRRs)	 that	 recognise	 pathogen	 associated	molecular	patterns	(PAMPs)	which	are	conserved	molecules	found	on	microorganisms	and	not	on	mammalian	cells.		The	best	understood	are	the	Toll-like	receptors	(TLRs),	of	which	there	 are	 ten	 and	 thirteen	 in	 humans	 and	 mice	 respectively	 (T.	 Kawai	 and	 Akira,	2009).		TLRs	recognise	PAMPs	on	the	surface	or	in	the	nucleic	acid	of	viral,	bacterial	and	 protozoal	 organisms.	 	 Other	 PRRs	 include	 surface	 C-type	 lectins	 and	 cytosolic	molecules	 such	 as	 retinoic	 acid-inducible	 gene-I	 (RIG-I)-like	 receptors	 (RLRs)	 and	nucleotide-binding	oligomerisation	domain	(NOD)-like	receptors	(NLRs)	(O.	T.	Kawai	and	Akira,	2009;	Medzhitov,	2001).		As	well	as	recognising	PAMPs	on	microbes,	some	of	these	PRRs	can	also	detect	the	products	of	damaged	cells	such	as	uric	acid	or	ATP,	and	 their	 effects	 are	 enhanced	 by	 proinflammatory	 cytokines	 such	 as	 TNFα.		Maturation	of	DC	in	response	to	these	signals	leads	to	a	number	of	changes	in	the	cell	including	 stabilisation	of	 the	MHC	 II	–	peptide	complex	due	 to	 reduced	recycling	of	MHC	 II	 (Sallusto	 et	 al.,	 1995),	 together	 with	 upregulation	 of	 the	 costimulatory	molecules	CD80	 (Larsen	et	 al.,	 1992),	 CD86	and	CD40	 (Lenschow	et	 al.,	 1993),	 and	reduced	 macropinocytotic	 activity.	 	 They	 are	 now	 ready	 to	 interact	 with	 and	stimulate	naïve	T	cells.	
 
 
 
40 
1.3.3.2 Migration of dendritic cells 
One	of	the	main	consequences	of	DC	maturation	is	the	induction	of	locomotor	activity	and	 the	 up-regulation	 of	 CCR7	 expression	 which	 allows	 the	 DC	 to	 migrate	 to	 the	draining	LN	 in	afferent	 lymph	(Dieu	et	al.,	1998;	Sallusto	et	al.,	1998;	Sozzani	et	al.,	1998;	 Yanagihara	 et	 al.,	 1998).	 	 CCR7	 has	 two	 ligands,	 one	 being	 CCL21	 that	 is	constitutively	 produced	 by	 fibroblastic	 reticular	 cells	 in	 the	 T	 cell	 rich	 areas	 of	secondary	lymphoid	tissues,	while	CCL19	is	produced	by	stromal	cells	and	mature	DC	in	the	T	cell	areas.		Although	it	is	not	entirely	clear	how	DC	enter	afferent	lymphatics	in	tissues,	it	is	believed	to	be	in	a	CC21	dependent	manner	(Tal	et	al.,	2011),	with	the	DC	 initially	 crawling	 actively	 along	 the	 lymphatics,	 before	 being	 carried	 along	passively	(Tal	et	al.,	2011).		On	entering	the	LN	via	the	sub-capsular	sinus,	the	DC	are	then	attracted	to	the	T	cell	rich	areas	by	CCL19.		It	is	thought	that	DC	in	these	regions	are	 also	 able	 to	 present	 or	 produce	 CCL19,	 thus	 further	 increasing	 the	 chemokine	gradient	towards	the	T	cells	(Alvarez	et	al.,	2008).	 	For	these	reasons	the	priming	of	immune	responses	by	DC	 is	entirely	dependent	on	CCR7.	 	Prostaglandin	E2	 (PGE2)	produced	 by	 epithelia,	 fibroblasts	 and	 recruited	 inflammatory	 cells	 is	 shown	 to	promote	 the	migration	 of	 DC	 to	 the	MLN	 through	 increased	 sensitivity	 of	 CCR7	 to	CCL19	and	CCL21	(Kalinski,	2012;	Yen	et	al.,	2008).			
The	“migratory”	DC	that	have	taken	up	antigen	in	tissues	and	have	arrived	in	draining	lymph	 nodes	 via	 afferent	 lymph	 can	 be	 distinguished	 from	 resident	 DC	 that	 enter	lymphoid	 tissues	directly	 from	 the	bloodstream	by	 the	 levels	 of	 CD11c	 and	MHC	 II	expression.	 	While	resident	DC	are	CD11c+	MHC	IIint,	migratory	DC	are	CD11c+	MHC	IIhi	(Cerovic	et	al.,	2013;	Henri	et	al.,	2001;	Houston	et	al.,	2015).		Migratory	DC	were	originally	 thought	 to	 only	 comprise	 the	 CD11b+	 SIRPα+	 subset	 in	 mice,	 but	 more	recently	it	has	become	clear	that	the	CD8α+	XCR1+	subset	can	also	migrate	from	non-lymphoid	tissues	and	these	are	characterised	by	expression	of	CD103	(Ginhoux	et	al.,	2009b).	 	 Lymph	 nodes	 contain	 both	 migratory	 and	 resident	 DC,	 whereas	 other	lymphoid	tissues	such	as	the	spleen	and	thymus	only	contain	resident	DC,	as	they	lack	an	afferent	lymph	supply	(Bogunovic	et	al.,	2009;	Denning	et	al.,	2011).		
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1.3.3.3 Priming of naïve lymphocytes by dendritic cells 
Once	the	DC	have	arrived	in	the	T	cell	area	of	draining	LN	they	contact	naïve	T	cells	that	are	 in	constant	 flux	 through	 this	 region	after	arriving	 through	high	endothelial	venules	(HEVs).	 	The	crucial	events	for	initiating	virtually	all	 immune	responses	are	the	 priming,	 proliferation,	 maturation	 and	 polarisation	 of	 naïve	 MHC	 II	 restricted	CD4+	T	cells.	 	Mature	DC	are	uniquely	able	 to	do	this	because	of	 their	high	 levels	of	stable	MHC	II	and	expression	of	costimulatory	molecules,	as	well	as	their	production	of	factors	that	drive	T	cell	differentiation.		This	process	involves	DC	forming	immune	synapses	 with	 cognate	 T	 cells,	 in	 which	 addressin	 molecules	 form	 a	 ring-like	structure	 that	 holds	 the	 TCR,	 peptide-MHC	 (pMHC),	 costimulatory	 molecules	 and	signalling	molecules	in	a	stable	manner	that	allows	the	TCR	to	signal.		As	a	result	the	naïve	T	cell	up	regulates	IL-2	and	the	IL-2	receptor	and	begins	the	process	of	clonal	expansion	by	entering	cell	 cycle	 (Guermonprez	et	al.,	2003;	Mellman	and	Steinman,	2001;	Théry	and	Amigorena,	2001).	 	After	several	rounds	of	cell	division,	the	T	cells	differentiate	 into	 one	 or	 other	 type	 of	 effector	 T	 cell,	 appropriate	 to	 the	 type	 of	immune	response	that	is	required.		CD4+	T	cells	can	differentiate	into	several	T	helper	(Th)	subsets,	namely	Th1,	Th2,	Th17	or	T	follicular	helper	(Tfh)	cells	as	well	as	Tregs,	and	this	fate	determination	is	controlled	by	the	nature	of	the	costimulatory	molecules	and	cytokines	expressed	by	the	DC.		In	turn,	the	environment	from	which	the	DC	has	emigrated,	determines	this.			
IFNγ	 producing	 Th1	 cells	 are	 generated	 in	 response	 to	 the	 IL-12	 heterodimer	produced	by	ligation	of	TLRs	and	CD40	on	DC	(Gubler	et	al.,	1991;	Urbain	et	al.,	1998),	and	 their	differentiation	requires	 the	 transcription	 factor	T-bet	 (Szabo	et	al.,	2000).		IFNγ	produced	by	Th1	cells	activates	mφ	to	kill	intracellular	pathogens	and	stimulates	the	production	of	nitric	oxide,	TNFα	and	other	pro-inflammatory	mediators	by	mφ,	as	well	as	causing	B	cells	to	produce	IgG2a	(Snapper	et	al.,	1988b).		Thus,	Th1	cells	are	important	drivers	of	inflammation.		A	different	cocktail	of	DC	cytokines	generates	IL-17	and	 IL-22	producing	Th17	effector	 cells.	 	 IL-1β,	 IL-6	and	TGF-β, largely	from	DC	and	mφ,	initiate	the	differentiation	of	Th17	cells,	and	induce	the	expression	of	IL-23R	on	these	cells,	which	allows	DC	derived	IL-23	to	stabilise	the	generation	of	Th17	cells	(Aggarwal	et	al.,	2003;	Bettelli	et	al.,	2006;	Mangan	et	al.,	2006;	Veldhoen	et	al.,	2006).		
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Th17	 cells	 require	 the	 transcription	 factor	 RORγt	 (Ivanov	 et	 al.,	 2006)	 and	 are	involved	 in	 controlling	 infection	 by	 extracellular	 bacteria	 and	 fungi	 (Happel	 et	 al.,	2005),	as	well	as	being	implicated	in	several	forms	of	inflammatory	disease	(Park	et	al.,	 2005).	 	 The	 largest	 population	 of	 Th17	 cells	 in	 healthy	 animals	 is	 found	 in	 the	intestine	 (see	below).	 	The	generation	of	Th2	cells	 require	 the	presence	of	 IL-4,and	given	 that	 DC	 do	 not	 produce	 this	 cytokine	 themselves,	 it	 remains	 unclear	 exactly	how	 DC	 drive	 Th2	 differentiation.	 	 IL-4	 may	 come	 from	 other	 T	 cells,	 basophils,	eosinophils	 or	 NKT	 cells	 (O'Garra,	 1998).	 	 	 IL-4	 induces	 the	 transcription	 factors	GATA-3,	 STAT-6	 and	 c-MAF	 in	 T	 cells	 (Agarwal	 and	 Rao,	 1998;	 Zhang	 et	 al.,	 1997;	Zheng	and	Flavell,	1997),	and	Th2	cells	produce	IL-4,	IL-5,	IL-9	and	IL-13	which	can	act	upon	naïve	B	cells	to	induce	class	switching	generating	IgE	and	IgG1.		The	role	of	Th2	cells	is	to	respond	to	and	clear	extracellular	nematodes,	but	they	also	play	a	part	in	 allergy	 and	 asthma	 (Finkelman	 et	 al.,	 1988;	 Katona	 et	 al.,	 1991;	 Snapper	 et	 al.,	1988a).		Tfh	cells	are	the	most	recently	described	T	cells.		They	express	Bcl6	and	IL-21,	provide	B	cell	help	by	promoting	class	switching,	and	do	this	by	acquiring	CXCR5	in	 the	 thymus-dependent	area	and	migrating	 into	 the	germinal	centres	of	 lymphoid	tissues	(Crotty,	2011;	Fazilleau	et	al.,	2009).			
In	addition	to	driving	CD4+	T	cell	responses,	DC	are	also	needed	to	initiate	CD8+	T	cell	responses.		CD8+	T	cells	differentiate	into	CTLs	that	are	capable	of	killing	cells	that	are	infected	 with	 viruses	 and	 other	 intracellular	 pathogens.	 	 DC	 present	 exogenous	antigen	 to	CD8+	T	cells	 in	an	MHC	 I	 restricted	manner	 in	a	process	known	as	cross	presentation.		
1.3.3.4 Dendritic cells and the induction of tolerance  
DC	that	have	acquired	antigen	in	the	tissues	in	the	absence	of	“danger	signals”	from	PRR	 can	 still	 mature	 to	 some	 extent	 and	 migrate	 to	 the	 draining	 LN.	 	 However,	because	 they	 do	 not	 express	 high	 levels	 of	 costimulatory	 molecules	 these	 “semi-mature”	DC	cannot	induce	the	differentiation	of	effector	T	cells,	even	though	they	can	present	 antigen	 to	naïve	 cognate	T	 cells.	 	 In	 contrast,	 this	 leads	 to	 the	 induction	of	tolerance	in	the	T	cell.		One	mechanism	of	this	is	anergy,	in	which	the	T	cell	is	unable	to	 undergo	 clonal	 expansion	 and	 becomes	 blocked	 in	 a	 non-functional	 state.		
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Alternatively	the	T	cells	become	inducible	FoxP3+	T	regs	due	to	the	production	of	IL-10	or	RA	by	the	DC,	and/or	the	presence	of	TGFβ.			
DC	are	also	important	for	the	induction	of	central	tolerance	that	prevents	responses	to	 self	 antigen	 via	 clonal	 deletion	 of	 self-reactive	 T	 cells	 in	 the	 thymus,	 or	 by	 the	induction	of	natural	 FoxP3+	Tregs	 (nTregs).	 	 There	 are	 two	ways	 this	 is	 thought	 to	occur;	 firstly	 by	 expression	 of	 autoimmune	 regulator	 (AIRE)	 on	 medullary	 thymic	epithelial	 cells	 (mTECs)	 which	 drives	 the	 expression	 of	 peripheral	 antigens	 in	 the	thymus	for	thymic	cDC	to	take	up	and	present	(Gallegos	and	Bevan,	2004;	Hubert	et	al.,	2011).		Alternatively,	cDC1	and	cDC2	may	carry	self-antigen	from	the	periphery	to	the	thymus	and	directly	induce	clonal	deletion	in	T	cells	(Bonasio	et	al.,	2006).		
Figure	1.1:	DC	–	T	cell	interactions.	 	DC	produce	a	number	of	different	cytokines	in	response	to	acquired	antigen.		These	polarise	naïve	T	cells	to	become	effector	T	cells	or	Tregs.	 	Each	of	the	T	cell	subsets	is	under	the	influence	of	a	specific	transcription	factor.	
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1.4 Development	of	dendritic	cells	
Haematopoiesis	 develops	 in	 two	 waves.	 	 The	 initial	 phase	 begins	 in	 mice	 at	approximately	 embryonic	day	7	 (E7)	 in	 the	yolk	 sac	of	 the	 embryo.	 	This	primitive	phase	 gives	 rise	 to	 mφ	 progenitors	 from	 the	 primitive	 ectoderm,	 which	 then	 seed	many	 tissues	 directly.	 	 Definitive	 haematopoiesis	 begins	 at	 around	 E10.5,	 when	haematopoietic	 stem	 cells	 (HSCs)	 formed	 in	 the	 yolk	 sac	 move	 to	 the	 foetal	 liver,	expanding	 and	 producing	 erythrocytes,	 lymphocytes	 and	myeloid	 cells.	 Just	 before	birth,	HSCs	colonise	the	BM,	which	is	then	the	source	of	haematopoiesis	throughout	adult	life.			
The	generation	of	the	individual	types	of	haematopoietic	cells	involves	a	linear	series	of	 precursors,	 each	 of	 which	 becomes	 increasingly	 committed	 to	 a	 specific	 lineage	(FIGURE	 1.2).	 	 In	 myelopoeisis,	 HSC	 give	 rise	 to	 the	 common	 myeloid	 progenitor	(CMP),	which	develops	 into	 the	 granulocyte/mφ	 progenitor	 (GMP),	 followed	by	 the	mφ/DC	 progenitor	 (MDP)	 that	 can	 generate	 both	 these	 populations.	 	 The	 MDP	 is	characterised	 by	 the	 expression	 of	 CX3CR1,	 CD135	 (Flt3),	 CD115	 and	 CD117,	 but	lacks	MHCII	and	lineage	markers	for	B	cells,	T	cells,	erythrocytes	and	NK	cells	(Fogg	et	 al.,	 2006).	 	 The	MDP	 then	 diverges	 to	 produce	 pro-monocytes	 (CD117-	 CX3CR1+	CD115+	 CD135-	 CD11b+	 Ly6Chi)	 or	 CD117lo	 CX3CR1+	 CD115+	 CD135+	 common	 DC	precursors	(CDP)	(Onai	et	al.,	2007)	(also	termed	pro-DC	(Naik	et	al.,	2007)),	that	can	give	rise	to	both	cDC	and	pDC.		Pro-monocytes	give	rise	to	two	subsets	of	monocytes;	Ly6Chi	 and	 Ly6Clo.	 	 It	 was	 originally	 believed	 that	 Ly6Chi	 monocytes	 were	“inflammatory”	 monocytes	 that	 gave	 rise	 to	 mφ	 in	 inflammation,	 while	 Ly6Clo	monocytes	were	thought	to	be	precursors	of	mφ	in	steady	state	tissues.		However,	it	is	now	 clear	 that	 Ly6Clo	 monocytes	 are	 derived	 from	 Ly6Chi	 monocytes	 and	 are	specialised	cells	that	persist	in	the	bloodstream	to	monitor	the	vasculature	(Yona	et	al.,	 2012).	 	 In	 addition,	 Ly6Chi	monocytes	 are	 known	 to	 give	 rise	 to	 mφ	 in	 healthy	tissues	 such	 as	 the	 gut	 (Bain	 et	 al.,	 2014;	 Tamoutounour	 et	 al.,	 2012),	 dermis	(Ginhoux	 et	 al.,	 2006)	 and	 heart	 (Heidt	 et	 al.,	 2014)	 and	 are	 now	 referred	 to	 as	“classical	 monocytes”.	 	 The	 exact	 contribution	 of	 monocytes	 to	 resident	 mφ	populations	in	different	parts	of	the	body	is	currently	controversial,	as	mφ	in	the	adult	brain	(Ajami	et	al.,	2007),	lung	(Guilliams	et	al.,	2013),	epidermis	(Hoeffel	et	al.,	2012)	
 
 
 
45 
and	 liver	 (Bain	et	al.,	2014)	are	derived	 from	self-renewal	of	embryonic	precursors	generated	in	either	the	yolk	sac	or	foetal	liver	(Yona	et	al.,	2012).			
	
Figure	1.2:	Myelopoeisis.	 	DC	progenitors	arise	from	the	bone	marrow	HSCs.		HSCs	give	 rise	 to	 CMPs	 that	 differentiate	 into	 GMPs	 or	 MDPs	 from	which	monocytes	 or	CDPs	are	derived.		Monocytes	enter	the	blood	stream	after	which	they	can	enter	the	peripheral	 tissues	and	give	 rise	 to	mature	mφ.	 	 CDPs	give	 rise	 to	a	pDC	progenitor,	which	 goes	 on	 to	 generate	 pDC,	 or	 the	 pre-DC,	 which	 can	 enter	 tissues	 and	immediately	differentiate	into	CD8+	cDC1	and	CD11b+	cDC2.	
 
 
 
46 
1.4.1 Dendritic cell ontogeny and development 
After	 differentiation	 from	 MDP,	 CDP	 lose	 the	 potential	 to	 enter	 the	 monocyte/mφ	lineage	 and	 instead	 can	 develop	 into	 either	 CD117-	 CX3CR1-	 CD135+	CD115-	 CCR9+	CD11c+	 B220+	 Ly6C+	 pDC	 or	 CD117-	 CX3CR1+	 CD135+	 CD115-	 CD11cint	 CD11b-precursors	of	conventional	DC	(pre-cDC)	(Naik	et	al.,	2007).		pDC	mature	fully	in	the	BM	before	 exiting	 into	 the	 circulation,	whereas	 pre-cDC	 leave	 the	BM	 as	 immature	cells	 and	 migrate	 in	 the	 bloodstream	 to	 peripheral	 tissues	 where	 they	 undergo	further	differentiation	 in	situ	 to	become	mature	DC	(Liu	et	al.,	2009).	 	 It	 is	not	clear	whether	 or	 not	 individual	 pre-DC	 can	 generate	 all	 mature	 DC	 subsets,	 or	 whether	there	are	pre-committed	precursors	for	each	subset.		Recent	work	has	suggested	that	the	pre-DC	population	 itself	 is	 heterogeneous	 for	 expression	of	CD24,	 and	 that	 this	might	identify	distinct	precursors	for	CD8+	and	CD11b+	DC,	suggesting	that	there	may	be	some	degree	of	lineage	commitment	before	exit	of	pre-cDC	from	the	BM	(Naik	et	al.,	2007;	2006).		It	has	also	been	suggested	that	pre-cDC	may	exhibit	some	degree	of	tissue	specificity	with	evidence	that	pre-cDC	expressing	α4β7	integrin	may	seed	the	gut	 preferentially	 (Zeng	 et	 al.,	 2012).	 	 However,	 others	 have	 proposed	 that	 these	CCR9-	B220+	CD11cint	α4β7+	DC	may	be	a	plastic	progenitor	with	some	characteristics	of	 pDC;	 but	with	 the	 potential	 to	 develop	 into	 pDC	 and	 cDC	 (Schlitzer	 et	 al.,	 2012;	2011).		
1.4.1.1 Transcriptional and Growth factors in DC development 
As	mentioned	previously,	cDC	subsets	are	under	the	control	of	specific	 factors.	 	The	cDC1	 require	 IRF8	 and	 Batf3,	 whilst	 cDC2	 require	 IRF4,	 Notch	 and	 ID2	 signalling.		However,	 prior	 to	 commitment	 to	 any	 specific	 DC	 subset,	 there	 are	 a	 number	 of	growth	factors	involved	in	the	development	of	DC.		Fms-like	tyrosine	kinase	-3	(Flt-3;	CD135)	 is	 expressed	 by	 several	 haematopoietic	 progenitors,	 but	 whereas	 others	down-regulate	 its	 expression,	 DC	 retain	 Flt3	 throughout	 their	 development	(Karsunky	et	al.,	2003;	Liu	et	al.,	2009).	 	Mice	that	lack	expression	of	Flt-3	or	ligand	(Flt3L-/-)	 have	 a	 profound	 defect	 in	 all	 tissue	 DC,	 although	 those	 that	 remain	 are	functional	(McKenna	et	al.,	2000).		Conversely,	mice	injected	with	Flt3	ligand	(Flt-3L)	have	expanded	DC	in	tissues	due	to	greater	 in	situ	proliferation	(Maraskovsky	et	al.,	1996;	Scott	et	al.,	2014a;	Waskow	et	al.,	2008).	
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Another	growth	 factor	 involved	 in	DC	development,	maturation	and	maintenance	 is	granulocyte-macrophage	colony-stimulating	factor	(GM-CSF;	CSF-2).	 	 It	was	the	first	growth	factor	used	to	generate	DC	from	mouse	BM	or	human	monocyte	precursors	in	
vitro	(Inaba	et	al.,	1992;	Sallusto	and	Lanzavecchia,	1994),	although	it	is	now	known	that	 this	 procedure	 also	 produces	mφ	 and	 other	myeloid	 cells.	 	 In	 addition	 in	 vivo	administration	of	CSF-2	or	overexpression	in	transgenic	mice	only	increases	DC	to	a	small	 extent	 (Maraskovsky	 et	 al.,	 1996;	 Vremec	 et	 al.,	 1997).	 	 Absence	 of	 CSF-2	 or	CSF-2R	 has	 little	 effect	 on	 DC	 populations	 in	 lymphoid	 tissues,	 but	 it	 leads	 to	 a	selective	 defect	 in	 CD103+CD8a+	DC	 in	 non-lymphoid	 tissue	 such	 as	 the	 lung,	 liver,	kidney	and	dermis,	as	well	as	in	CD103+CD11b+	DC	in	the	intestine	(Bogunovic	et	al.,	2009;	Greter	et	al.,	2012;	King	et	al.,	2010;	Varol	et	al.,	2009).	 	These	effects	are	not	simply	 because	 CSF-2	 directly	 induces	 the	 expression	 of	 CD103,	 but	 reflects	 a	generalised	defect	in	their	lineage	(Greter	et	al.,	2012).		Unlike	monocytes	and	mφ,	DC	are	independent	of	mφ	colony	stimulating	factor	(M-CSF;	CSF-1)	or	its	receptor	CSF-1R	(CD115),	for	their	maintenance.	
1.5 Intestinal	mononuclear	phagocytes		
Both	DC	and	mφ	are	highly	abundant	in	the	intestine,	where	they	play	important	roles	in	the	balance	between	tolerance	and	immunity.	 	DC	can	be	found	in	the	LP,	PP,	ILF	and	MLN,	 as	 well	 as	 in	 the	 LP	 and	 in	 the	 afferent	 lymph	 that	 drains	 the	 intestine	(Cerovic	et	al.,	2013).	 	Large	numbers	of	CD64+	mφ	are	also	present	throughout	the	small	 and	 large	 intestinal	 LP,	 where	 they	 are	 sessile,	 tissue	 resident	 cells.	 	 The	possibility	 that	 functionally	 distinct	DC	 subsets	 exist	 in	 the	 intestine	 has	 generated	much	 interest	 in	 recent	 years,	 and	 as	 noted	 above,	work	 in	 our	 lab	 has	 elucidated	methods	 for	 discriminating	 mucosal	 DC	 from	 mφ	 and	 for	 characterising	 the	 cells	present	within	 each	 group.	 	When	 I	 started	my	 project,	 this	 work	 had	 shown	 that	tissue	resident	mφ	expressed	high	levels	of	CD64	and	CX3CR1	and	are	derived	from	‘classical’	 Ly6Chi	 monocytes	 in	 a	 CSF-1	 dependent	 manner	 (Bain	 et	 al.,	 2012;	Tamoutounour	et	al.,	2012).		In	contrast,	CD11c+	MHCII+	DC	express	zbtb46	(zDC)	but	not	F4/80	or	CD64.		cDC	derive	from	pre-DC	and	rely	on	Flt3L	and	GM-CSF	for	their	development	as	well	as	having	a	rapid	turnover	in	vivo	of	around	6-7	days	(Bogunovic	et	al.,	2009;	Scott	et	al.,	2014a;	Varol	et	al.,	2009).				
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1.5.1 Intestinal DC subsets 
The	 conclusion	 of	 earlier	work	was	 that	 all	 intestinal	DC	 could	 be	 defined	 by	 their	expression	of	CD103	and	that	this	was	a	homogeneous	population.		However	when	it	became	possible	to	distinguish	DC	and	mφ	more	precisely,	it	was	clear	that	intestinal	CD103+	DC	were	heterogeneous	and	that	there	were	also	CD103-	subsets	of	genuine	DC.		As	a	result	the	current	view	is	that	four	subsets	of	genuine	intestinal	DC	can	be	found	 based	 on	 the	 expression	 of	 CD11b	 and	 CD103	 (TABLE	 1.2).	 	 Notably,	 these	include	substantial	numbers	of	CD103+CD11b+	DC,	not	found	in	other	tissues.	 	All	of	these	are	derived	from	pre-DC,	require	Flt3L	for	development,	migrate	constitutively	from	mucosa	to	MLN,	express	DC-specific	markers	and	genes	shown	in	Table	1.1	and	can	prime	naïve	T	cells.	
The	function	of	CD103	on	DC	is	unknown,	although	one	of	its	ligands	is	known	to	be	E-cadherin	expressed	by	intestinal	epithelial	cells.	 	This	interaction	may	be	involved	in	the	maintenance	of	CD103+	T	cells	and	DC	in	intestine	(Siddiqui	and	Powrie,	2008),			although	it	has	never	been	shown	to	influence	DC	behaviour	directly.	 	Once	believed	to	be	uniformly	tolerogenic	in	nature,	it	is	now	clear	that	all	intestinal	DC	can	induce	a	variety	of	T	cell	functions	depending	on	the	circumstances.		However,	the	exact	role	of	each	DC	subset	in	vivo	is	still	being	elucidated.	
Table	1.2:	Intestinal	DC	subsets	
MP	Subset		 Phenotype		 Location		 Growth	Factor		
	 	 	 	CD103+CD11b+		 CD11c+,	MHCII+,	F4/80-,	CX3CR1-,	SIRPα+,	XCR1-		 SI	LP	>>	CLP	 Flt3L,	CSF-2			 	 	 	CD103+CD11b-		 CD11c+,	MHCII+,	F4/80-,	CX3CR1-,	SIRPα-,	XCR1+		 SI	LP	<<	CLP	 Flt3L		 	 	 	CD103-CD11b+		 CD11c+,	MHCII+,	F4/80-,	CX3CR1+,	SIRPα+,	XCR1-		 SI	LP	<	CLP	 Flt3L		
	 	 	 	CD103-CD11b-	 CD11c+,	MHCII+,	F4/80-,	CX3CR1-,	SIRPα+/-,	XCR1-		 SI	LP	=	CLP	 Flt3L			
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1.5.1.1 CD103+ CD11b+ DC 
This	is	the	most	numerous	population	in	the	SI	and	unlike	CD103+	DC	in	other,	non-lymphoid	tissues,	these	are	CD8α- and	are	largely	unique	to	the	GI	tract	(Fujimoto	et	al.,	2011;	Sun	et	al.,	2007),	although	they	can	be	found	in	small	numbers	in	the	lung	(own	observations).		They	are	also	present	in	the	colon,	but	in	lower	numbers	than	in	the	SI	and	indeed	their	relative	frequency	decreases	progressively	going	down	the	SI	from	 duodenum	 to	 ileum	 (Denning	 et	 al.,	 2011).	 	 They	 can	 also	 be	 isolated	 from	intestinal	afferent	lymph	and	the	migratory	compartment	of	the	MLN.		As	well	as	Flt3,	CD103+CD11b+	 DC	 require	 CSF-2	 for	 their	 development	 (Bogunovic	 et	 al.,	 2009;	Greter	et	al.,	2012),	together	with	IRF4	(Persson	et	al.,	2013b),	Notch2	(Lewis	et	al.,	2011),	 IkkB	(Mancino	et	al.,	2013),	vitamin	A	(Agace	and	Persson,	2012)	and	SIRPα	(Scott	et	al.,	2014b).		Originally	held	to	be	responsible	for	induction	of	tolerance	and	Tregs	in	vivo	(Coombes	et	al.,	2007),	they	can	drive	the	generation	of	FoxP3	Tregs	in	
vitro	(Siddiqui	and	Powrie,	2008).	 	However,	 in	vivo	studies	 show	 that	mice	 lacking	CD103+CD11b+	DC	have	normal	numbers	of	Tregs	in	the	intestine,	but	have	defects	in	the	 generation	 of	 Th17	 cells	 (Welty	 et	 al.,	 2013)	 and	 in	 Th17	mediated	 responses	towards	Citrobacter	rodentium	 infection	(Denning	et	al.,	2011;	Fujimoto	et	al.,	2011;	Lewis	 et	 al.,	 2011;	 Scott	 et	 al.,	 2014b).	 	 It	 has	 been	 suggested	 that	 this	 reflects	 the	ability	of	CD103+CD11b+	DC	to	produce	IL-6	that	drives	Th17	generation	(Persson	et	al.,	 2013b).	 	 Conversely,	 it	 has	 also	 been	 reported	 that	 IRF4	 dependent	CD103+CD11b+	DC	are	required	for	the	generation	of	Th2	responses	in	the	intestine,	as	they	are	able	to	clear	Citrobacter	rodentium	infection,	but	succumb	to	Schistosoma	
mansoni	 infection	 (Tussiwand	 et	 al.,	 2015).	 	 Furthermore,	 CD103+CD11b+	 DC	 are	thought	 to	be	 responsible	 for	TLR5-mediated	 induction	of	 IgA	producing	B	cells,	 as	well	 as	 antigen	 specific	 Th17	 and	 Th1	 cells	 after	 TLR5	 stimulation	 with	 flagellin	(Cerovic	et	al.,	2013;	Uematsu	et	al.,	2008).				
1.5.1.2 CD103+ CD11b- DC 
CD103+CD11b-	DC	are	 found	in	the	SI	LP,	CLP,	PP,	 lymph	and	both	the	resident	and	migratory	compartment	of	the	MLN	(Cerovic	et	al.,	2014b;	Houston	et	al.,	2015).		DC	with	 this	 phenotype	 in	 the	 intestine	 also	 express	 CD8α,	XCR1	 and	 DNGR1,	 but	 not	SIRPα	 and	 they	 appear	 to	 be	 conventional,	 cross-presenting	DC.	 	 They	 are	 present	
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throughout	 the	 GI	 tract	 and	 their	 frequency	 is	 similar	 between	 the	 duodenum	 an	ileum.		However,	they	make	up	the	majority	of	DC	in	the	colon	(Denning	et	al.,	2011).		As	 in	other	parts	 of	 the	body,	CD103+CD11b-	DC	 in	 the	 intestine	 require	BATF3	 for	their	 development.	 	Mice	with	 a	 selective	 defect	 in	 CD103+CD11b-	DC	 have	 normal	numbers	of	Tregs	in	the	intestine,	whilst	mice	lacking	both	subsets	of	CD103+	DC	do	have	reduced	numbers	of	these	T	cells,	suggesting	that	there	is	redundancy	amongst	the	two	subsets	of	DC	(Welty	et	al.,	2013).			
1.5.1.3 CD103-CD11b+ DC 
Until	the	improved	strategies	for	characterising	intestinal	MP,	this	subset	was	usually	included	 amongst	 mφ,	 based	 on	 their	 failure	 to	 express	 CD103.	 	 This	 was	 further	complicated	 by	 the	 fact	 that	 genuine	 CD103-CD11b+	 DC	 express	 some	 CX3CR1,	 the	marker	 usually	 associated	 with	 monocytes	 and	 mφ	 (Cerovic	 et	 al.,	 2014a).	 	 The	relative	frequency	of	CD103-CD11b+	DC	increases	from	the	SI	to	the	colon	(Denning	et	al.,	2011),	but	although	it	is	clearly	similar	to	conventional	CD11b+	SIRPα+	DC	in	other	tissues,	 the	 exact	 role	 of	 this	 subset	 in	 the	 intestine	 is	 unknown,	 as	 is	 their	relationship	 to	 the	 more	 abundant	 CD103+CD11b+	 DC.	 	 They	 are	 also	 largely	unaffected	 in	CD11c-cre	 IRF4fl/fl	 and	SIRPα	mt	mice,	despite	 the	 fact	 that	 there	 is	 a	defect	in	the	conventional	CD11b+	SIRPα+	DC	subset	in	other	tissues.		This	subset	also	appears	 to	be	heterogeneous	 in	 the	 intestine,	 as	 recent	work	 in	 our	 lab	has	 shown	that	 some	 of	 them	 are	 absent	 in	 CCR2	 KO	mice	 and	 a	 proportion	 of	 them	 express	CCR2,	again	usually	thought	to	be	a	feature	of	the	monocyte/	mφ	 lineage.	 	However,	these	 CCR2	 expressing	 CD103-CD11b+	 DC	 are	 derived	 from	 Flt3	 dependent	 pre-DC	and	do	not	express	CD64	or	F4/80.	 	They	appear	 to	have	an	even	greater	ability	 to	drive	 Th17	 cell	 differentiation	 in	 vitro	 when	 compared	 to	 CCR2-CD103-CD11b+	 DC	(Scott	et	al.,	2014a).			
1.5.1.4 CD103-CD11b- DC 
This	 subset	 of	 DC	 lacks	 CD11b	 and	 CD103	 expression	 and	 is	 the	 smallest	 in	 the	intestine.	 	 Although	 they	 migrate	 to	 the	 MLN,	 their	 nature	 is	 unclear.	 	 They	 are	heterogeneous	 for	DC	markers	 such	as	SIRPα	 and	 it	 is	 thought	 that	 this	population	could	 contain	 DC	 precursors	 that	 become	 CD103+CD11b-,	 CD103-CD11b+,	 or	
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CD103+CD11b+	DC.		Their	relative	frequency	does	not	change	much	from	the	SI	to	the	colon	(Denning	et	al.,	2011).			
Although	 much	 has	 been	 learnt	 about	 intestinal	 DC	 subsets	 in	 recent	 years,	 their	biology	 is	 not	 yet	 fully	 understood.	 	 It	 is	 clear	 that	 there	 is	 a	 certain	 amount	 of	redundancy	 amongst	 the	DC	 subsets,	which	may	 account	 for	 the	 conflicting	 results	seen	in	the	literature.	 	However	unknown,	and	to	my	knowledge	unexplored,	is	why	there	 are	 CD103+CD11b+	 DC	 in	 the	 intestine	 in	 the	 first	 place	 when	 they	 are	 not	present	at	other	mucosal	and	epithelial	sites,	and	at	what	stage	in	development	they	appear.		This	becomes	the	main	focus	of	this	thesis.				
	
Figure	1.3:	Schematic	representation	of	the	LP	and	associated	lymphoid	tissue.		DC	 in	 the	 LP	 constitutively	migrate	 to	 the	MLN	via	 afferent	 lymphatics	where	 they	interact	with	T	cells	in	order	to	generate	an	effector	or	regulatory	immune	response.		CD103+CD11b+	DC,	CD103-CD11b+	DC,	CD103+CD11b-	DC,	CD103-CD11b-	DC.			
1.5.2 Functions of Intestinal DC 
The	main	 function	 of	 DC	 is	 to	 take	 up	 antigen	 and	migrate	 to	 the	 draining	 LNs	 to	present	 antigen	 to	 naïve	T	 cells.	 	 There	 are	 several	 sites	where	 antigen	 acquisition	may	 occur	 in	 the	 intestine,	 including	 via	 M	 cells	 in	 ILFs	 or	 PP.	 	 Although	 DC	 also	
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clearly	 appear	 to	 be	 loaded	 with	 intestinal	 antigen	 in	 the	 LP	 villus,	 it	 remains	unknown	how	this	occurs.		One	possibility	is	direct	access	of	soluble	antigen	across	or	between	epithelial	cells.	 	It	has	also	been	suggested	that	there	may	be	M	cells	in	the	epithelium	of	conventional	villi	in	the	SI	(Jang	et	al.,	2004).		Early	work	using	in	vivo	microscopy	 suggested	 that	 a	 population	 of	 CX3CR1+MHC	 II+	 “DC”	 could	 extend	dendrites	 across	 the	 epithelium	 to	 capture	 luminal	 bacteria	 (Chieppa	 et	 al.,	 2006;	Niess	et	al.,	2005;	Rescigno	et	al.,	2001).		However,	these	were	never	proved	to	be	DC	or	 to	present	antigen	 to	T	cells	and	even	 if	 this	phenomenon	could	be	replicated,	 it	now	seems	more	 likely	 that	mφ	were	 the	cells	 involved	 (Schulz	et	 al.,	 2009).	 	More	recent	twin-photon	microscopy	work	using	CD11c+/YFP	x	CX3CR1+/GFP	transgenic	mice,	suggested	that	goblet	cell	associated	antigen	passages	(GAPs)	could	allow	the	passage	of	soluble	dextran	and	proteins	to	underlying	DC.		However,	this	route	was	shown	to	be	 ineffective	 for	 the	 passage	 of	 particulate	 antigens	 >0.2µm	 and	 thus	 would	 be	unlikely	to	account	for	the	uptake	of	bacteria	(McDole	et	al.,	2012).		Other	work	using	twin-photon	 microscopy	 found	 no	 role	 for	 GAPs,	 but	 did	 report	 the	 presence	 of	CD103+	DC	 in	 the	 epithelia	 itself	 that	 could	 extend	 dendrites	 into	 the	 lumen	 and	sample	bacteria	(Farache	et	al.,	2013).		A	further	mechanism	that	has	been	suggested	is	that	soluble	antigens	may	be	taken	up	initially	by	CX3CR1+	mφ	before	being	passed	on	 to	 CD103+	 DC	 via	 connexin	 43+	 gap	 junctions.	 	 This	 process	 was	 shown	 to	 be	important	for	the	induction	of	oral	tolerance	to	protein	antigen	(Mazzini	et	al.,	2014).		Thus	a	number	of	routes	have	been	proposed	to	account	for	antigen	acquisition	by	DC	in	 the	LP,	but	 there	may	be	 contradictions	 and	 the	 lack	of	 reproduction	of	 some	of	these	data	mean	that	more	work	is	required	to	understand	the	exact	modus	operandi.			
As	elsewhere	in	the	body,	DC	migrate	from	the	intestine	in	a	CCR7	dependent	manner	and	this	involves	all	the	subsets	based	on	CD103	and	CD11b	(Jang	et	al.,	2006;	Worbs	et	 al.,	 2006).	 Studies	 using	 pseudo	 afferent	 lymph	 from	 mesenteric	lymphadenectomised	 mice,	 show	 that	 the	 relative	 proportions	 of	 each	 subset	 in	lymph	correspond	to	those	seen	in	mucosal	LP	and	in	the	migratory	compartment	of	MLN	(Cerovic	et	al.,	2013).		The	migration	of	intestinal	DC	in	lymph	is	a	constitutive	process,	 even	 in	 steady	 state.	 	 The	 mechanisms	 involved	 are	 unknown	 though	 it	requires	MyD88,	but	not	TLRs	and	is	intact	in	GF	mice,	although	can	be	enhanced	by	LPS	 or	 TNFα.	 	 Importantly,	 recent	 work	 in	 our	 laboratories	 has	 been	 unable	 to	
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confirm	 a	 recent	 report	 that	 CX3CR1+	 mφ	 might	 migrate	 in	 intestinal	 lymph,	 even	during	infection,	and	it	appears	that	this	study	did	not	distinguish	mφ	from	CX3CR1+	DC	properly	(Diehl	et	al.,	2013).		DC	migrating	to	the	MLN	have	been	shown	to	carry	both	 soluble	 and	 bacterial	 antigen	 (Bogunovic	 et	 al.,	 2009;	 Jaensson	 et	 al.,	 2008;	Macpherson	 and	 Uhr,	 2004)	 and	 this	 is	 essential	 for	 the	 development	 of	 both	tolerance	and	immunity	in	the	intestine,	with	oral	tolerance	to	proteins	being	entirely	dependent	on	CCR7	driven	migration	of	DC	(A.	Mowat,	2003;	Worbs	et	al.,	2006).		DC	migrating	in	lymph	do	not	go	further	than	the	MLN,	as	few	are	present	in	the	thoracic	duct	 before	 mesenteric	 lymphadenectomy	 (Cerovic	 et	 al.,	 2013),	 and	 commensal	bacteria	 that	 are	 taken	 up	 by	 intestinal	 DC	 are	 never	 found	 in	 other	 tissues	 in	 the	presence	of	intact	MLN	(Yrlid	et	al.,	2006).	
After	arrival	in	the	MLN,	a	unique	feature	of	intestinally	derived	DC	is	their	ability	to	generate	 retinoic	 acid	 (RA)	 from	 dietary	 vitamin	 A,	 inducing	 the	 expression	 of	 gut	homing	 markers	 CCR9	 and	 α4β7	 integrin	 on	 naïve	 T	 cells	 (Annacker	 et	 al.,	 2005;	Johansson-Lindbom	 et	 al.,	 2005).	 	 This	 ensures	 that	 the	 T	 cells	 primed	 in	 the	MLN	return	to	the	intestinal	mucosa	to	express	their	effector	functions	(Iwata	et	al.,	2004).		All	 intestinal	DC	express	the	Aldh1a1	and	Aldh1a2	enzymes	necessary	for	producing	RA,	although	the	CD103+	subsets	are	particularly	effective	in	this	respect	(Coombes	et	al.,	2007).	 	Firstly,	vitamin	A	 is	oxidised	to	retinaldehyde	by	ALDH	and	then	further	oxidised	to	RA	by	RALDH	(Duester,	2001;	Maden,	2002).		The	production	of	RA	by	DC	is	restricted	to	the	small	intestine	and	is	not	found	in	the	colon	or	systemic	lymphoid	organs,	 although	 a	 recent	 study	has	 suggested	 that	CD103+	 and	CD103-	DC	 subsets	from	the	lung	can	produce	RA	and	induce	T	cell	homing	to	the	intestine	(Ruane	et	al.,	2013).	 	 It	 is	unclear	whether	DC	are	 the	only	source	of	RA	 in	 the	 intestine	and	 it	 is	likely	that	epithelial	and	stromal	cells	also	produce	it.		The	only	source	of	vitamin	A	in	mammals	is	the	diet	and	it	is	delivered	to	the	mucosa	directly,	or	from	the	liver	stores	also	 shown	 to	 generate	 RA	 from	 vitamin	 A,	 with	 the	 potential	 to	 enhance	 RA	production	by	DC,	or	imprinting	gut	homing	properties	on	T	cells	(Agace	and	Persson,	2012;	Annacker	et	al.,	2005).	
Under	steady	state	conditions,	RA	 induces	 the	generation	of	FoxP3+	Treg	cells	 from	naïve	 CD4+	 T	 cells	 (Sun	 et	 al.,	 2007),	 thus	 favouring	 the	 induction	 of	 tolerance	 to	
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harmless	 antigens	 in	 the	 intestine.	 	 The	 generation	 of	 FoxP3+	 Tregs	 also	 requires	collaboration	with	TGF-β,	that	can	be	produced	by	many	cells	in	the	intestine	such	as	mφ	and	DC	themselves.		However	TGF-β	is	synthesised	in	an	inactive	form	and	must	be	cleaved	to	be	biologically	active	(Annes	et	al.,	2003).		One	molecule	that	can	do	this	is	αvβ8	 integrin,	which	 is	expressed	by	CD103+CD11b-	DC,	and	mice	 that	 lack	αvβ8	expression	 on	 CD11c+	 cells	 have	 reduced	 numbers	 of	 FoxP3	 Tregs	 and	 develop	spontaneous	inflammation.	 	Tregs	also	express	αvβ8;	when	they	lack	its	expression,	mice	succumb	to	IBD	(Travis	et	al.,	2007;	Worthington	et	al.,	2012;	2015).			
Although	 earlier	 studies	 suggested	 that	 CD103+	 DC	 had	 a	 selective	 role	 in	 the	generation	of	gut	homing	Tregs	and	 tolerance,	many	were	performed	before	 it	was	known	 that	 there	 were	 two	 subsets	 of	 intestinal	 CD103+	 DC,	 and	 the	 population	responsible	was	not	 identified.	 	As	mentioned	earlier,	Batf3-/-	mice	have	a	 selective	defect	 in	 CD103+CD11b-	 DC,	 but	 have	 normal	 numbers	 of	 FoxP3+	 Tregs	 in	 the	intestine	(Edelson	et	al.,	2010b),	as	do	mice	with	reduced	CD103+CD11b+	DC	due	to	a	mutation	 in	 SIRPα	 (Scott	 et	 al.,	 2014b).	 	 Some	 of	 these	 studies	 did	 not	 distinguish	between	thymically	derived	nTregs	(which	make	up	a	 large	proportion	of	 intestinal	Tregs	(Cebula	et	al.,	2013;	Weiss	et	al.,	2012))	and	inducible	iTregs,	which	would	be	the	 ones	 that	would	 be	 expected	 to	 require	 gut	 DC	 for	 their	 generation.	 	 However	other	 work	 in	 CD11c-cre	 IRF4fl/fl	 mice	 that	 also	 have	 a	 selective	 reduction	 in	CD103+CD11b+	DC,	found	normal	numbers	of	both	iTregs	and	nTregs	(Persson	et	al.,	2013b).	 	 Similar	 results	 were	 obtained	 in	 human-langerin	 diphtheria	 toxin	 (hu-Langerin	 DTR)	 transgenic	 mice	 that	 lack	 CD103+CD11b+	 DC,	 but	 ablation	 of	 both	CD103+	DC	 subsets	did	 lead	 to	a	 reduction	 in	both	 types	of	Tregs,	 suggesting	 there	may	be	redundancy	between	these	DC	populations	(Welty	et	al.,	2013).			
Redundancy	amongst	DC	subsets	in	their	ability	to	produce	RA	and	to	migrate	to	the	MLN	may	also	explain	the	apparently	contradictory	data	reported	by	different	groups	examining	 the	 ability	 of	 DC	 subsets	 to	 imprint	 T	 cell	 responses.	 	 Although	 the	CD103+CD11b-CD8α+	 subset	 appears	 to	 be	 the	 only	 one	 that	 can	 cross	 present	antigen	 to	 CD8+	 T	 cells	 (Cerovic	 et	 al.,	 2014b;	 Fujimoto	 et	 al.,	 2011)),	 both	CD103+CD11b+	 and	 CD103+CD11b-	 DC	 can	 drive	 IFNγ	 production	 by	 CD4+	 T	 cells	(Fujimoto	 et	 al.,	 2011).	 	Both	CD103+CD11b+	 and	CD103-CD11b+	DC	have	 also	been	
 
 
 
55 
reported	to	polarise	T	cells	towards	Th17	effector	cells	in	vitro	(Denning	et	al.,	2011;	Fujimoto	et	al.,	2011;	Lewis	et	al.,	2011;	Persson	et	al.,	2013b;	Schlitzer	et	al.,	2013).		However,	 as	 noted	 above,	 depletion	 of	 CD103+CD11b+	DC	 in	 vivo	 leads	 to	 reduced	Th17	 cells	 in	 the	 gut	 despite	 normal	 numbers	 of	 the	 other	 subsets	 (Cerovic	 et	 al.,	2013;	 Scott	 et	 al.,	 2014a).	 	 As	 the	DC	 subsets	 express	 distinct	 patterns	 of	 TLR	 and	other	 PRR,	 this	 could	 mean	 that	 the	 population	 involved	 in	 any	 response	 may	 be	dependent	 on	 the	 environment	 and	 that	 there	 is	 substantial	 plasticity	 amongst	 the	subsets.			
1.5.3 Local conditioning of intestinal dendritic cells 
While	there	has	been	one	report	that	there	may	be	distinct	pre-cDC	that	give	rise	to	intestinal	DC	(Zeng	et	al.,	2012),	it	seems	more	likely	the	unusual	properties	of	these	cells	is	due	to	local	factors	that	condition	the	local	differentiation	of	pre-DC	once	they	arrive	in	the	intestine.		There	are	a	number	of	possible	candidates	for	producing	such	effects.			
1.5.3.1 Epithelial cell derived mediators  
IECs	can	produce	several	 immunoregulatory	factors	that	can	affect	DC	development	including	thymic	stromal	lymphopoeitin	(TSLP),	TGF-β	and	prostaglandin	E2.		TSLP	is	the	 best	 studied	 of	 such	 factors	 and	 is	 expressed	 constitutively	 by	 IEC	 in	 an	NFκB	dependent	manner	and	is	further	up	regulated	in	response	to	infection,	inflammation	and	tissue	injury	(Allakhverdi	et	al.,	2007;	Bogiatzi	et	al.,	2007;	Rimoldi	et	al.,	2005).		Specific	deletion	of	NFκB	in	IEC	leads	to	dysregulation	of	cytokine	production	in	DC	leading	 to	 intestinal	 inflammation.	 	 TSLP	 has	 been	 shown	 to	 condition	 human	monocyte	 derived	 DC	 to	 drive	 Th2	 anti-inflammatory	 responses	 and	 upregulate	CD103	on	DC	which	can	then	drive	Treg	generation	in	vitro	(Iliev	et	al.,	2009a;	2009b;	Spadoni	et	al.,	2012).	 	TSLP	produced	by	Hassal’s	corpuscles	 in	the	thymus	has	also	been	suggested	to	support	the	differentiation	of	DC	that	drive	the	local	development	of	 nTregs	 (Watanabe	 et	 al.,	 2005).	 	 Furthermore,	 deletion	 of	 TSLP	 in	mice	 leads	 to	overexpression	of	IL-12/IL-23p40	in	DC	and	the	inability	to	generate	Th2	responses	against	Trichuris	muris	infection	(Zaph	et	al.,	2007).		DC	themselves	may	also	produce	TSLP	 in	 response	 to	MyD88	 signalling	 (Spadoni	 et	 al.,	 2012).	 	 Other	DC	 regulatory	
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factors	produced	by	IEC	include	TGF-β	that	conditions	intestinal	DC	to	generate	Treg	differentiation.	 	Other	cell	types	can	also	drive	the	production	of	TGF-β in	vivo,	such	as	CD4+	T	cells	and	mφ	(Fukaura	et	al.,	1996;	Gonnella	et	al.,	1998;	Weber	et	al.,	2011).					
1.5.3.2 Intestinal microbes  
Given	 the	close	proximity	of	 intestinal	DC	 to	 the	microbiota,	 it	would	seem	obvious	that	their	behaviour	might	be	influenced	by	microbial	products.		This	is	supported	by	the	 findings	 that	 commensal	 bacteria	 such	 as	 Bacteroides	 and	 Bifidobacteria	 can	induce	monocyte-derived	DC	 to	 acquire	 tolerogenic	 properties	 in	vitro	(Baba	 et	 al.,	2008).		Furthermore,	the	ability	of	polysaccharide	A	derived	from	Bacteroides	fragilis	to	promote	IL-10	producing	Tregs	in	the	colon	induces	interaction	with	CD11c+	cells	(Mazmanian	et	al.,	2005),	as	do	the	Th17	inducing	effects	of	SFB	(Ivanov	et	al.,	2009).		However	 the	 exact	 mechanisms	 by	 which	 the	 bacteria	 do	 this	 are	 unclear.	 	 The	normal	 intestine	 also	 contains	 commensal	 fungal	 populations	 and	 zymosan	 from	yeast	cell	walls	can	induce	both	IL-10	production	and	Aldh1a2	expression	in	DC	that	then	 favour	 the	generation	of	FoxP3+	Treg	cells.	 	These	effects	are	TLR2	and	 the	C-type	 lectin,	 dectin-1	 dependent	 (Dillon	 et	 al.,	 2006).	 	 MyD88	 dependent	 TLR1	 and	TLR2	signals	are	required	for	RA	synthesis,	suggesting	that	ligation	of	these	receptors	by	the	microbiota	may	be	at	least	partly	responsible	for	the	ability	of	DC	to	produce	RA	and	the	resultant	imprinting	of	gut	homing	T	cells	(Wang	et	al.,	2011).			
Despite	 these	clues,	 the	role	of	 the	microbiota	on	the	development	and	 functions	of	intestinal	 DC	 remains	 to	 be	 elucidated	 in	 full	 and	 has	 not	 been	 studied	 using	 the	recently	improved	means	of	analysing	these	cells.		In	this	thesis	I	therefore	explored	the	effects	of	antibiotics	and	a	germ	free	environment	on	DC	in	the	intestine.	
1.5.3.3 Dietary constituents 
DC	 in	 the	 intestine	 are	 constantly	 encountering	 dietary	 constituents	 and	 some	 of	these	may	play	a	role	in	the	conditioning	of	local	DC.		Most	studied	is	vitamin	A,	which	is	 acquired	 purely	 via	 the	 diet	 in	 mammals.	 	 As	 well	 as	 being	 important	 for	 the	characteristic	effector	functions	of	intestinal	DC,	RA	also	conditions	their	properties.		A	vitamin	A	deficient	diet	leads	to	reduced	numbers	of	CD103+CD11b+	DC	in	the	SI	LP,	
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and	 the	 remaining	 CD103+	 DC	 are	 impaired	 in	 their	 ability	 to	 generate	 Tregs	 and	imprint	gut	homing	T	cells	in	the	MLN	(Klebanoff	et	al.,	2013).		The	source	of	RA	may	be	DC	themselves,	or	epithelial	and	stromal	cells	(Agace	and	Persson,	2012)	although	it	 has	 also	 been	 shown	 that	 bile	 is	 a	 source	 of	 retinol	 that	 induces	 RA	 receptor-dependent	 retinol	 metabolising	 activity	 in	 CD103+	 DC	 (Jaensson-Gyllenbäck	 et	 al.,	2011).	 	 This	 imprinting	 of	 CD103+	 DC	 in	 the	 SI	 may	 explain	 the	 fact	 that	CD103+CD11b+	DC	are	more	frequent	in	the	duodenum.		
1.5.3.4 Neuroendocrine pathways 
The	GI	 tract	 is	highly	 innervated	and	produces	 large	 amounts	of	neurotransmitters	that	 are	 essential	 for	 physiological	 functions	 of	 the	 intestine	 such	 as	 peristalsis,	digestion,	fluid	secretion	and	appetite	control.		Many	immune	cells	express	high	levels	of	 receptors	 for	 neurotransmitters,	 and	 the	 best	 described	 neural	 regulator	 of	immune	 function	 is	vasoactive	 intestinal	peptide	 (VIP).	 	 It	 is	produced	by	 intestinal	enteroendocrine	 cells,	 where	 it	 acts	 as	 a	 vasodilator	 and	 regulator	 of	 epithelial	permeability	(Bellinger	et	al.,	1996).		VIP	has	potent	anti-inflammatory	effects	in	the	immune	system	and	has	been	shown	to	inhibit	mφ	function	as	well	as	DC	maturation	and	migration	via	an	ability	 to	suppress	LPS-induced	CCR7	expression	(Weng	et	al.,	2007).	 	VIP	can	also	 induce	 the	differentiation	of	 IL-10	and	TGF-β	producing	Tregs,	and	 they	 promote	 the	 induction	 of	 tolerance	 rather	 than	 active	 immunity	 in	 the	intestine	(Gonzalez	Rey	and	M.	Delgado,	2006).			
1.6 Triggering	receptor	on	myeloid	cells	–	1	(Trem-1)	
Triggering	 receptor	 on	 myeloid	 cells	 –	 1	 (Trem-1)	 is	 one	 of	 a	 number	 of	 innate	immune	receptors	of	 the	Trem	and	Trem-like	 family	 that	are	 thought	 to	amplify	or	dampen	TLR	signals	in	neutrophils,	monocytes,	mφ,	DC,	osteoclasts	and	microglia.			
1.6.1 The Trem family 
All	the	proteins	of	the	Trem	family	are	structurally	related	and	are	found	on	mouse	chromosome	 17C	 and	 human	 chromosome	 6p21.1	 (Ford	 and	McVicar,	 2009).	 	 The	Trem	 genes	 encode	 mRNA	 for	 Trem-1,	 Trem-2	 and	 Trem-3	 (mouse	 only)	 surface	
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proteins,	along	with	the	Trem-like	family	genes	for	Trem-like	transcript	(TLT)	-1	and	TLT-2.	 	 They	 are	 all	 members	 of	 the	 immunoglobulin	 superfamily	 and	 are	 highly	conserved	 throughout	 vertebrate	 evolution	 (Klesney-Tait	 et	 al.,	 2006).	 	 Trem-1,	Trem-2	 and	 Trem-3	 all	 associate	with	 the	DAP12	 adaptor	 protein	 that	 contains	 an	immunoreceptor	tyrosine-based	activation	motif	(ITAM)	which	is	phosphorylated	by	Src	 kinases	 on	 ligation	 of	 Trem-1	 leading	 to	 downstream	 signalling	 via	 the	 protein	tyrosine	 kinase	 Syk.	 	 TLT-1	 does	 not	 associate	 with	 DAP12	 and	 instead	 has	 a	cytoplasmic	domain	containing	ITIMs,	which	recruit	SHP-1,	and	SHP-2	phosphatases.			
Trem-1	is	the	best	characterised	of	the	Trem	and	Trem-like	family,	and	consists	of	an	extracellular	 Ig	 V-type	 domain,	 a	 transmembrane	 region	 and	 a	 short	 cytoplasmic	portion	 involved	 in	 the	 recruitment	 of	 DAP12.	 	 Trem-1	 is	 an	 amplifier	 of	inflammatory	 responses,	 increasing	 the	 levels	 of	 cytokines	 produced	 after	 TLR	signalling	(Bouchon	et	al.,	2000;	2001)	and	expression	is	upregulated	in	response	to	LPS	 (Dower	 et	 al.,	 2008).	 	 Ligation	 of	 Trem-1	 leads	 to	 increased	 inflammatory	responses	 during	 sepsis	 and	 these	 effects	 can	 be	 reduced	 by	 treatment	 with	 an	inhibitory	peptide	of	Trem-1	(Bouchon	et	al.,	2001;	Gibot	et	al.,	2004).		As	a	result	it	is	thought	 that	 Trem-1	 may	 reduce	 the	 threshold	 at	 which	 microbial	 threats	 are	detected.		Trem-1	is	expressed	by	blood	neutrophils	and	monocytes,	but	it	decreases	with	maturation	of	monocytes	and	mφ	(Bouchon	et	al.,	2001;	2000).		
Unlike	Trem-1,	Trem-2	has	been	proposed	to	be	a	negative	regulator	of	inflammation.		Initial	 experiments	 showed	 that	 Trem-2	 ligation	 could	 suppress	 TNFα	 and	 IL-6	production	 by	 mφ	 (Turnbull	 et	 al.,	 2006),	 and	 subsequent	 work	 indicated	 that	blockade	of	Trem-2	led	to	more	severe	experimental	autoimmune	encephalomyelitis	(EAE),	a	mouse	model	 for	multiple	sclerosis	(Piccio	et	al.,	2007).	 	Trem-2	also	has	a	role	 in	 osteoclastogenesis,	 as	 evidenced	 by	 the	 bone	 cysts	 seen	 in	 Nasu-Hakola	disease,	which	is	due	to	a	loss	of	function	mutation	in	DAP12	or	Trem-2	(Klesney-Tait	et	al.,	2006).	 	There	is	little	known	about	Trem-3	and	its	functions,	as	its	expression	has	only	been	observed	at	the	transcript	level	in	mouse	mφ	cell	lines.		In	humans	it	is	a	 pseudogene	 (Ford	 and	 McVicar,	 2009).	 	 TLT-1	 and	 TLT-2	 promote	 cellular	activation	but	do	not	associate	with	DAP12.	 	TLT-1	can	prevent	platelet	aggregation	(Ford	 and	 McVicar,	 2009)	 whereas	 TLT-2	 has	 more	 widespread	 effects	 being	
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expressed	on	T-	and	B-	lymphocytes	as	well	as	myeloid	cells	and	has	been	shown	to	enhance	CD3-mediated,	IL-2	and	IFNγ	production	by	T	cells	(Hashiguchi	et	al.,	2008).			
Most	of	the	Trem	family	members	bind	bacterial	components	directly	(Cannon	et	al.,	2012),	 but	 the	 ligand	 for	 Trem-1	 has	 been	 unclear	 until	 recently	 when	 it	 was	suggested	 that	 neutrophil	 peptidoglycan	 recognition	 protein	 1	 (PGLYRP1)	 may	 be	involved	(Read	et	al.,	2015).		Peptidoglycan	(PGN)	is	a	macromolecular	component	of	the	 bacterial	 cell	 wall	 and	 binds	 to	 PGLYRP1	 found	 in	 the	 tertiary	 granules	 of	neutrophils,	where	 it	 induces	production	of	 reactive	oxygen	species	 (Dziarski	et	al.,	2003).	 	Although	PGN	can	also	be	sensed	by	TLR2	and	NOD1/2,	 it	 is	proposed	 that	Trem-1	mediated	recognition	of	 the	PGLYRP1:PGN	complex	released	by	neutrophils	may	be	an	important	mechanism	of	PGN	sensing	by	myeloid	cells	(Read	et	al.,	2015).		The	 role	 of	 Trem-1	 in	 DC	 is	 largely	 unknown,	 although	 it	 has	 been	 shown	 to	 be	upregulated	on	monocyte	derived	DC	when	 they	are	exposed	 to	hypoxic	 conditions	(Bosco	et	al.,	2010).	
1.6.2 Trem-1 in the intestine 
Trem-1	has	been	examined	 in	 the	 intestine	mostly	 in	 the	context	of	monocytes	and	macrophages,	 although	 early	 studies	 suggested	 that	 it	 was	 not	 expressed	 by	 these	cells	 in	 steady	 state	 (Schenk	 et	 al.,	 2005).	 	 It	was	postulated	 that	 this	might	 reflect	down-regulation	 of	 Trem-1	 by	 local	 IL-10	 and	 TGF-β	 thus	 helping	 to	 prevent	overactive	 responses	 to	 bacterial	 PAMPs (Schenk	 et	 al.,	 2005).	 	 However,	 it	 is	important	to	note	that	these	experiments	failed	to	find	monocytes	and	early	stage	mφ	now	 known	 to	 be	 present	 in	 the	 healthy	 intestine,	 and	 the	 cells	 that	 might	 be	expected	 to	 respond	 to	 bacteria.	 	 Indeed,	 increased	Trem-1+	mφ	were	 found	 in	 the	mucosa	of	patients	with	IBD	and	during	experimental	colitis	in	mice.		Treatment	with	the	antagonistic	blocking	peptide	based	on	the	extracellular	domain	of	Trem-1,	led	to	reduced	levels	of	serum	TNF	and	to	less	intense	intestinal	pathology	in	experimental	colitis	 (Schenk	 et	 al.,	 2007).	 	 More	 recent	 work	 reported	 that	 Trem1-/-	 mice	 were	normal	 under	 homeostatic	 conditions,	 but	 they	 were	 resistant	 to	 dextran	 sodium	sulphate	 (DSS)	 colitis	 and	 had	 attenuated	 disease	 (Weber	 et	 al.,	 2014),	 although	 it	was	not	clear	whether	this	reflected	the	absence	of	Trem-1	on	mφ	or	neutrophils.		The	
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expression	and	role	of	Trem-1	in	intestinal	DC	has	not	been	investigated	and	this	was	one	aim	of	my	thesis.	
1.7 Thesis	aims	
Dendritic	 cells	 are	 crucial	 for	 determining	whether	 active	 immunity	 or	 tolerance	 is	generated	 in	 the	 intestine.	 	Recent	work	has	established	methods	 for	characterising	mucosal	 DC	 precisely	 and	 has	 revealed	 unusual	 properties	 and	 heterogeneity	amongst	these	cells.		However	much	remains	to	be	learnt	about	the	specific	functions	of	the	various	DC	subsets	found	in	the	intestine,	as	well	as	of	the	factors	controlling	their	development	in	early	life.			
The	overall	goal	of	this	thesis	was	to	explore	the	processes	that	might	be	involved	in	the	development	of	 intestinal	DC	under	steady	state	conditions.	To	achieve	this,	my	first	 specific	 aim	was	 to	 describe	 the	 dynamics	 of	 intestinal	 DC	 development	 from	birth	 onwards	 and	 then	 to	 investigate	 the	 role	 of	 SIRPα	 in	 determining	 DC	 subset	development.	 	Next,	 I	 aimed	 to	 identify	markers	 that	were	 specific	 to	 the	 intestine-restricted	subset	of	CD103+CD11b+	DC	and	use	them	to	interrogate	the	development	of	this	population	in	greater	depth	in	wild	type	mice.	Lastly,	I	aimed	to	exploit	these	insights	to	investigate	the	role	of	different	molecular	mechanisms,	and	the	microbiota	in	shaping	intestinal	DC	population	development.			
In	Chapter	3,	I	introduced	the	DC	subsets,	and	showed	that	intestinal	CD103+CD11b+	DC	are	reduced	in	adult	SIRPα	mt	mice	but	not	in	bone	marrow	chimeric	mice.		I	went	on	to	test	the	hypothesis	that	the	defect	seen	in	adult	SIRPα	mt	mice	was	related	to	their	age.		This	showed	a	greater	defect	in	four-week	old	mice,	which	led	me	to	carry	out	 a	more	detailed	 analysis	 of	 how	 intestinal	DC	 subsets	 changed	 from	birth	until	adult	life	in	Chapter	4.			I	established	CD101	and	Trem-1	as	markers	for	dissecting	the	differentiation	of	CD103+CD11b+	DC	in	more	detail.	 	 I	 then	used	these	to	extend	my	analysis	of	DC	development	from	birth	onwards.		From	these	findings,	I	predicted	that	intestinal	DC	function	developed	with	age,	which	I	showed	by	using	RA	metabolism	as	a	readout.	 	Lastly,	in	Chapter	5	I	explored	some	of	the	factors	that	might	control	the	development	of	intestinal	DC,	examining	how	the	expression	of	transcription	factors	and	 growth	 factor	 receptors	 changed.	 	 I	 then	 exploited	 Trem-1	 and	 CD101	 to	
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investigate	how	SIPRα,	CCR2	and	the	microbiota	influenced	the	appearance	of	the	DC	subsets.			
 	
	
	
	
	
2 Chapter	2	
Materials	and	Methods	
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2.1 Mice	
All	mice	were	maintained	under	specific	pathogen	free	(SPF)	conditions	at	the	Central	Research	 Facility	 (CRF)	 or	 the	 Veterinary	 Research	 Facility	 (VRF),	 University	 of	Glasgow.	They	were	used	between	6	and	12	weeks	of	age,	unless	otherwise	specified.		Table	2.1	details	the	mouse	strains	used	throughout	these	studies.		All	strains	were	on	the	C57/Bl6	background	and	were	CD45.2+	unless	 stated	otherwise.	All	procedures	were	carried	out	in	accordance	with	UK	Home	Office	regulations.			
Table 2.1: Mice Strains 
Strain Source 
C57Bl/6	 Harlan	Olac	(Bicester,	Oxfordshire)	C57Bl/6.SJL	(CD45.1+)	 Kindly	provided	by	Prof.	W.	Agace	(Lund	University,	Sweden)	CD45.1+/CD45.2+	 Generated	by	crossing	C57Bl/6	with	C57Bl/6.SJL		SIRPα	Mutant	 Provided	by	Prof.	P.A.	Oldenburg	(Umeå	University,	Sweden)	 with	 kind	 permission	 from	 Prof.	 T.	Matozaki	 (University	 of	 Tokyo,	 Japan)	 (Inagaki,	Yamao	et	al.	2000)	CCR2-/-		 Kindly	 provided	 by	 Prof.	 Robert	 Nibbs	 (University	of	 Glasgow)	 (“Impaired	 monocyte	 migration	 and	reduced	 type	 1	 (Th1)	 cytokine	 responses	 in	 C-C	chemokine	receptor	2	knockout	mice.,”	1997)		Trem-1-/-	 Bones	kindly	sent	by	Prof.	C.	Mueller	(University	of	Bern,	Switzerland)	
Germ	Free	C57Bl/6	 Kindly	 allowed	 to	perform	experiments	with	Dr.	 L.	Hall	(University	of	East	Anglia,	Norwich,	UK)	
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2.1.1 Treatment of mice with antibiotics 
Mice	 received	 1	mg/ml	 Cefoxitin	 (Santa	 Cruz	 Biotechnology),	 1	mg/ml	 Gentamicin	(Sigma),	 1	 mg/ml	 Metronidazol	 (Roche),	 and	 1	 mg/ml	 Vancomycin	 (Hospira,	 UK	Limited)	 in	 their	drinking	water,	with	 the	addition	of	artificial	 sweetener	 (Sweetex,	Reckitt	Benckiser	Household,	UK)	 for	 two	weeks.	 	Control	mice	 received	sweetener	only	 for	 two	 weeks.	 	 Antibiotic	 solutions	 were	 made	 up	 on	 the	 day	 of	 issue	 and	replaced	every	two	days.		Mice	weights	were	recorded	everyday.			
2.1.2 Analysis of germ free mice 
All	experiments	done	on	germ	free	(GF)	mice	were	performed	in	Dr	Lindsay	Hall’s	lab	at	the	Institute	of	Food	Research,	University	of	East	Anglia,	Norwich,	UK.	In	order	to	assess	the	GF	status,	in-house	testing	of	ceacal	contents	from	GF	mice	was	carried	out.		FACS	analysis	was	using	a	BD	FACSAria	II	(BD	Biosciences). 
2.2 Genotyping	Mice	
2.2.1 Genomic DNA Isolation 
Tail	 tips	 from	SIRPα	mutant	(mt)	and	CD47KO	mice	were	stored	at	 -20°C	until	use.	DNA	 was	 isolated	 using	 the	 DNeasy	 Blood	 and	 Tissue	 Kit	 (Qiagen)	 as	 per	 the	manufacturer’s	 guidelines.	 	 Briefly,	 25mg	 of	 each	 tail	 tip	was	 digested	 overnight	 at	56°C	with	Proteinase	K.		The	following	day,	DNA	was	purified	by	binding	to	the	spin	column	 membrane	 provided,	 washed	 and	 eluted	 in	 the	 elution	 buffer	 supplied.	Genomic	DNA	was	frozen	and	stored	at	-20°C	until	needed.	
2.2.2 Genotyping 
DNA	 from	 tail	 tips	 was	 diluted	 1:2	 prior	 to	 polymerase	 chain	 reaction	 (PCR)	 and	analysed	using	the	primers	(Integrated	DNA	Technologies,	IDT)	detailed	in	Table	2.2.		Each	PCR	mixture	had	a	final	volume	of	20µl,	containing	1µl	of	diluted	genomic	DNA,	0.2µl	each	of	10µM	sense	and	anti-sense	primers,	0.4µl	of	10µM	dNTPs	(25mM),	0.1µl	of	5U/ml	Go	Taq	polymerase,	4µl	of	5X	reaction	buffer	and	14.1µl	nuclease	free	water	(all	Life	Technologies,	Paisley,	UK).	The	PCR	entailed	one	cycle	of	5	minutes	at	95°C,	
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thirty-five	cycles	of	1	minute	at	95°C,	annealing	at	58	oC	and	elongation	at	72°C	for	2	minutes,	followed	by	one	more	cycle	of	elongation	at	72°C	for	10	minutes.			The	 products	 of	 the	 PCR	 were	 visualised	 by	 electrophoresis	 on	 a	 2%	 agarose	 gel	(Sigma-Aldrich,	Poole,	UK)	in	1X	TAE	with	5µl	ethidium	bromide	(Life	Technologies)	per	 100ml	 gel.	 10µl	 of	 the	 PCR	 reaction,	 along	 with	 2µl	 of	 6X	 loading	 dye	 (Life	Technologies)	were	 loaded	onto	 the	gel	with	5µl	of	DNA	 ladder	 (Life	Technologies)	and	 1µl	 of	 6X	 loading	 dye.	 Gels	 were	 run	 in	 1X	 TAE	 for	 approximately	 1	 hour	 at	100mV,	before	being	visualised	under	a	UV	light.	
Table 2.2 Primers for Genotyping 
 
2.3 Isolation	of	Leukocytes	from	Tissues	
2.3.1 Intestinal Lamina Propria Cells 
The	small	intestines	(SI)	from	adult	mice	were	excised	and	soaked	in	PBS	(Gibco,	Life	Technologies).	After	removal	of	Peyer’s	patches	and	 fat,	 the	 intestines	were	opened	longitudinally.	Faeces	were	 removed	by	washing	 in	calcium/magnesium	 free	 (CMF)	Hank’s	balanced	salt	solution	(HBSS;	Gibco)	supplemented	with	2%	foetal	calf	serum	(FCS;	Gibco)	and	the	intestines	were	cut	into	approximately	0.5cm	segments.		Tissues	were	 shaken	 in	 HBSS/2%	 FCS	 and	 supernatant	 removed	 by	 passing	 tissue	 and	supernatant	 through	 Nitex	 mesh	 (Cadisch	 and	 Sons,	 London,	 UK)	 followed	 by	collection	 of	 the	 tissue	 sections	 remaining	 on	 the	mesh.	 	 To	 remove	 the	 epithelial	layer,	 tissues	 were	 incubated	 at	 37°C	 whilst	 shaking	 in	 10ml	 pre-warmed	 HBSS	supplemented	with	2mM	EDTA	(Sigma-Aldrich,	Poole,	UK)	for	20	minutes.	The	tubes	were	 shaken	 again,	 supernatants	 discarded	 and	 the	 tissues	washed	 in	 pre-warmed	
Gene Sense Antisense 	
Sirpa	wt	
	ATACCATTGGCTGAGCCCACTGGGAAAGAA	
	TAGTACAGACCACAGCCCCATTCACTTCCT	
	
Sirpa	mt	
	TCGTGCTTTACGGTATCGCCGCTCCCGAAT		
	TAGTACAGACCACAGCCCCATTCACTTCCT	
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HBSS	 before	 a	 second	 incubation	 in	 HBSS/2mM	 EDTA	 for	 a	 further	 20	 minutes.	Following	 a	 repeat	 of	 the	 wash	 step,	 the	 tissues	 were	 digested	 with	 1mg/ml	collagenase	VIII	(Sigma)	in	10ml	pre-warmed	complete	RPMI	(RPMI	1640	containing	50mM	 2-β-mercaptethanol,	 2mM	 L-glutamine,	 100µg/ml	 penicillin,	 100µg/ml	streptomycin,	1.25µg/ml	Fungizone,	 and	10%	FCS;	all	Gibco)	by	 incubation	at	37°C	with	shaking	for	20-30	minutes.	The	tubes	were	shaken	vigorously	every	5	minutes	to	 increase	 digestion.	 Following	 this,	 the	 cell	 suspensions	were	 passed	 through	 an	100µm	filter	(BD	Falcon),	followed	by	a	40µm	filter	(BD	Falcon),	then	washed	twice	in	 complete	RPMI	 to	 remove	 any	 residual	 enzyme,	 resuspended	 in	 complete	RPMI,	counted	and	kept	on	ice	until	use.		Absolute	numbers	were	calculated	by	multiplying	the	cell	count	by	the	percentage	population	of	interest,	as	a	proportion	of	live	cells.			Adult	 colonic	 LP	 (CLP)	 cells	were	 isolated	 in	 a	 similar	 fashion,	 except	 that	 the	 two	HBSS/2mM	EDTA	incubations	were	performed	for	15	minutes	and	30	minutes,	while	digestion	was	carried	out	for	30-45	minutes	using	0.625mg/ml	collagenase	D	(Roche;	Roche	Diagnostics	GmbH,	Mannheim,	Germany),	0.425mg/ml	collagenase	V	(Sigma),	1mg/ml	dispase	(Gibco),	and	30U/ml	DNase	(Roche)	diluted	in	complete	RPMI.		Neonatal	 intestines	were	treated	in	the	same	manner,	except	that	 it	was	not	always	possible	to	open	the	intestine	longitudinally,	or	remove	the	Peyer’s	patches;	digestion	times	 were	 also	 reduced	 and	 were	 determined	 by	 continuous	 observation	 of	 how	much	intact	tissue	remained	in	the	digest	mix.	
2.3.2 Lymph Node and Spleen Cells 
Lymph	nodes	and/or	spleens	were	excised	 from	mice	and	 fat	 removed.	The	 tissues	were	washed	 in	HBSS	and	 cut	 into	 small	pieces.	When	 lymphocytes	were	 required,	the	tissues	were	mashed	through	an	100mm	filter	in	complete	RPMI,	counted	and	left	on	 ice	 until	 use.	 To	 isolate	 DC,	 tissues	 were	 digested	 by	 incubating	 at	 37°C	 with	shaking	in	HBSS	supplemented	with	1mg/ml	collagenase	D	for	40	minutes.	After	the	digestion,	 cell	 suspensions	were	 passed	 through	 an	 100mm	 filter,	washed	 twice	 in	complete	 RPMI	 to	 remove	 any	 residual	 enzyme,	 resuspended	 in	 complete	 RPMI,	counted	and	left	on	ice	until	use.	Red	blood	cells	in	spleen	preparations	were	lysed	by	incubation	 for	 6	 minutes	 on	 ice	 with	 ammonium	 chloride/EDTA	 solution	 (0.8%	
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NH4Cl/0.1mM	EDTA,	Stem	Cell	Technologies,	Grenoble,	France)	prior	to	resuspension	in	complete	RPMI	and	counting.	
2.3.3 Liver Leukocytes 
CO2-euthanised	mice	were	 perfused	 by	 intra-cardiac	 injection	 of	 10ml	 PBS	 and	 the	livers	 were	 removed.	 They	were	 then	 cut	 into	 small	 pieces	 (<2mm)	 and	 placed	 in	HBSS	supplemented	with	2%	FCS.	Tissues	were	shaken	vigorously	 in	HBSS/2%	FCS	and	the	supernatant	removed	by	pouring	through	Nitex	mesh.	The	 livers	were	then	digested	 in	 complete	 RPMI	 supplemented	 with	 an	 enzyme	 cocktail	 containing	0.75mg/ml	collagenase	D,	0.425mg/ml	collagenase	V,	1mg/ml	dispase,	 and	30U/ml	DNase	at	37oC	with	shaking	for	20	minutes.	After	digestion,	the	cell	suspensions	were	passed	 through	 a	 40µm	 filter,	 washed	 twice	 in	 complete	 RPMI	 to	 remove	 residual	enzymes	 and	 red	 blood	 cells	 were	 lysed	 by	 incubation	 for	 6	 minutes	 on	 ice	 with	ammonium	 chloride/EDTA	 solution,	 before	 being	 resuspended	 in	 complete	 RPMI,	counted	and	kept	on	ice	until	use.	
2.3.4 Lung Leukocytes 
CO2-euthanised	mice	were	 perfused	 by	 intra-cardiac	 injection	 of	 10ml	 PBS	 and	 the	lungs	were	 excised.	These	were	 then	 cut	 into	 small	 pieces	 (<2mm)	and	digested	 in	complete	 RPMI	 supplemented	 with	 an	 enzyme	 cocktail	 containing	 0.625mg/ml	collagenase	 D	 (Roche;	 Roche	 Diagnostics	 GmbH,	 Mannheim,	 Germany),	 0.45mg/ml	collagenase	V	(Sigma),	1mg/ml	dispase	(Gibco),	and	30U/ml	DNase	(Roche)	at	37oC	with	shaking	 for	45	minutes.	Following	digestion,	 the	cell	 suspensions	were	passed	through	 a	 40µm	 filter,	 washed	 twice	 in	 complete	 RPMI	 to	 remove	 any	 residual	enzyme,	 and	 red	 blood	 cells	 were	 lysed	 by	 incubation	 for	 6	 minutes	 on	 ice	 with	ammonium	 chloride/EDTA	 solution	 before	 being	 resuspended	 in	 complete	 RPMI,	counted	and	kept	on	 ice	until	use.	 	The	same	protocol	was	used	 for	 the	 isolation	of	leucocytes	from	the	kidney	and	heart.			
2.3.5 Peripheral Blood Leukocytes 
Whole	blood	was	obtained	from	mice	by	cardiac	puncture	and	collected	into	heparin.	Red	 blood	 cells	 (RBCs)	 were	 lysed	 by	 incubating	 on	 ice	 with	 ammonium	
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chloride/EDTA	solution	for	10	minutes	and	washed	twice	in	PBS.		Cells	were	counted	and	left	on	ice	until	use.		
2.3.6 Bone Marrow Cells 
Femurs	 and	 tibiae	were	 isolated	 from	mice	 and	 the	 bone	marrow	was	 flushed	 out	using	RPMI	1640	and	filtered	through	Nitex.		For	flow	cytometric	analysis,	RBCs	were	lysed	 and	 the	 cells	were	washed	 twice	 in	 FACS	 buffer	 (PBS/2%	FCS/	 2mM	EDTA).		Cells	were	then	counted	and	left	on	ice	until	required.		
2.4 Flow	Cytometry	
2.4.1 Cell Surface Staining 
Freshly	 isolated	 cells	 were	 resuspended	 in	 FACS	 buffer	 and	 2.5-5x106	 cells	 were	added	to	12x75mm	polystyrene	tubes	(BD	Falcon).	Non-specific	binding	of	antibodies	to	Fc	receptors	was	prevented	by	incubation	of	cells	with	anti-CD16/CD32	(‘Fc	Block’;	BD	Biosciences)	at	4°C	for	10-20	minutes.	Cells	were	then	washed	in	FACS	buffer	and	incubated	with	the	required	antibodies	or	isotype	controls	(Table	2.4)	at	a	dilution	of	1:200	unless	 otherwise	 specified	by	 the	manufacturer	 at	 4°C	 for	 20	minutes.	 	 Cells	were	then	washed	and	if	biotinylated	antibodies	had	been	used,	were	incubated	with	streptavidin	conjugates	at	4°C	for	a	 further	20	minutes	and	washed	once	more.	 Just	prior	to	analysis,	15µl	of	7-aminoactinomycin	D	(7-AAD;	Biolegend)	was	added	to	the	cells	to	allow	dead	cell	discrimination.	Cells	were	acquired	on	BD	LSRII,	BD	FACSAriaI	or	 BD	 FACSAriaIII	 flow	 cytometers	 with	 Diva	 software	 and	 analysed	 using	 FlowJo	Software	(Treestar	Inc.,	USA).	
2.4.2 Intracellular Staining 
When	 staining	 for	 intracellular	 cytokines	 or	 transcription	 factors,	 the	 staining	protocol	was	 adapted	 slightly	 to	 be	 compatible	with	 the	 fixable	 dead	 cell	 exclusion	dyes	 used.	 	 4x106	 cells	 were	 incubated	 in	 complete	 RPMI	 for	 4.5	 hrs	 in	 5ml	polystyrene	 tubes	 in	 the	 presence	 of	 phorbol	 12-myristate	 13-acetate	 (PMA)	 and	ionomycin	(Cell	stimulation	cocktail	plus	protein	transport	inhibitors,	eBioscience)	to	restimulate	the	cells.		After	culture,	the	cells	were	washed	in	PBS	and	then	incubated	
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for	20	minutes	protected	 from	 light	at	4oC	with	LIVE/DEAD®	fixable	dead	cell	 stain	(eBioscience)	as	per	the	manufacturer's	guidelines.	Cells	were	then	washed	in	FACS	buffer,	 incubated	 with	 purified	 anti-CD16/CD32	 and	 stained	 with	 the	 appropriate	antibodies	 for	 cell	 surface	 antigens	 as	 described	 above,	 before	 being	washed	 three	times	in	FACS	buffer.	After	being	fixed	and	permeabilised	using	the	eBioscience	Flow	Kit	 according	 to	 manufacturer’s	 instructions,	 the	 cells	 were	 then	 incubated	 with	purified	 anti	 CD16/CD32	 and	 stained	 with	 antibodies	 to	 stain	 for	 intracellular	cytokines	 or	 transcription	 factors	 in	 permeabilisation	 buffer	 for	 20	 mins	 at	 4oC	protected	from	light.	They	were	then	washed	in	permeabilisation	buffer,	resuspended	in	FACS	buffer	and	analysed	by	flow	cytometry	as	described	above.	
2.4.3 Fluorescence Activated Cell Sorting 
Cells	were	prepared	for	FACS	as	described	above	but	under	sterile	conditions,	before	being	sorted	using	a	BD	FACSAria	I	or	BD	FACSAria	III	cell	sorter	and	were	typically	94-99%	pure.		
2.4.4 Aldefluor assay 
Aldehyde	dehydrogenase	 activity	was	 assessed	using	 the	 aldefluorTM	kit,	 as	per	 the	manufacturer’s	instructions	(Stemcell	Technologies,	Manchester,	UK).		The	cells	were	digested	as	 explained	above	and	 then	 incubated	with	 the	 aldefluorTM	 reagent	or	 its	inhibitor	diethylaminobenzaldehyde	(DEAB).		Cells	were	then	washed	and	stained	for	flow	cytometry.		
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Table 2.3: Antibodies and Isotype Controls 
  
Antibody Clone Isotype Source B220	 RA3-6B2	 Rat	IgG2a	 Biolegend	CCR2	 475301	 Rat	IgG2b	 R	&	D	Systems	CD3	 145-2C11	 Hamster	IgG	 Biolegend	CD4	 GK1.5	 Rat	IgG2b	 Biolegend	CD8	 53-6.7	 Rat	IgG2a	 Biolegend	CD11b	 M1/70	 Rat	IgG2b	 Biolegend	CD11c	 HL3	 Hamster	IgG1	 BD	Biosciences	CD11c	 N418	 Hamster	IgG	 Biolegend	CD19	 1D3	 Rat	IgG2a	 BD	Biosciences	CD45	 30-F11	 Rat	IgG2b	 Biolegend	CD45.1	 A20	 Mouse	IgG2a	 Biolegend	CD45.2	 104	 Mouse	IgG2a	 Biolegend	CD64	 X54-5/7.1	 Mouse	IgG1	 Biolegend	CD101	 Moushi101	 Rat	IgG2a	 eBioscience	CD103	 M2/90	 Rat	IgG2a	 BD	Biosciences	CD103	 2E7	 Hamster	IgG	 Biolegend	F4/80	 BM8	 Rat	IgG2a	 eBioscience	FoxP3	 FJK-16s	 Rat	IgG2a	 eBioscience	IFNγ	 XMG1.2	 Rat	IgG1	 BD	Biosciences	IL17a	 TC11-18H10.1	 Rat	IgG1	 Biolegend	Ly6C	 AL-21	 Rat	IgM	 BD	Biosciences	Ly6G	 1A8	 Rat	IgG2a	 BD	Biosciences	MHC	II	(IA-IE)	 M5/114.15.2	 Rat	IgG2b	 eBiosciences	SIRPα	(CD172a)	 P84	 Rat	IgG1	 BD	Biosciences	TNFα	 MP-6XT22	 Rat	IgG1	 BD	Biosciences	TREM-1	(CD354)	 TR3MBL1	 	Rat	IgG2a	 eBiosciences	Streptavidin	BV605	 Biolegend	Streptavidin	QDot	605	 Molecular	Probes	
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2.5 Transcriptional	Analysis	of	Cell	Populations	
2.5.1 RNA Extraction 
Cells	were	sorted	directly	into	500	µL	RLT	buffer	(Qiagen)	and	RNA	was	then	isolated	using	 the	 RNeasy	 Micro	 kit	 (Qiagen)	 according	 to	 the	 manufacturer’s	 guidelines.	Contaminating	genomic	DNA	was	removed	on	the	column	during	RNA	isolation	with	the	RNase-free	DNase	Set	(Qiagen)	according	to	the	manufacturer’s	instructions.	The	RNA	was	 quantified	 using	 a	 nanodrop	 spectrophotometer	 (Amersham	Biosciences)	and	RNA	was	stored	at	–20oC	until	use.	
2.5.2 cDNA Synthesis 
cDNA	was	reverse	transcribed	from	DNase-treated	RNA	using	Superscript	III	Reverse	Transcriptase	(RT)	(Life	Technologies)	according	to	the	manufacturer’s	instructions.	Briefly,	10ng	of	RNA,	1µl	Oligo(dT)12-18	(500µg/ml;	Life	Technologies),	1µl	dNTP	mix	(25mM	each;	Life	Technologies),	and	nuclease-free	water	were	added	to	a	nuclease-free	microcentrifuge	tube	(ABgene,	Surrey,	UK)	in	a	total	volume	of	10µl.	The	mixture	was	heated	at	65°C	for	5	minutes,	and	then	chilled	on	ice.	4µl	5X	First-Strand	Buffer,	2µl	0.1M	DTT,	and	1µl	RNaseOUT	(40	units/ml)	(Life	Technologies)	were	added	and	incubated	at	42°C	 for	2	minutes.	1µl	 (200	units)	Superscript	 III	RT	was	 then	added	and	the	RNA	was	reverse	transcribed	at	42°C	for	50	minutes.	The	Superscript	III	RT	was	 inactivated	 by	 heating	 at	 70°C	 for	 15	 minutes	 and	 RNA	 was	 degraded	 using	
Escherchia	 coli	 RNase	 H	 (10units)	 (Life	 Technologies)	 at	 37°C	 for	 20	 minutes.	Negative	 control	 samples	 were	 incubated	 in	 the	 absence	 of	 Superscript	 III	 and	 all	cDNA	was	stored	at	–20°C	until	use.	
2.5.3 Real-Time PCR  
Gene	 expression	was	 assayed	 by	 quantitative	 reverse	 transcription	 PCR	 (qRT-PCR)	using	 Brilliant	 III	 Ultra	 Fast	 SYBR	 qPCR	master	mix	 (Agilient	 Technologies)	 on	 the	7900HT	Fast	system	(Applied	Biosystems).	Primers	(Table	2.5)	were	designed	using	Primer	 Express	 software	 (Applied	 Biosystems,	 Life	 Technologies)	 and	 purchased	from	IDT	(Iowa,	USA).	cDNA	samples	were	assayed	in	triplicate	and	gene	expression	
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levels	were	normalised	to	TATA	binding	protein	(TBP)	as	a	housekeeping	gene.	The	mean	relative	gene	expression	was	calculated	using	the	2-ΔΔC(t)	method.	
Table 2.4: Primers for qRT-PCR 	
	
 
2.6 Generation	of	BM	Chimeras	
8	 week	 old	 C57Bl/6.SJLxC57Bl/6	 (CD45.1+/CD45.2+)	 mice	 were	 irradiated	 with	 2	doses	of	5	Gy	2	hours	apart.	 	Mice	then	received	1x106	BM	cells	 from	WT	(CD45.1+)	and	TREM1	KO	(CD45.2+)	mice	or	SIRPa	(CD45.2)	mice.		Recipient	mice	were	left	for	8	weeks	to	allow	BM	engraftment.		
2.7 Statistical	analysis	
Results	are	presented	as	means	±1	standard	deviation	unless	stated	otherwise	stated	and	 normally	 distributed	 groups	 were	 compared	 using	 a	 Student’s	 t-test	 or	 for	multiple	 groups,	 a	 one-way	 or	 two-way	ANOVA	 followed	 by	 a	 Bonferroni	 post	 test	using	Prism	Software	(GraphPad	Software	Inc.,	USA).		Values	of	less	than	p<0.05	were	considered	to	be	statistically	significant.	
Gene Sense Antisense 
TBP	 TCCACAGCCTATTCAGAACACC	 CTACTGCCTGCTGTTGTTGC	
Rara	 CTTCGAGCACCACAGGACAT		 GTTAAGCGGTCCTGGGAGAC	
Csf2ra	 CGTGGCGCGATGCAT		 TCACGACCAAGTAGGCCTCACT	
Tgfbr1	 TTGCACTTATGCTGATGGTCT		 AGTGATGGATCCTCTTCATTT	
Irf4	 TCTCTGAGGGTCTGGAAACT	 GCCCAAGCTAGAAAG	
			
	
	
	
3 Chapter	3	
 Characterisation	of	intestinal	dendritic	cells	in		
 SIRPα 	mt	mice	
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3.1 Introduction	
Signal	 regulatory	 protein	α	 (SIRPα)	 is	 an	 inhibitory	 receptor	 expressed	 by	 several	different	myeloid	cells,	and	has	been	suggested	to	control	the	behaviour	of	CD11b+	DC	in	the	spleen	and	skin	(Iwamura	et	al.,	2011;	Saito	et	al.,	2010).	 	At	the	outset	of	my	PhD,	the	laboratory	had	obtained	evidence	that	although	SIRPα	was	expressed	by	mφ	and	 most	 DC	 in	 the	 intestine,	 mice	 carrying	 a	 non-signalling	 mutation	 in	 SIRPα	(SIRPα mt)	had	a	selective	reduction	in	CD103+CD11b+	DC.  Subsequently,	the	initial	aim	of	my	PhD	was	to	extend	this	work	and	to	investigate	the	effects	of	aging	on	the	phenotype.	
3.2 Effects	 of	 defective	 SIRPα 	 signalling	 on	 myeloid	 cells	 in	 the	
intestinal	lamina	propria	and	MLN 
When	 I	 began	 in	 the	 laboratory,	 much	 groundwork	 had	 established	 methods	 for	isolating	and	characterising	DC	and	mφ	from	the	lamina	propria.		Furthermore,	recent	evidence	had	shown	that	CD11b,	CD11c	and	MHC	II	were	 insufficient	 to	distinguish	between	DC	and	mφ.		To	address	this	problem,	previous	members	of	the	lab	devised	a	rigorous	gating	strategy	 that	allowed	mφ	 	and	distinct	 subsets	of	bona	fide	DC	 to	be	identified.		I	adopted	this	approach	to	examine	MPs	in	SIRPα	mt	mice	(Fig.	3.1A).		In	this	 protocol	 single,	 live	 CD45+	 leukocytes	 were	 first	 identified	 amongst	enzymatically-digested	samples	of	SI	LP,	and	MPs	were	then	defined	as	CD11c+	MHC	II+.		CD64,	restricted	to	tissue	mφ	in	mice,	was	used	to	identify	CD11c+	MHC	II+	CD64+	mφ	 (Fig.	 3.1B)	 (Bain	 et	 al.,	 2013;	 Tamoutounour	 et	 al.,	 2012).	 	 B220	 was	 used	 to	exclude	pDCs	and	the	remaining	CD11c+	B220-	CD64-	cells	could	 then	be	subdivided	into	 four	distinct	populations	based	on	expression	of	CD11b	and	CD103	(Fig.	3.1B).		Our	own	work,	alongside	that	of	other	groups	(Persson	et	al.,	2013a;	Tamoutounour	et	al.,	2012),	has	confirmed	that	all	these	four	subsets	are	genuine	conventional	DC,	as	defined	by	their	ability	to	migrate	via	lymph	to	the	draining	MLN	and	present	antigen	to	naïve	T	cells,	and	to	express	DC	specific	markers	such	as	Zbtb46	and	Flt3	(Cerovic	et	 al.,	 2013).	 	 The	 CD103+CD11b+	 DC	 population,	 which	 is	 unique	 to	 the	 intestine	(Denning	 et	 al.,	 2011),	 makes	 up	 the	 biggest	 subset	 in	 SI	 LP	 (~40%	 of	 all	 DC),	followed	by	 the	CD103-CD11b+	 subset	 and	 then	 smaller	 numbers	 of	 CD103+CD11b-	
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and	CD103-CD11b-	subsets	(Fig.	3.1B).	 	The	 intestinal	DC	subsets	expressed	varying	levels	of	SIRPα, with	the	CD103+CD11b+	and	CD103-CD11b+	DC	expressing	high	levels,	whereas	 CD103+CD11b-	 DC	were	 SIRPα-.	 	 The	DC	 that	 lacked	 expression	 of	 CD103	and	CD11b	were	heterogeneous	for	the	expression	levels	of	SIRPα,	while	CD64+	mφ	expressed	the	highest	levels	of	SIRPα	(Fig.	3.1C).	 	Replicating	the	results	of	a	former	PhD	student,	I	found	that	mice	carrying	a	non-functional	mutation	in	the	cytoplasmic	domain	of	the	SIRPα molecule	had	significantly	reduced	frequencies	and	numbers	of	CD103+CD11b+	DC	compared	with	WT	controls	(Fig.	3.2A).	 	 In	parallel	there	was	an	increased	 frequency	 of	 CD103+CD11b-	 DC	 in	 the	 SIRPα	 mt	 SI	 LP,	 although	 their	absolute	numbers	were	not	significantly	different	to	WT	mice.		No	differences	in	the	proportions	 or	 numbers	 of	 CD103-CD11b+	 or	 CD103-CD11b-	 DC	 subsets	 were	observed.	 	 Although	 mφ	 also	 expressed	 SIRPα,	 the	 frequencies	 of	 MHC	 II+	CD11b+	CD64+	mφ	were	not	significantly	different	in	the	SI	LP	of	SIRPα	mt	mice,	although	the	absolute	numbers	were	significantly	reduced	(Fig.	3.2B).			
The	effect	of	the	SIRPα	mutation	on	SI	LP	DC	was	mirrored	amongst	migratory	DC	in	the	 draining	 MLN.	 	 Migratory	 DC	 having	 arrived	 in	 the	 MLN	 from	 the	 LP	 can	 be	identified	 as	 CD11c+MHC	 IIhi	whereas	 those	 “resident”	 DC	 that	 are	 derived	 directly	from	the	bloodstream	are	CD11chi	MHC	IIint	(Henri	et	al.,	2001)(Fig.	3.3A).		The	total	numbers	and	frequencies	of	both	migratory	and	resident	DC	were	severely	reduced	in	the	MLN	of	SIRPα	mt	mice	compared	with	their	WT	counterparts.		This	observation	translated	 into	a	significant	reduction	 in	the	numbers	of	all	DC	subsets	 in	SIRPα	mt	MLN.		Consistent	with	their	origin	in	the	LP,	there	was	a	significant	reduction	in	the	relative	proportion	of	CD103+CD11b+	DC	amongst	the	migratory	population	in	SIRPα	mt	MLN,	 while	 the	 proportion	 of	 migratory	 CD103+CD11b-	 DC	was	 increased	 (Fig.	3.3B).	 	 In	 contrast	 to	what	 I	 found	 in	 the	 SI	 LP,	 the	 relative	 proportions	 of	 CD103-CD11b+	DC	were	also	reduced	amongst	migratory	DC	in	the	SIRPα	mt	MLN	(Fig.	3.3B).		CD103+CD11b+	DC	were	rare	amongst	resident	DC	in	WT	MLN	and	there	were	only	a	few	CD103+CD11b-	DC.		The	relative	proportions	of	both	these	subsets	and	of	CD103-CD11b-	 DC	were	 actually	 significantly	 increased	 in	 the	 SIRPα	 mt	MLN,	 reflecting	 a	severe	reduction	in	resident	CD103-CD11b+	DC	in	the	SIRPα	mt	MLN.		Consistent	with	previous	findings,	the	proportions	and	numbers	of	CD11b+	DC	were	also	reduced	in	
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the	spleen	of	SIRPα	mt	mice,	with	a	parallel	increase	in	the	proportion	of	CD11b-	DC	(Fig.	3.4)	(Saito	et	al.,	2010;	Washio	et	al.,	2015).			
3.3 Requirement	for	SIRPα  signalling	on	haematopoietic	cells	
Whilst	these	initial	experiments	confirmed	previous	findings	in	the	lab	that	SIRPα	mt	mice	have	a	defect	 in	 intestinal	CD103+CD11b+	DC,	 they	could	not	determine	 if	 this	effect	was	intrinsic	to	haematopoietic	cells	or	not.		To	explore	this,	I	generated	bone	marrow	chimeric	mice	by	reconstituting	irradiated	(CD45.1+	CD45.2+)	WT	mice	with	CD45.2+	SIRPα	mt	BM,	or	by	reconstituting	CD45.2+	SIRPα	mt	animals	with	CD45.1+	BM	(Fig.	3.5A).		After	eight	weeks,	the	SI	LP	was	harvested,	and	engraftment	of	donor	BM	 assessed	 by	 examining	 the	 expression	 of	 CD45.1	 and	 CD45.2	 on	 leukocyte	populations.	 	Approximately	95%	of	CD45+	DC	in	the	SI	LP	of	WT	recipients	were	of	SIRPα	mt	origin	whilst	96%	were	of	WT	origin	in	the	SIRPα	mt	SI	LP,	confirming	the	virtually	complete	replacement	of	DC	by	precursors	of	donor	origin	(Fig	3.5B).			
Somewhat	 surprisingly,	 analysis	 of	 the	 live	 leukocyte	 populations	 in	 the	 SI	 LP	revealed	 few	 differences	 in	 the	 frequencies	 or	 cell	 numbers	 of	 the	 DC	 subsets	between	 the	 two	groups	of	 chimeras,	apart	 from	a	significantly	higher	 frequency	of	CD103+CD11b-	DC	in	SIRPα	mt	->	WT	chimeras	compared	with	the	WT	->	SIRPα	mt	mice,	 similar	 to	 what	 was	 seen	 in	 intact	 SIRPα	 mt	mice	 (Fig	 3.5C).	 	 However	 it	 is	important	to	note	that	the	percentage	of	CD103+CD11b+	DC	appeared	to	be	lower	in	both	groups	of	chimeras	(~	30%)	compared	with	what	I	had	found	in	intact	WT	mice	(~	40%)	(Fig	3.2B).	 	 In	parallel,	 the	proportion	of	CD103+CD11b-	DC	appeared	to	be	higher	in	the	chimeras.		In	light	of	this	observation,	it	was	difficult	to	interpret	the	DC	subset	data	in	the	chimeric	mice.		This	was	compounded	further	by	the	fact	that	I	had	insufficient	mice	to	set	up	WT	->	WT	or	SIRPα	mt	->	SIRPα	mt	chimeras,	which	would	have	provided	controls	for	the	generic	effects	of	BM	reconstitution	on	DC	populations.		There	were	no	significant	differences	in	the	frequencies	or	absolute	numbers	of	mφ	in	the	SI	LP	of	the	two	groups	of	chimeras	(Fig.	3.6).			
The	 total	 numbers	 of	 DC	 were	 low	 in	 the	 MLN	 of	 both	 chimeras	 and	 this	 was	especially	true	for	the	SIRPα mt	->	WT	mice,	suggesting	that	the	defect	in	these	cells	in	 the	 intact	 SIRPα-expressing	 (WT)	 mouse	 was	 intrinsic	 to	 haematopoietic	 cells.		
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There	was	a	trend	towards	a	reduction	in	the	frequency	and	absolute	number	of	both	total	migratory	and	resident	MLN	DC	in	the	SIPRα	mt	->	WT	mice,	similar	to	what	was	seen	 in	 the	 intact	 SIRPα mt	 MLN.	 	 However,	 insufficient	 sample	 size	 prevented	statistical	 analyses	 of	 these	 data	 (Fig	 3.7A).	 	 Despite	 identical	 populations	 of	CD103+CD11b+	DC	in	the	SI	LP	of	the	two	sets	of	chimeras	(~	30%),	this	subset	was	reduced	 amongst	 migratory	 DC	 in	 the	 MLN	 of	 SIRPα	 mt	 ->	 WT	 mice	 (~	 18%)	compared	with	WT	 ->	 SIRPα	 mt	 chimeric	mice	 (~	 25%).	 	 Again	 this	mirrored	 the	intact	SIRPα	mt	mouse,	although	the	frequencies	of	both	were	lower	than	in	the	intact	WT	or	SIRPα	mt	 (Fig	3.3B).	 	 Similarly	 there	was	also	a	 trend	 towards	an	 increased	frequency	 of	 CD103+CD11b-	DC	 in	 SIRPα	 mt	 ->	 WT	 MLN.	 	 However,	 unlike	 intact	SIRPα	mt	MLN,	there	was	no	decrease	in	CD103-CD11b+	DC	amongst	the	SIRPα	mt	->	WT	 migratory	 DC	 (Fig.	 3.7B).	 	 Analysis	 of	 the	 subsets	 of	 DC	 in	 the	 resident	compartment	of	the	chimeric	MLN	showed	the	presence	of	CD103+CD11b+	DC	in	the	SIRPα	mt	->	WT	MLN.		As	this	observation	differs	from	that	seen	in	intact	mice,	it	may	indicate	that	the	gating	strategy	for	distinguishing	resident	and	migratory	DC	may	not	be	 reliable	 after	 irradiation	and	BM	 transfer.	 	However,	CD103+CD11b+	DC	 resident	MLN	DC	were	rare	in	WT	->	SIRPα	mt	chimeras.		Unlike	intact	SIRPα mt	MLN,	there	were	no	differences	in	the	proportion	of	CD103-CD11b+	resident	DC	in	the	SIRPα mt			->	WT	and	WT	->	SIRPα mt	mice.	 	The	frequencies	of	CD103+CD11b-	DC	and	CD103-CD11b-	DC	appeared	to	be	reduced	in	the	SIRPα	mt	->	WT	chimeras	compared	with	WT	 ->	 SIRPα mt MLN,	 although	 again,	 I	 was	 unable	 to	 analyse	 these	 differences	statistically	(Fig	3.7C).			
I	 next	 analysed	 the	 spleen	of	 the	 chimeric	mice	using	CD4	as	 an	 additional	marker	that	 can	 define	 two	 subsets	 of	 splenic	 CD11b+	 DC	 (Miller	 et	 al.,	 2012)	 (Fig.	 3.8A).			Rather	 strikingly,	 the	 spleen	 of	 SIRPα	mt	 ->	WT	mice	 had	 a	 profound	defect	 in	 the	frequency	 and	 number	 of	 both	 CD11b+CD4+	 and	 CD11b+CD4-	 DC	 (and	 thus	 total	CD11b+)	populations	compared	with	those	from	WT	->	SIRPα	mt	mice.	 	By	contrast,	the	 CD11b-	 DC	 population	 significantly	 increased	 (Fig.	 3.8B).	 	 These	 findings	 are	therefore	similar	to	the	behaviour	of	splenic	CD11b+	DC	in	the	intact	SIRPα	mt	mice	(Fig	3.4).			
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These	 data	 suggest	 that	 the	 systemic	 DC	 defect	 in	 SIRPα	 mt	 mice	 may	 reflect	 an	intrinsic	effect	on	the	haematopoietic	compartment.	However	the	 lack	of	phenotype	in	the	SI	LP	of	the	SIRPα	mt	->	WT	chimeras	means	that	it	was	impossible	to	assess	the	cell	type	responsible	for	the	effect	in	the	intestine.			
3.4 Effects	of	age	on	dendritic	cells	in	SIRPα 	mt	mice	
One	possible	explanation	for	the	lack	of	a	DC	phenotype	in	the	SIRPα	mt	BM	chimeras	was	 that	 it	could	reflect	an	effect	of	age.	 	This	 is	because	 the	recipients	of	BM	were	eight	weeks	 old	when	 irradiated	 and	were	 then	 left	 for	 a	minimum	of	 eight	weeks	before	being	analysed,	meaning	they	were	approximately	twice	the	age	of	the	intact	SIRPα	mt	mice	I	had	examined	earlier.		To	explore	whether	there	might	be	a	selective	loss	of	the	intestinal	DC	phenotype	in	intact	SIRPα	mt	mice	with	age,	I	analysed	the	SI	LP,	 MLN	 and	 spleen	 of	 WT	 and	 SIRPα	 mt	 mice	 from	 four	 until	 24	 weeks	 of	 age.		Furthermore,	I	examined	how	SI	LP	T	cell	populations	changed	with	age	to	determine	the	 relationship	between	T	 cells	 and	DC	 subsets	 in	 this	model,	 in	which	 a	 selective	defect	in	Th17	cells	has	been	reported	(Scott	et	al.,	2014b).				
The	 frequency	of	CD103+CD11b+	DC	 in	 the	SI	LP	remained	constant	 throughout	 the	time	 course	 in	 both	 WT	 and	 SIRPα	 mt	 mice,	 and	 the	 degree	 of	 the	 defect	 in	 the	SIRPα mt	 SI	LP	 remained	 relatively	 constant	 (Fig.	 3.9A).	 	 The	 numbers	 of	CD103+CD11b+	 DC	 in	 the	 SI	 LP	 were	 not	 significantly	 different	 between	 the	 two	strains	 at	 any	 age,	 although	 they	were	 generally	 lower	 in	 the	 SIRPα	mt	mice.	 	 This	difference	 appeared	 most	 apparent	 at	 four	 weeks	 of	 age	 when	 there	 was	approximately	a	50%	reduction	in	numbers	in	SIRPα	mt	mice	(Fig.	3.9A).			
As	 I	 had	 found	 previously	 in	 eight	 week	 old	 mice,	 the	 frequency	 of	 SI	 LP	 CD103-CD11b+	DC	was	not	significantly	different	between	the	WT	and	SIRPα	mt	mice	at	four,	eight	or	24	weeks	of	age,	although	it	was	significantly	decreased	in	the	SIRPα	mt	SI	LP	at	16	weeks	of	age	(Fig	3.9B).		Absolute	numbers	of	CD103-CD11b+	DC	were	reduced	in	 SIRPα	 mt	 mice	 at	 four	 weeks,	 but	 not	 at	 the	 later	 time	 points	 (Fig.	 3.9B).		CD103+CD11b-	DC	were	significantly	increased	in	frequency	in	the	SIRPα	mt	SI	LP	at	all	ages,	as	was	their	absolute	number	at	eight	weeks	of	age,	similar	to	my	previous	
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experiments	(Fig.	3.9C).		Lastly,	the	CD103-CD11b-	DC	were	not	significantly	different	in	the	SI	LP	of	WT	and	SIRPα	mt	mice	in	frequency	or	absolute	number,	except	for	a	slightly	reduced	frequency	in	16	week	old	SIRPα	mt	mice	(Fig.	3.9D).		There	were	no	differences	in	the	frequency	or	absolute	numbers	of	Th1	or	Th17	cells	in	the	SI	LP	of	24-week-old	SIRPα	mt	or	WT	mice,	suggesting	that	the	reported	defect	in	Th17	cells	may	have	resolved	by	24	weeks	of	age	(Fig.	3.10). 
The	 proportions	 and	 numbers	 of	 migratory	 CD103+CD11b+	 MLN	 DC	 were	significantly	reduced	in	SIRPα	mt	mice	at	four	and	eight	weeks	of	age	(Fig.	3.11A),	but	at	later	times	there	was	a	marked	reduction	in	the	proportion	of	CD103+CD11b+	DC	in	WT	MLN	which	meant	that	the	difference	in	DC	frequency	could	be	seen	between	the	strains	 (Fig.	 3.11A).	 	 The	 frequency	 and	 numbers	 of	 migratory	 CD103-CD11b+	 DC	were	significantly	reduced	in	the	SIRPα	mt	MLN	at	all	time	points	(Fig.	3.11B).	 	The	frequency	of	CD103+CD11b-	DC	was	increased	in	the	SIRPα	mt	at	both	four	and	eight	weeks	of	age,	but	this	was	not	apparent	at	later	times	(Fig.	3.11C).		Although	absolute	numbers	of	CD103+CD11b-	DC	 in	SIRPα	mt	mice	were	significantly	 reduced	at	both	four	and	eight	weeks	of	age,	this	also	resolved	by	16	weeks	of	age	(Fig.	3.11C).		There	were	no	significant	differences	between	the	frequencies	of	migratory	CD103-CD11b-	DC	 in	WT	 and	 SIRPα	 mt	 MLN	 at	 any	 age,	 although	 the	 numbers	 were	 reduced	 in	SIRPα	mt	mice	at	all	times	(Fig.	3.11D).			
As	I	found	previously	in	young	adult	mice,	all	subsets	of	resident	MLN	DC	were	very	scarce	in	number	in	SIRPα	mt	mice	throughout	the	time	course,	especially	after	four	weeks	of	age	and	they	were	significantly	lower	than	in	WT	MLN	at	all	times.		Despite	this	 generalised	 effect	 the	 relative	 frequency	 of	 CD103-CD11b+	 DC	 was	 markedly	reduced	amongst	resident	MLN	from	SIRPα mt	mice	at	all	ages	(Fig.	3.12A),	while	the	proportions	 of	 CD103+CD11b-	 DC	 were	 always	 higher	 in	 the	 SIRPα	 mt	 MLN	 (Fig.	3.12B).		The	frequency	of	resident	CD103-CD11b-	DC	was	significantly	higher	in	SIRPα	mt	MLN	at	four	and	eight	weeks	of	age,	but	was	then	similar	to	that	in	the	WT	mice	thereafter	(Fig.	3.12C).			
The	frequency	and	number	of	CD11b+	DC	in	the	spleen	of	SIRPα	mt	were	profoundly	reduced	compared	with	WT	mice	at	all	times,	while	the	proportion	of	CD11b-	DC	was	
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reciprocally	higher	at	all	ages.	However,	the	absolute	numbers	of	CD11b-	DC	in	SIRPα	mt	 spleen	were	 similar	 to	 those	 in	WT	mice,	 except	 for	 a	 significant	 increase	 at	16	weeks	(Fig.	3.13).			
3.5 Summary	
In	this	chapter,	 I	 first	confirmed	previous	findings	in	the	laboratory	that	had	shown	that	 although	 SIRPα was	expressed	by	 several	 intestinal	DC	subsets	 and	 mφ,	 there	was	a	selective	reduction	in	the	number	of	CD103+CD11b+	DC	in	the	small	intestine	of	SIRPα	mt	mice.	 	This	effect	was	phenocopied	amongst	migratory	DC	in	the	draining	MLN,	while	 the	population	of	CD103-CD11b+	DC	was	reduced	 in	both	resident	MLN	DC	 and	 in	 the	 spleen,	 where	 proportions	 of	 CD103+CD11b-	 DC	 were	 significantly	increased.		Despite	their	expression	of	SIRPα,	there	were	no	differences	in	frequency	or	number	of	mφ in	the	intestine.	Based	on	these	observations	I	investigated	whether	the	reduction	of	these	DC	subsets	was	due	to	an	intrinsic	defect	within	the	haematopoietic	compartment	by	generating	SIRPα	 mt	 ->	 WT	 and	 WT	 ->	 SIRPα	 mt	 BM	 chimeras.	 	 After	 eight	 weeks	 of	reconstitution	with	donor	BM,	there	were	no	differences	in	the	frequency	or	number	of	 DC	 subsets	 or	 mφ	 in	 the	 SI	 LP	 or	 MLN	 between	 the	 two	 groups	 of	 chimeras.	Interestingly,	the	defect	 in	CD11b+	DC	in	the	spleen	was	present	in	SIRPα mt	->	WT	chimeras,	suggesting	this	phenomenon	was	distinct	from	that	affecting	intestinal	DC.		I	considered	the	possibility	that	the	loss	of	phenotype	in	the	intestine	of	either	group	of	 chimeric	mice	might	 have	 been	 due	 to	 the	 age	 of	 the	 animals,	 as	 the	mice	were	approximately	twice	the	age	of	those	in	which	the	phenotype	was	first	described.		To	investigate	 this,	 I	 analysed	 the	 SI	 LP,	MLN	and	 spleen	of	 four	 to	24	week	old	mice.		This	 showed	 that	 the	 selective	 CD103+CD11b+	DC	 defect	 in	 SIRPα	mt	mice	 did	 not	diminish	with	 age	 in	 the	 SI	 LP.	 	 There	were	 no	 consistent	 changes	with	 age	 in	 the	numbers	or	frequencies	of	CD103-CD11b+	DC,	while	the	frequencies	of	CD103+CD11b-	DC	generally	increased	in	the	SI	LP,	although	they	were	reduced	in	number	amongst	all	MLN	DC	at	all	times.			By	 24	 weeks	 there	 were	 no	 differences	 in	 the	 SI	 LP	 Th1	 or	 Th17	 populations	 in	SIRPα mt	and	WT	mice,	although	the	defect	in	CD11b+	DC	in	the	spleen	was	found	in	
 
 
 
81 
SIRPα	 mt	 mice	 of	 all	 ages.	 	 While	 these	 results	 suggest	 that	 the	 DC	 phenotype	 in	SIRPα mt	mice	may	be	age	dependent	in	the	intestine	but	not	in	the	spleen,	it	should	be	noted	 that	many	of	 the	 effects	 of	 age	were	not	 consistent	 and	 I	was	not	 able	 to	carry	out	many	 replicate	 experiments,	 especially	 in	older	mice.	 	 Furthermore,	 I	 did	not	have	access	 to	SIRPα mt	->	SIRPα mt	or	WT	->	WT	BM	chimeras	 that	would	be	necessary	to	interpret	the	apparent	absence	of	an	age	dependent	loss	of	phenotype	in	the	 intestine	 of	 SIRPα mt	 ->	 WT	 chimeras.	 	 In	 the	 next	 chapter,	 I	 went	 on	 to	investigate	 how	 DC	 subsets	 develop	 from	 the	 neonate	 in	 order	 to	 gain	 a	 better	understanding	of	the	dynamics	of	DC	subsets	over	time.				 	
Figure 3.1: Gating strategy for identifying mononuclear phagocytes in small 
intestinal lamina propria 
A SI LP cells were isolated from WT mice by enzymatic digestion and after identifying 
single cells based on FSC-A and FSC-H, mononuclear phagocytes (MP) were identified 
amongst live 7AAD- CD45+ leukocytes as MHC II+ CD11c+. After B220+ CD11c+ 
plasmacytoid DC (pDC) were excluded, B conventional DC were then identified as 
CD11c+ CD64-, while mφ are CD11c+ CD64+.  The DC were then subdivided into four 
populations based on expression of CD103 and CD11b.  C Expression of SIRPα by DC 
populations and CD64+ mφ. Results are representative of at least 10 individual 
experiments.  
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Figure 3.2: Mononuclear phagocytes in the small intestinal lamina propria of 
SIRPα mt mice  
A Representative dot plots showing DC subsets amongst live (7-AAD-) CD11c+ MHC II+ 
CD64- B220- leukocytes isolated from SI LP of WT or SIRPα mt mice (top panels).  
Frequencies amongst total DC (left) and absolute numbers of DC subsets (right) are 
shown (bottom panels).  B Total mφ  were identified as live (7-AAD-) CD45+ CD11b+ MHC 
II+ CD64+ B220- cells and the frequency amongst CD11b+ cells and absolute numbers are 
shown.  Data are from a single experiment with n=4-5. *p<0.05, **p<0.01, ****p<0.0001 
Student’s t-test.   
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Figure 3.3: Dendritic cells in the MLN of SIRPα mt mice 
A MLN cells were isolated from WT and SIRPα mt mice and migratory (MHCIIhi CD11c+) 
and resident (MHCIIint CD11c+) DC were identified amongst 7AAD- CD45+ leukocytes 
(representative dot plot; left).  The graphs show the frequency (centre) and absolute 
numbers (right) in WT and SIRPα mt MLN.  B Frequency (centre) and absolute numbers 
(right) of DC subsets amongst migratory MLN DC based on expression of CD103 and 
CD11b (representative dot plot; left).  C Frequency (centre) and absolute numbers (right) 
of DC subsets amongst resident MLN DC based on expression of CD103 and CD11b 
(representative dot plot; left). Data are from a single experiment with n=4-5. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 3.4: Dendritic cells in the spleen of SIRPα mt mice 
A Spleen cells were isolated from WT and SIRPα mt mice and conventional DC were 
identified as live (7-AAD-) CD45+ CD11c+ B220- leukocytes.  B CD11b+ and CD11b- 
subsets were identified.  C Frequency of CD11b+ and CD11b- DC amongst total DC (left) 
and absolute numbers (right) are shown.  Data are from a single experiment with n=4-5. 
***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 3.5: Dendritic cells in the small intestinal lamina propria of WT -> 
SIRPα mt and SIRPα mt -> WT BM chimeras  
A Bone marrow chimeras were generated by either transfer of CD45.1+ WT BM into 
irradiated CD45.2+ SIRPα mt recipients, or by transfer of CD45.2+ SIRPα mt BM into 
irradiated CD45.1+x CD45.2+ WT recipients. B Engraftment of donor cells was assessed 
eight weeks later by analysing expression of CD45.2 or CD45.1 on live, MHC II+ CD11c+ 
CD64- DC in SI LP.  C Frequencies amongst total DC (left panel) and absolute numbers 
(right panel) of DC subsets based on CD11b and CD103 expression. Data are from a 
single experiment with n=3-5. *p<0.05, Student’s t-test.   
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Figure 3.6: Mφ in the small intestinal lamina propria of WT -> SIRPα mt and 
SIRPα mt -> WT BM chimeras  
Bone marrow chimeras were generated by transfer of CD45.1+ WT BM into irradiated 
CD45.2+ SIRPα mt recipients, or by transfer of CD45.2+ SIRPα mt BM into irradiated 
CD45.1+x CD45.2+ WT recipients.  Engraftment of donor cells was assessed eight weeks 
later. Frequency amongst CD45+ leukocytes (left panel) and absolute numbers (right 
panel) of live CD11b+ CD64+ mφ.  Data are from a single experiment with n=3-5.  
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Figure 3.7: Dendritic cells in the MLN of WT -> SIRPα mt and SIRPα mt -> WT BM 
chimeras  
Bone marrow chimeras were generated by transfer of CD45.1+ WT BM into irradiated 
CD45.2+ SIRPα mt recipients, or by transfer of CD45.2+ SIRPα mt BM into irradiated 
CD45.1+x CD45.2+ WT recipients.  Engraftment of donor cells was assessed eight weeks 
later.  A Frequency (left panel) and absolute numbers (right panel) of migratory (MHCIIhi 
CD11c+) and resident (MHCIIint CD11c+) DC in the MLN.  B Frequency (left panel) and 
absolute numbers (right panel) of DC subsets amongst migratory MLN DC based on 
expression of CD103 and CD11b.  C Frequency (left panel) and absolute numbers (right 
panel) of DC subsets amongst resident MLN DC based on expression of CD103 and 
CD11b. Data are from a single experiment with n=2-5. 
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Figure 3.8: Dendritic cells in the spleen of WT -> SIRPα mt and SIRPα mt -> WT 
BM chimeras  
Bone marrow chimeras were generated by either transfer of CD45.1+ WT BM into 
irradiated CD45.2+ SIRPα mt recipients, or by transfer of CD45.2+ SIRPα mt BM into 
irradiated CD45.1+x CD45.2+ WT recipients.  Engraftment of donor cells was assessed 
eight weeks later.  A Representative dot plots showing identification of DC subsets based 
on CD4 and CD11b expression.  B Frequency (left panel) and absolute numbers (right 
panel) of live MHC II+ CD11c+ CD64- DC based on CD4 and CD11b expression.  Data are 
from a single experiment with n=3-5. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
Student’s t-test.   
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Figure 3.9: Effects of age on DC subsets in the small intestinal lamina propria of 
SIRPα mt mice 
Live CD11c+ MHC II+ B220- CD64- leukocytes in SI LP were analysed for the 
expression of CD103 and CD11b in WT and SIPRα mt mice from four to 24 weeks of 
age.  Frequency amongst total DC (left) and absolute numbers (right) are shown for 
A CD103+CD11b+ B CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC.  
Data are from at least three experiments with a total of 9 mice per group.  *p<0.05, 
**p<0.01, ****p<0.0001 Student’s t-test.   
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Figure 3.10: Effects of age on CD4+ T cell subsets in the small intestinal lamina 
propria of aged SIRPα mt mice 
Total SI LP cells were isolated from 24 week old WT and SIRPα mt mice and incubated 
for 4.5 hours with PMA, ionomycin, brefeldin and monensin before analysis of CD4+ T 
cells by intracellular staining.  A Gating strategy for identifying CD4+ T cells as live CD11b- 
CD3+ cells.  B Intracellular expression of INFγ  and IL-17 assessed by flow cytometry 
using appropriate antibodies with gates set on isotype controls. C Frequencies and 
absolute numbers of Th1 and Th17 cells amongst CD4+ T cells.  Data are from a single 
experiment with n=4 mice/group.  
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Figure 3.11: Effects of age on migratory DC subsets in the MLN of SIRPα mt mice 
Live CD11c+ MHC IIhi B220- CD64- migratory D Cin MLN were analysed for the 
expression of CD103 and CD11b in WT and SIPRα mt mice from four to 24 weeks of 
age.  Frequency amongst total DC (left) and absolute numbers (right) are shown for 
A CD103+CD11b+ B CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC.  
Data are from at least three experiments with a total of 9 mice per group.  *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 3.12: Effects of age on resident DC subsets in the MLN of SIRPα mt mice 
Live CD11c+ MHC IIint B220- CD64- resident DC in MLN were analysed for the 
expression of CD103 and CD11b in WT and SIPRα mt mice from four to 24 weeks of 
age.  Frequency amongst total DC (left) and absolute numbers (right) are shown for 
A CD103-CD11b+ B CD103+CD11b- and C CD103-CD11b- DC.  Data are from at least 
three experiments with a total of 9 mice per group.  *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001 Student’s t-test.   
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Figure 3.13: Effects of age on DC subsets in the spleen of SIRPα mt mice 
Spleen cells were isolated from WT and SIRPα mt mice and live CD11c+ MHC II+ 
CD64- leukocytes were analysed for the expression of CD11b from between four 
weeks to 24 weeks of age.  Frequency and absolute numbers are shown for A 
CD11b+ B CD11b-.  Data are from at least three experiments with n=4-9. *p<0.05, 
***p<0.001, ****p<0.0001 Student’s t-test.   
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4 Chapter	4	
Development	of	dendritic	cells	in	neonatal	mice		
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4.1 Introduction	
In	 Chapter	 3,	 I	 confirmed	 previous	 findings	 from	 our	 laboratory	 that	 there	 was	 a	selective	reduction	in	CD103+CD11b+	DC	in	the	intestine	of	SIRPα	mt	mice.		However,	when	I	generated	BM	chimeras,	I	observed	a	resolution	of	the	DC	phenotype	in	both	the	intestine	and	MLN	of	these	animals.		As	this	suggested	these	could	be	age-related	changes	 in	 DC	 development,	 I	 went	 on	 to	 assess	 how	 populations	 of	 DC	 subsets	changed	with	age	in	the	intestine	of	SIRPα	mt	and	WT	mice.	
As	a	result	of	these	studies,	I	became	interested	in	when	the	DC	defect	first	appeared	in	 life	and	how	 intestinal	DC	populations	are	shaped	 throughout	development	 from	early	 life	 onwards.	 	 In	 this	 chapter	 I	 explored	 DC	 subset	 development	 from	 late	embryogenesis,	 throughout	 the	 neonatal	 period	 and	 into	maturity.	 	 To	 extend	 this	work,	I	also	established	how	two	other	molecules	(CD101	and	Trem-1)	could	be	used	to	define	DC	differentiation	in	more	depth.		Lastly,	I	examined	how	DC	function	and	T	cell	composition	changed	with	age.			
4.2 Age	dependent	effects	on	intestinal	dendritic	cell	subsets	
Having	 identified	 a	 reduction	 in	 CD103+CD11b+	 DC	 in	 SIRPα	mt	mice,	 I	 decided	 to	investigate	at	which	stage	of	development	 this	defect	 first	occurs.	 	To	do	 this	 I	 first	had	to	establish	protocols	for	characterising	intestinal	DC	early	in	life.	 	Recent	work	by	Bain	et	al.	had	shown	that	this	was	possible	 for	macrophages	(Bain	et	al.,	2014);	therefore	I	adapted	these	methods	to	study	DC	in	the	SI,	colon,	MLN	and	lung	of	WT	mice.			
4.2.1 Development of dendritic cell subsets in the small intestinal lamina 
propria 
Firstly,	 I	 examined	 the	 SI	 and	 isolated	 lamina	propria	 cells	 from	embryonic	day	18	(E18)	mice	(Fig.	4.1A).	 	Using	the	same	digestion	protocol	as	in	adults,	I	was	able	to	retrieve	enough	cells	to	analyse	individual	animals	separately,	and	as	in	adults,	I	first	identified	 live,	 single	CD45+	 leukocytes	 before	 assessing	 their	 expression	of	MHC	 II	and	CD11c.		cDC	were	then	identified	by	exclusion	of	B220+	pDC	and	B	cells;	and	after	
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excluding	CD64+	Mφ,	I	analysed	the	expression	of	CD11b	and	CD103	by	the	resulting	
bona	fide	DC.		This	showed	the	same	four	populations	that	were	present	in	the	adult	SI	LP,	although	the	relative	proportions	were	markedly	different,	with	very	few	of	the	CD103+CD11b+	 subset,	 predominant	 in	 adult	 SI	 LP	 (5%	 vs	 40%	 respectively).	CD103+CD11b-	DC	were	the	most	abundant	subset	at	E18	(approx.	53%),	followed	by	CD103-CD11b+	 DC	 (27%)	 and	 lastly	 CD103-CD11b-	 DC	 (11%).	 	 CD103+CD11b+	 DC	were	also	 rare	 in	 the	 intestine	at	postnatal	D1,	but	 there	was	a	 large	proportion	of	CD103-CD11b+	 DC	 (10%	 and	 47%	 respectively)	 as	 well	 as	 substantial	 numbers	 of	CD103+CD11b-	DC,	which	were	not	as	abundant	as	at	E18.	 	 Some	CD103-CD11b-	DC	were	also	present	on	D1	(Fig.	4.1B).			
I	then	went	on	to	analyse	the	different	DC	populations	in	the	SI	LP	at	different	times	after	 birth.	 	 This	 showed	 that	 after	 a	 significant	 increase	 from	 E18	 to	 D1,	 the	frequency	of	CD103+CD11b+	DC	then	increased	only	very	slowly	during	the	first	few	weeks	 of	 life,	 only	 becoming	 apparent	 between	 14	 and	 21	 days	 and	 not	 attaining	adult	levels	until	42	days,	when	there	was	another	marked	rise	in	their	frequency.		By	one	 year	 of	 age,	 the	 frequency	 of	 CD103+CD11b+	 DC	 had	 declined	 somewhat,	confirming	what	I	had	found	in	24	week	old	mice	in	the	previous	chapter.		In	parallel	with	 the	 frequency,	 the	 absolute	 number	 of	 CD103+CD11b+	 DC	was	 low	 until	 D21,	after	which	it	rose	towards	adult	levels,	with	an	especially	marked	increase	between	D28	and	D42	(Fig	4.2A).			
The	 CD103-CD11b+	 DC	 population	 showed	 a	 different	 pattern,	 rising	 significantly	from	 approximately	 20%	 at	 E18	 to	 greater	 than	 40%	 by	 D3	 (Fig	 4.2B).	 	 This	population	then	fell	sharply	until	D21,	remaining	at	around	the	same	level	thereafter	into	 adult	 life.	 	 The	 absolute	 numbers	 of	 this	 subset	 also	 began	 to	 increase	 more	rapidly	 after	 birth	 than	 the	CD103+CD11b+	DC,	 although	 the	 greatest	 changes	were	also	seen	from	D28.		
Although	 CD103+CD11b-	 DC	made	 up	 the	majority	 of	 DC	 at	 E18,	 by	 birth	 they	 had	halved	 in	 proportion	 and	 this	 remained	 low	 until	 D7,	 after	 which	 they	 increased	significantly	 to	 reach	roughly	 the	proportions	 that	were	 then	maintained	 into	adult	life	(Fig	4.2C).		As	with	the	other	populations,	the	absolute	numbers	of	CD103+CD11b-	
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DC	remained	 low	until	D28,	when	 they	expanded	drastically,	before	 falling	again	 in	mature	adults.			
The	 population	 of	 CD103-CD11b-	 DC	 was	 the	 smallest	 throughout	 life	 and	 their	proportion	showed	few	changes	over	this	period	(Fig	4.2D).		Their	absolute	numbers	were	 also	 lower	 than	 those	 of	 the	 other	 subsets,	 although	 interestingly,	 the	 age	related	expansion	in	this	subset	seemed	to	occur	earlier,	being	most	apparent	on	D21.		
Thus	 there	 are	marked	 changes	 in	 the	 number	 and	 composition	 of	 the	 DC	 subsets	found	 in	 the	 SI	 from	 before	 birth	 onwards,	 with	 the	 numbers	 of	 all	 DC	 showing	 a	dramatic	 expansion	 around	 the	 fourth	 week	 of	 life.	 	 Around	 the	 time	 of	 birth	 the	predominant	population	was	the	CD103+CD11b-	subset,	whilst	the	CD103+CD11b+	DC	appeared	to	develop	most	slowly,	not	attaining	adult	proportions	until	around	three	to	 four	weeks	 of	 age:	 their	 expansion	was	 preceded	 by	 an	 increased	 proportion	 of	CD103-CD11b+	DC.			
4.2.2 Development of dendritic cell subsets in the colonic lamina propria 
Next	 I	 analysed	 the	 development	 of	 DC	 in	 the	 colon,	where	 the	 composition	 of	 DC	subsets	in	adults	is	different	to	those	of	the	SI	LP.		Using	the	same	digestion	protocol	as	 in	 adults	 and	 a	 similar	 gating	 strategy	 applied	 to	 the	 SI	 LP,	 the	 same	 DC	populations	could	be	identified	in	the	colon	at	E18	(Fig	4.3A).		However,	the	relative	proportions	were	different;	the	CD103+CD11b+	subset	was	smaller	than	in	adult	colon	(2%	vs.	 11%	 respectively)	 and	was	 even	 lower	 in	 the	 embryonic	 colon	 than	 in	 the	SI	LP	at	the	same	stage	(Fig	4.3B).		CD103+CD11b-	DC	were	the	most	abundant	subset	in	E18	colon	(approx.	48%),	followed	by	CD103-CD11b+	DC	(27%)	and	CD103-CD11b-	DC	(18%).		In	the	colon	at	D1,	there	were	virtually	no	CD103+CD11b+	DC	and	an	even	higher	proportion	of	CD103-CD11b+	DC	was	present	(2%	and	68%	respectively).	 	In	turn,	the	CD103+CD11b-	DC	were	no	longer	predominant	by	D1	and	only	a	few	CD103-CD11b-	DC	were	present	(Fig	4.3B).			
Analysis	 of	mice	 of	 different	 ages	 showed	 that	 the	 frequency	 of	 CD103+CD11b+	DC	increased	very	slowly	throughout	development,	rising	to	20-30%	at	D14,	which	was	far	 lower	 than	 in	 the	 SI	 LP.	 The	 frequency	 then	 remained	 relatively	 constant	 until	
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reducing	 at	 D28,	 before	 rising	 again	 significantly	 at	 D42.	 	 In	 parallel,	 the	 absolute	number	 of	 CD103+CD11b+	 DC	 was	 low	 throughout	 life,	 although	 it	 increased	significantly	on	D21	(Fig	4.4A).				
The	 CD103-CD11b+	 DC	 population	 in	 the	 colon	 showed	 a	 similar	 developmental	pattern	 to	 those	 in	 the	 SI	 LP,	 although	 they	 appeared	 to	 decrease	more	 rapidly	 in	proportion	 between	 D3	 and	 D14	 in	 the	 colon	 than	 in	 the	 SI	 LP,	 before	 increasing	steadily	 into	 adult	 life.	 	 The	 absolute	numbers	of	 this	 subset	 increased	 slowly	 after	birth	 and	 reached	a	peak	 at	D21,	 compared	with	D42	 in	 the	 SI	 LP.	 	 Their	numbers	then	fell	again	around	D28	and	plateaued	from	D42	onwards	(Fig	4.4B).			
Although	 CD103+CD11b-	 DC	made	 up	 the	majority	 of	 colonic	 DC	 at	 E18	 there	was	then	 a	 small	 and	 non-significant	 fall	 in	 proportion	 on	 D1	 before	 they	 increased	gradually	again	up	until	D14.		After	a	further	small	fall	towards	D28,	the	proportion	of	CD103+CD11b-	DC	stabilised	around	40%.	 	The	absolute	numbers	of	CD103+CD11b-	DC	 remained	 low	 until	 increasing	 significantly	 at	 D42,	 after	 which	 they	 fell	 again	towards	adult	 levels	 at	D28	 (Fig	4.4C).	 	The	proportions	of	CD103-CD11b-	DC	were	low	throughout	life,	without	obvious	changes	over	this	time.		Their	absolute	numbers	were	also	lower	than	those	of	the	other	subsets,	although	these	increased	somewhat	after	D21	(Fig	4.4D).			
Thus	there	were	changes	in	the	number	and	composition	of	the	DC	subsets	found	in	the	colon	from	before	birth	onwards,	although	these	were	not	as	marked	as	in	the	SI	LP	 and	 the	 generalised	 expansion	 in	 colonic	DC	 occurred	 earlier	 than	 in	 the	 SI	 LP.		Around	 the	 time	 of	 birth	 in	 the	 colon,	 the	 predominant	 population	 was	 the	CD103+CD11b-	 subset,	 whilst	 the	 CD103+CD11b+	 DC	 appeared	 to	 attain	 adult	proportions	 around	 D3	 and	 was	 preceded	 by	 an	 expanded	 proportion	 of	 CD103-CD11b+	DC,	which	then	reduced	in	frequency.			
4.2.3 Development of dendritic cell subsets in the MLN 
I	 next	 examined	 how	 the	 populations	 of	 DC	 in	 the	 draining	 MLN	 developed	 in	comparison	with	 those	 in	 the	 intestinal	mucosa,	assessing	both	 the	CD11c+	MHC	IIhi	‘migratory’	 DC	 that	 had	 arrived	 from	 the	 gut	 and	 the	 CD11c+	MHC	 IIint	 subset	 of	
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resident	 DC	 as	 a	 representative	 source	 of	 DC	 found	 in	 secondary	 lymphoid	 organs	(Fig	4.5A).	 	In	these	experiments	I	could	not	begin	the	time	course	before	birth,	as	I	could	not	identify	MLN	in	E18	mice.		However,	both	migratory	and	resident	subsets	of	DC	could	be	identified	in	the	MLN	of	D1	mice,	where	they	were	as	well	defined	as	in	adult	mice	(Fig	4.5A).		It	was	also	possible	to	see	the	four	populations	of	migratory	DC	based	on	CD11b	and	CD103	expression	(Fig	4.5B-C).			
The	proportion	of	CD103+CD11b+	DC	within	 the	migratory	DC	population	remained	low	 from	 birth	 until	 there	 was	 a	 small	 increase	 at	 D14,	 followed	 by	 a	 further	significant	 increase	after	D28,	when	adult	 levels	were	attained.	 	This	contrasts	with	the	SI	LP,	where	the	adult	proportion	of	approximately	40%	was	already	present	by	D28.	 	 Absolute	 numbers	 of	 this	 subset	 were	 low	 until	 D14,	 before	 increasing	significantly	 on	D21	 and	 reaching	 adult	 numbers	 around	D45,	with	 a	 further	 slight	increase	at	1	year	(Fig	4.6A).			
As	 in	 the	 SI	 LP,	 the	 frequency	 of	 CD103-CD11b+	 DC	 was	 highest	 at	 birth,	 before	decreasing	into	adulthood	at	D28.		However,	the	absolute	numbers	of	this	subset	did	not	approach	adult	levels	until	after	D42	(Fig	4.6B).		There	were	very	few	migratory	CD103+CD11b-	 DC	 immediately	 after	 birth,	 but	 this	 population	 then	 increased	 in	proportion	and	did	so	more	rapidly	when	compared	with	the	other	subsets,	reaching	adult	 values	 from	D14	 onwards.	 	 As	with	 the	 other	 subsets	 however,	 the	 absolute	numbers	of	CD103+CD11b-	DC	did	not	change	until	D21	or	later,	although	again	adult	levels	 were	 then	 attained	 relatively	 quickly	 compared	 with	 the	 other	 subsets	 (Fig	4.6C).		The	proportion	of	migratory	CD103-CD11b-	DC	remained	low	from	birth	until	increasing	 from	D7	 to	D21	and	 then	decreasing	 subsequently	 to	adult	 levels.	 	Total	numbers	of	this	subset	were	low	until	D21,	after	which	they	rose	to	adult	values	(Fig	4.6D).			
As	expected,	 few	 if	 any	CD103+CD11b+	DC	could	be	 found	amongst	 the	 resident	DC	population	 at	 any	 time	 and	 if	 present,	 were	 likely	 to	 be	 contamination	 from	 the	migratory	compartment	(Fig	4.7A).		At	birth,	the	majority	of	resident	DC	belonged	to	the	 CD103+CD11b-	 DC	 subset,	 but	 the	 proportion	 of	 CD103-CD11b+	 DC	 expanded	rapidly	between	D1	and	D3,	which	was	also	reflected	in	a	transient	increase	in	their	number	at	D3.		The	frequency	of	these	DC	then	remained	similar	(40%)	until	adult	life,	
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apart	from	a	further	fleeting	increase	at	D28	to	around	70%.		The	absolute	number	of	these	cells	began	to	increase	after	D21,	reaching	adult	levels	after	D42	(Fig	4.7B).			
The	 proportion	 of	 resident	 CD103+CD11b-	 DC	 fell	 significantly	 and	 dramatically	 to	around	20%	by	D3,	before	increasing	again	on	D5	and	then	falling	gradually	to	their	adult	levels	thereafter	(Fig	4.7C).		As	with	the	other	subsets,	the	absolute	numbers	of	these	cells	increased	towards	adult	values	after	D21.		In	contrast	to	their	behaviour	in	intestinal	mucosa	or	amongst	migratory	MLN,	the	resident	CD103-CD11b-	DC	showed	a	 gradual	 increase	 in	 frequency	 from	 birth	 (Fig	 4.7D),	 although	 their	 absolute	numbers	did	not	approach	adult	levels	until	D42.			
4.2.4 Overview of intestinal dendritic cell development 
By	 collating	 the	 composition	of	 the	 intestinal	DC	dynamics	 in	 composite	bar	 charts	over	time,	it	was	possible	to	compare	how	the	different	DC	populations	developed.		A	clear	 feature	was	 the	 gradual	 expansion	 of	 the	 CD103+CD11b+	DC	 in	 the	 SI	 LP	 and	migratory	MLN.		In	both	tissues	this	was	preceded	by	expansion	of	the	CD103-CD11b+	population,	which	then	shrank	reciprocally	as	the	CD103+CD11b+	subset	increased.	It	was	notable	that	these	changes	appeared	to	occur	somewhat	earlier	in	the	SI	LP	than	in	the	MLN,	consistent	with	these	populations	developing	first	in	the	mucosa,	before	migrating	to	the	MLN	(Fig	4.8	A	and	C).	 	The	age-related	increase	in	CD103+CD11b+	DC	 and	 the	 reciprocal	 behaviour	 of	 the	 CD103-CD11b+	 subset	was	 also	 seen	 in	 the	colon,	although	there	were	considerably	fewer	CD103+CD11b+	DC	here	than	in	the	SI	LP	(Fig	4.8B).			
The	CD103+CD11b-	DC	population	also	showed	marked	changes	with	age	in	the	SI	LP	and	migratory	MLN.		These	were	the	largest	population	in	the	SI	LP	before	birth,	but	their	 proportion	 then	 fell	 in	 the	 first	 week	 of	 life,	 before	 increasing	 towards	 adult	levels	 thereafter.	 	 By	 contrast,	 this	 subset	was	 rare	 in	 the	migratory	MLN	until	D5,	paralleling	the	loss	of	these	DC	from	SI	LP	and	again	consistent	with	their	emigration	from	 the	 mucosa.	 	 This	 population	 also	 decreased	 at	 birth	 in	 the	 colon,	 perhaps	suggesting	 emigration	 from	 this	 tissue	 too,	 or	 reflecting	 the	 expansion	 of	 CD103-CD11b+	DC	that	occurs	at	this	time.		However,	by	D7	and	afterwards,	CD103+CD11b-	DC	rapidly	became	the	largest	population	in	the	colon,	in	marked	contrast	to	the	SI	LP.		
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By	comparison,	 the	proportions	of	CD103-CD11b-	DC	did	not	change	markedly	with	time	and	the	pattern	showed	no	clear	relationship	to	any	of	the	other	subsets.			
I	 used	 resident	 MLN	 DC	 to	 represent	 the	 development	 of	 lymphoid	 DC	 derived	directly	from	the	bloodstream,	and	this	showed	that	the	dominance	of	CD103+CD11b-	DC	 at	 birth	 was	 rapidly	 replaced	 by	 increasing	 proportions	 of	 CD103-CD11b+	 DC,	which	were	 the	majority	 subset	 from	D3	 onwards.	 	 There	was	 also	 an	 age	 related	increase	in	the	proportion	of	CD103-CD11b-	DC	(Fig	4.8D).			
The	 results	 above	 showed	 that	 the	 absolute	 numbers	 of	 DC	 increased	 with	 age.		However,	 this	was	unsurprising	given	that	all	 the	organs	 themselves	expand	 in	size	from	 birth	 onwards	 (Fig	 4.9A).	 	 To	 correct	 for	 this,	 I	 assessed	 the	 density	 of	 each	population,	 measured	 as	 numbers	 per	 gram	 of	 tissue.	 	 This	 showed	 that	 there	appeared	to	be	an	intense	burst	in	DC	development	in	both	the	SI	LP	and	CLP	around	D14,	 when	 the	 relative	 dominance	 of	 CD103+CD11b+	 and	 CD103+CD11b-	 DC	respectively	became	established.		There	was	then	a	second,	smaller	increase	in	some	populations	after	D42,	especially	in	the	colon	(Fig	4.9	B-C).		As	might	be	anticipated,	the	density	of	migratory	DC	 in	 the	MLN	also	 increased	 transiently	between	D7	and	D14,	 but	 then	 increased	markedly	 throughout	 adult	 life	 (Fig	4.9D).	 	 Interestingly,	 a	similar	 pattern	 was	 seen	 amongst	 the	 resident	 DC	 in	 the	 MLN,	 suggesting	 these	changes	reflect	a	generalised	process	in	DC	development	rather	than	changes	driven	by	the	intestinal	environment	(Fig	4.9E).			
4.2.5 Development of dendritic cells in the lung 
As	a	control	for	my	studies	of	DC	development	in	the	intestine,	I	examined	the	lung	as	an	 additional	 mucosal	 tissue.	 	 Using	 a	 similar	 gating	 strategy	 to	 that	 used	 for	 the	intestinal	 lamina	 propria,	 MP	 were	 identified	 amongst	 live	 (7AAD-)	 CD45+	 cells	 as	CD11c+	MHC	 II+	 B220-	 (Fig	 4.10A),	 CD64+	mφ	 were	 excluded,	 and	 DC	 analysed	 for	CD103	and	CD11b	expression	(Fig	4.10B).			
Unlike	 the	 intestine,	 the	 majority	 of	 DC	 in	 the	 lung	 were	 either	 CD103-CD11b+	 or	CD103+CD11b-	DC	 at	 all	 time	points	 except	 for	D5,	when	 approximately	 50%	were	CD103-CD11b-	DC.	 	As	expected,	 few	 if	 any	CD103+CD11b+	DC	could	be	 seen	at	any	
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age,	although	in	D1	~3.6%	had	this	phenotype,	which	then	decreased	to	~0.8%	by	D3	(Fig	4.11A).	 	 The	proportion	of	 CD103-CD11b+	DC	 remained	 fairly	 constant	 at	 20%	until	 D14,	 after	 which	 it	 doubled	 until	 dropping	 back	 to	 the	 adult	 levels	 of	 20%	between	D28	and	D42.	 	The	absolute	numbers	of	this	subset	were	low	apart	from	a	marked,	but	 transient	expansion	at	D21	(Fig	4.11B).	 	CD103+CD11b-	DC	 formed	 the	majority	subset	on	D1,	but	fell	transiently	at	D3.		The	proportion	of	CD103+CD11b-	DC	dropped	 further	 at	 D21	 and	 D28,	 probably	 reflecting	 the	 increased	 frequency	 of	CD103-CD11b+	DC,	while	the	absolute	numbers	of	CD103+CD11b-	DC	increased	until	D21,	 before	 falling	 at	 D28	 (Fig	 4.11C).	 	 Although	 the	 proportions	 and	 numbers	 of	CD103-CD11b-	DC	were	generally	low,	their	numbers	showed	a	transient	expansion	at	D21,	similar	to	that	seen	for	the	other	subsets	(Fig	4.11D).			
The	composite	bar	chart	highlighted	the	absence	of	CD103+CD11b+	DC,	as	well	as	the	expansion	 of	 CD103-CD11b+	 DC	 and	 reciprocal	 decrease	 in	 CD103+CD11b-	 DC	 at	around	D21	(Fig	4.12A).		Measuring	the	density	of	the	DC	subsets	per	gram	of	tissue	showed	 that	 lung	 mass	 increased	 steadily	 to	 D42	 and	 that	 there	 was	 a	 transient	expansion	 in	 DC	 numbers	 at	 D7	 (Fig	 4.12B).	 	 CD103	 expression	 increased	 in	 the	CD103+CD11b-	DC	to	D7,	after	which	it	increased	only	slightly	further	to	D21.		
4.3 Phenotypic	dissection	of	intestinal	dendritic	cell	development	
The	results	above	suggested	that	the	maturation	of	CD103+CD11b+	DC	in	the	intestine	was	delayed	in	comparison	to	the	other	subsets	and	that	this	may	be	preceded	by	the	development	of	the	CD103-CD11b+	subset.		While	performing	these	experiments,	on-going	work	in	the	laboratory	of	Professor	Mowat	suggested	that	these	subsets	might	be	related	to	each	other	in	adulthood.	Therefore	I	decided	to	explore	further	whether	such	a	connection	could	explain	my	results.			
4.3.1 CD103 expression on intestinal dendritic cell subsets 
To	 determine	 if	 one	 DC	 subset	 was	 developmentally	 related	 to	 another,	 I	 first	examined	 the	 phenotype	 of	 the	 individual	 subsets	 in	more	 detail	 to	 study	whether	this	 might	 reveal	 additional	 stages	 in	 development.	 	 To	 begin	 with,	 I	 assessed	 the	levels	 of	 CD103	 expression	 on	 the	 DC	 subsets	 at	 different	 times	 after	 birth.	 	 This	
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showed	 that	 CD103+CD11b+	 DC	 consistently	 expressed	 lower	 levels	 than	CD103+CD11b-	DC	in	both	the	SI	LP	and	CLP	at	all	ages.	 	This	seemed	to	reflect	 that	whereas	 CD103	 expression	 by	 CD103+CD11b+	DC	 increased	 only	modestly	 to	 adult	levels	 from	 D21,	 there	 were	 marked	 increases	 in	 CD103	 expression	 by	 the	CD103+CD11b-	 subset	 over	 time.	 	 This	 was	 seen	 most	 dramatically	 on	 D14	 in	 the	colon	 but	 not	 until	 D21	 in	 the	 SI	 LP	 (Fig	 4.13A-B).	 	 The	 difference	 in	 CD103	expression	between	 the	 subsets	was	not	as	marked	amongst	migratory	DC	 in	MLN,	except	at	D14,	when	there	was	a	large	but	transient	increase	in	CD103	expression	by	the	 CD103+CD11b-	 subset	 (Fig	 4.13C).	 	 CD103	 expression	 by	 CD103+CD11b-	 DC	amongst	 resident	MLN	DC	did	not	vary	much	with	age,	apart	 from	a	small	 increase	towards	D7	(Fig	4.13D).			
4.3.2 Trem-1 and CD101 as markers of tissue specific dendritic cell 
differentiation  
Next	I	investigated	whether	the	delayed	appearance	of	CD103+CD11b+	DC	was	simply	due	to	an	isolated	defect	in	expression	of	the	CD103	molecule,	or	indicated	a	failure	of	the	entire	developmental	program.		Therefore	I	decided	to	try	and	find	other	markers	that	might	allow	the	CD103+CD11b+	DC	lineage	to	be	identified	without	using	CD103.		To	do	this,	I	exploited	microarray	data	generated	by	a	previous	PhD	student	in	the	lab,	which	 had	 identified	 a	 number	 of	 genes	 that	 were	 significantly	 over-expressed	 by	CD103+CD11b+	DC	compared	with	 the	CD103-CD11b+	subset.	 	We	hypothesised	 that	some	of	these	would	act	as	surrogate	markers	that	would	allow	CD103+CD11b+	DC	to	be	identified	(Fig	4.14).		Antibodies	against	some	of	these	markers	were	screened	for	their	 ability	 to	 discriminate	 intestinal	 DC	 subsets	 by	 flow	 cytometry	 and	 amongst	these,	Trem-1	and	CD101	were	selected	as	being	particularly	useful.			
To	investigate	whether	Trem-1	and	CD101	could	be	used	to	dissect	the	development	of	 intestinal	 DC	 subsets	 in	 more	 depth,	 I	 first	 examined	 their	 expression	 by	 DC	populations	 in	 different	 organs	 of	 adult	 mice,	 before	 moving	 on	 to	 the	 neonatal	intestine.			
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4.3.2.1 Small intestinal lamina propria 
Initially,	I	looked	in	the	SI	LP	and	analysed	the	four	DC	subsets	based	on	CD103	and	CD11b	for	their	expression	of	Trem-1	or	CD101.		This	showed	that	CD103+CD11b+	DC	expressed	 the	 highest	 levels	 of	 CD101,	 while	 some	 CD103-CD11b+	 DC	 expressed	CD101,	and	the	CD103+CD11b-	and	CD103-CD11b-	DC	expressed	very	little.		A	similar	pattern	 was	 seen	 for	 Trem-1	 expression	 (Fig	 4.15A).	 	 An	 even	 clearer	 pattern	emerged	when	CD101	and	Trem-1	were	examined	in	combination,	showing	that	most	CD103+CD11b+	DC	expressed	both	CD101	and	Trem-1	(88%),	with	a	few	expressing	CD101	 or	 Trem-1	 alone	 (4%).	 	 ~20%	 of	 CD103-CD11b+	 DC	 also	 expressed	 both	CD101	 and	 Trem-1,	 while	 ~15%	 were	 positive	 for	 either	 marker	 alone	 and	 the	remainder	 expressed	 neither	 molecule.	 	 By	 contrast,	 CD103+CD11b-	 and	 CD103-CD11b-	DC	expressed	very	little	CD101	or	Trem-1,	with	only	a	few	expressing	Trem-1	alone	and	no	CD101+Trem-1+	cells	being	found	(Fig	4.15B-C).			
4.3.2.2 Small intestine draining mesenteric lymph nodes 
Next	I	analysed	adult	MLN	and	took	advantage	of	recent	work	in	Dr.	Simon	Milling’s	lab	that	had	distinguished	the	segments	of	the	MLN	chain	that	drain	the	SI	LP	and	CLP	(sMLN	and	cMLN	respectively)	(Houston	et	al.,	2015).	 	This	allowed	the	comparison	of	migratory	DC	deriving	from	the	SI	or	colon	specifically.	 	The	expression	of	CD101	and	Trem-1	by	migratory	DC	in	the	sMLN	mirrored	that	of	the	SI	LP,	whereby	most	CD103+CD11b+	DC	expressed	both	CD101	and	Trem-1,	as	did	some	CD103-CD11b+	DC.		A	 few	 CD103-CD11b+	 DC	 also	 expressed	 CD101	 and	 Trem-1	 alone,	 but	 again	 the	CD103+CD11b-	 and	 CD103-CD11b-	 DC	 were	 mainly	 negative	 for	 CD101,	 and	 a	 few	expressed	Trem-1	alone	(Fig	4.16).	 	Resident	DC	in	the	sMLN	were	quite	distinct,	as	most	 expressed	 no	 CD101	 or	 Trem-1,	 apart	 from	 a	 small	 population	 (~30%)	 of	CD103-CD11b+	DC	that	were	CD101+	(Fig	4.17).			
4.3.2.3 Colonic lamina propria 
Somewhat	surprisingly,	a	different	pattern	was	seen	in	the	colon	compared	with	SI	LP.		Although	most	CD103+CD11b+	DC	expressed	CD101,	the	levels	of	Trem-1	were	much	lower	than	in	the	SI	LP	and	no	Trem-1	was	found	on	any	other	subset.		As	in	the	SI	LP,	
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some	colonic	CD103-CD11b+	DC	were	CD101+	(Fig	4.18).		I	considered	the	possibility	that	there	may	have	been	specific	cleaving	of	 the	Trem-1	molecule	 from	the	colonic	DC	 subsets	 during	 the	 digestion	 process,	which	 uses	 different	 enzymes	 from	 those	used	 in	 isolating	 SI	 LP.	 	 To	 rule	 this	 out,	 I	 examined	 the	migratory	DC	 in	 the	 colon	specific	 cMLN	 that	 was	 obtained	 using	 the	 same	 digestion	 protocol	 as	 the	 sMLN,	where	Trem-1+	DC	were	abundant.		
4.3.2.4 Colonic draining mesenteric lymph nodes 
The	expression	of	CD101	and	Trem-1	by	migratory	cMLN	DC	was	similar	 to	 that	 in	the	CLP,	with	far	fewer	CD103+CD11b+	DC	expressing	CD101	and	Trem-1	compared	with	SI	LP	or	MLN.		Thus	the	lack	of	Trem-1	in	the	colon	does	not	appear	to	reflect	an	effect	of	enzymatic	digestion	(Fig	4.19).		As	in	the	sMLN,	resident	cMLN	DC	had	little	expression	of	CD101	or	Trem-1	on	any	of	the	DC	subsets,	except	for	a	small	amount	(~12%)	of	CD101	expression	on	CD103-CD11b+	DC	(Fig	4.20).			
4.3.2.5 Non-intestinal tissues 
As	 these	 results	 suggested	 that	 CD101	 and	 Trem-1	 expression	 was	 a	 particular	feature	 of	 CD103+CD11b+	 DC	 in	 SI	 LP,	 I	 interrogated	 this	 observation	 further	 by	examining	 the	 expression	 of	 Trem-1	 and	 CD101	 by	 DC	 subpopulations	 in	 non-intestinal	tissues.	 	First	I	examined	the	skin	draining	peripheral	lymph	nodes	(PLN),	where	both	migratory	and	 resident	DC	can	be	 identified	on	 the	basis	of	CD11c	and	MHC	 II	 expression	 (as	 in	 the	 MLN).	 	 As	 expected,	 there	 were	 virtually	 no	CD103+CD11b+	 DC	 amongst	 either	 the	 migratory	 or	 resident	 populations	 in	 skin	draining	PLN,	with	most	 being	CD103-CD11b+,	 CD103+CD11b-	 or	 CD103-CD11b-	DC.		Apart	 from	a	very	 small	 subset	of	CD103-CD11b+	DC	 that	were	CD101+,	CD101	and	Trem-1	were	not	expressed	to	any	significant	extent	by	any	of	the	DC	subsets	within	either	the	migratory	or	resident	compartment,	nor	by	the	rare	CD103+CD11b+	DC	(Fig	4.21	and	4.22,	respectively).			
None	of	the	three	subsets	of	DC	found	in	the	spleen	expressed	Trem-1,	but	~40%	of	CD103-CD11b+	 DC	 expressed	 CD101,	 as	 did	 a	 few	 CD103-CD11b-	 DC.	 	 CD101	 was	absent	from	CD103+CD11b-	DC	(Fig	4.23).		The	liver	(Fig	4.24)	and	kidney	(Fig	4.25)	
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also	contained	three	DC	populations	based	on	CD103	and	CD11b	expression,	lacking	the	CD103+CD11b+	DC	subset.		The	pattern	of	CD101	and	Trem-1	expression	by	these	subsets	was	similar	to	the	spleen,	with	no	Trem-1	expressed	by	any	DC	and	variable	proportions	of	CD103-CD11b+	DC	expressing	CD101.		I	also	examined	DC	in	the	heart,	where	CD103+CD11b+	DC	were	also	absent.		Here	none	of	the	DC	expressed	CD101	or	Trem-1	(Fig	4.26).			
Four	 DC	 subsets	 could	 be	 identified	 in	 the	 lung,	 although	 as	 noted	 earlier,	 the	frequencies	 of	 CD103+CD11b+	 DC	 were	 variable	 and	 generally	 very	 low,	 with	 the	majority	of	DC	being	CD103-CD11b+	or	CD103+CD11b-.	 	As	 in	 the	PLN,	Trem-1	was	not	expressed	by	any	DC	subset	in	the	lung,	but	some	of	them	did	express	CD101	to	some	extent,	with	 this	being	most	apparent	 in	 the	 rare	CD103+CD11b+	DC	 (~60%),	followed	by	the	CD103-CD11b+	DC	(~20%)(Fig	4.27).			
Together	 these	 data	 show	 that	 CD101	 and	 Trem-1	 can	 further	 distinguish	CD103+CD11b+	DC	and	that	co-expression	of	these	markers	is	selective	for	this	subset	in	 the	 SI	 LP.	 	 I	 went	 on	 to	 use	 these	 markers	 to	 analyse	 in	 more	 detail	 the	development	of	the	CD103+CD11b+	DC	lineage	in	neonatal	intestine.	
4.4 Trem-1	and	CD101	expression	by	dendritic	cells	during	development	
Having	 established	 that	 Trem-1	 and	 CD101	 were	 suitable	 for	 identifying	 the	CD103+CD11b+	subset	of	 intestinal	DC	(at	 least	 in	the	SI	LP),	 I	went	on	to	use	these	markers	 to	extend	my	analysis	of	DC	development	 in	 the	neonatal	 intestine.	 	To	do	this	I	isolated	cells	from	D1,	D14	and	8-10	week	old	adult	mice,	having	chosen	these	time	points	because	my	earlier	studies	indicated	these	were	times	when	substantial	changes	were	taking	place	in	the	composition	of	the	DC	compartment.			
As	before,	CD103+CD11b+	DC	were	rare	 in	D1	SI	LP,	but	 their	proportion	 increased	substantially	 by	 D14	 and	 again	 in	 adults	 (Fig	 4.28A).	 	 Even	 on	 D1,	 the	 majority	(~60%)	 of	 these	 DC	 expressed	 CD101	 and	 this	 was	 found	 on	 virtually	 all	CD103+CD11b+	DC	 by	D14.	 	 Trem-1	 expression	 took	 longer	 to	 become	 established,	with	 only	 a	 few	 CD103+CD11b+	 DC	 expressing	 Trem-1	 on	 D1.	 	 The	 proportion	 of	Trem-1+	cells	had	increased	markedly	by	D14	(76%)	and	increased	only	a	little	more	
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into	adults	(88%).		At	all	times	the	Trem-1+	cells	also	expressed	CD101	(Fig	4.28B;	Fig	4.29A).	 	 As	 I	 found	 previously,	 the	 CD103-CD11b+	 DC	 subset	 appeared	 to	 develop	more	 quickly	 than	 the	 CD103+CD11b+	 DC	 subset,	 being	 present	 in	 substantial	proportions	by	D1	and	reducing	somewhat	thereafter	(Fig	4.28A).		At	D1	around	50%	of	CD103-CD11b+	DC	expressed	CD101,	with	~15%	of	these	also	expressing	Trem-1.		The	 proportions	 of	 CD103-CD11b+	 DC	 expressing	 CD101,	 either	 alone	 or	 together	with	 Trem-1,	 increased	 at	 D14	 before	 returning	 to	 the	 adult	 values	 of	 ~25%	 and	~15%	respectively	 (Fig	4.28C;	Fig	4.29B).	 	The	CD11b-	 subsets	 (CD103+CD11b-	and	CD103-CD11b-	 DC)	 had	 virtually	 no	 CD101	 expression	 and	 only	 small	 numbers	 of	Trem-1+	cells	at	any	time	after	birth,	consistent	with	what	I	found	in	adult	SI	LP	(Fig	4.28	D-E;	Fig	4.29C-D).			
I	next	examined	the	colon,	where	there	were	very	few	CD103+CD11b+	DC	on	D1	but	where	these	increased	in	frequency	to	adult	levels	by	D14	(Fig	4.30A).	 	Due	to	their	low	numbers,	it	was	difficult	to	assess	the	expression	of	CD101	and	Trem-1	on	these	DC	at	D1,	but	by	D14	virtually	all	of	these	expressed	CD101,	as	in	adults.		Interestingly,	unlike	 adult	 CLP,	 significant	numbers	 of	 CD103+CD11b+	DC	 expressed	both	Trem-1	and	 CD101	 on	 D14	 (~27%).	 	 As	 in	 SI	 LP,	 CD103-CD11b+	 DC	 were	 already	 well	established	 in	 the	 colon	on	D1	 and	 remained	 abundant	 into	 adulthood	 (Fig	 4.30A).		Interestingly,	at	D1	some	of	these	DC	expressed	Trem-1	either	alone,	or	together	with	CD101,	 similar	 to	 what	 I	 found	 in	 neonatal	 SI	 LP	 (Fig	 4.30B;	 Fig	 4.31A).	 	 These	populations	were	virtually	absent	in	the	adult	CLP.		CD103-CD11b+	DC	also	expressed	CD101+	 alone	 in	 substantial	 numbers	 on	 D1	 and	 appeared	 to	 expand	markedly	 on	D14	 before	 falling	 again	 in	 adulthood.	 	 As	 in	 the	 SI	 LP,	 more	 than	 90%	 of	 the	CD103+CD11b-	and	CD103-CD11b-	DC	were	negative	for	CD101	or	Trem-1	at	all	times	(Fig	4.30	D-E;	Fig	4.31C-D).			
As	 I	had	 found	earlier,	 very	 few	migratory	DC	were	present	 in	 the	MLN	on	D1	and	therefore	 it	was	difficult	 to	assess	the	expression	of	CD101	and	Trem-1	at	 this	 time	point.	 	 By	D14,	 the	 numbers	 of	migratory	DC	 had	 increased,	 and	 at	 this	 time	most	CD103+CD11b+	 DC	 were	 CD101+,	 with	 ~28%	 expressing	 both	 CD101	 and	 Trem-1,	which	was	much	lower	than	in	the	SI	LP	at	this	time.		By	adulthood,	50%	of	migratory	CD103+CD11b+	DC	were	CD101+Trem-1+	 (Fig	4.32B;	Fig	4.33A).	Similar	proportions	(~25%)	of	CD103-CD11b+	DC	expressed	CD101	throughout	development,	and	on	D14	
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some	expressed	Trem-1	alone,	but	this	was	reduced	by	adulthood.		Very	few	cells	in	this	 subset	 expressed	 both	 molecules	 together	 (Fig	 4.32C;	 Fig	 4.33B).	 	 As	 before,	CD103+CD11b-	and	CD103-CD11b-	DC	had	little	or	no	expression	of	CD101	or	Trem-1	at	any	time	(Fig	4.32	D-E;	Fig	4.33C-D).			
As	in	my	previous	experiments,	most	of	the	resident	DC	in	the	adult	MLN	expressed	neither	CD101	nor	Trem-1	and	this	was	generally	the	case	throughout	development,	apart	 from	 transient	 expression	 of	 Trem-1	 on	CD103-CD11b+	DC	 at	D14,	 similar	 to	what	 I	 observed	 amongst	 migratory	 and	 mucosal	 DC	 in	 this	 subset	 at	 this	 time.		Whether	 this	 reflects	 contamination	 from	 the	 migratory	 gate	 remains	 to	 be	determined	(Fig	4.34;	Fig	4.35).			
4.5 Functional	consequences	of	intestinal	dendritic	cell	development		
In	the	final	experiments	in	this	chapter,	I	examined	whether	the	age-related	changes	in	DC	subsets	had	functional	consequences.			
4.5.1 Retinoic acid production by dendritic cells in neonatal intestine 
As	described	earlier,	a	characteristic	feature	of	intestinal	DC	is	their	ability	to	produce	retinoic	 acid	 by	 the	metabolism	 of	 vitamin	A	 and	 therefore	 I	 used	 this	 property	 to	assess	 how	DC	 function	 in	 the	 intestine	 changed	 during	 early	 life.	 	 First	 I	 analysed	RALDH	activity	in	total	SI	LP	DC	from	D1,	D7	or	8-10	week	old	adult	mice	using	the	AldefluorTM	assay	(Fig	4.36A).	 	As	expected,	a	 large	proportion	of	adult	mucosal	DC	were	AldefluorTM+.	 	 By	 contrast,	 very	 few	AldefluorTM+	DC	were	 present	 on	D1	 and	these	 positive	 cells	 expressed	 only	 low	 levels	 of	 RALDH.	 	 AldefluorTM	 activity	 was	somewhat	 increased	on	D7,	but	was	still	 significantly	 less	 than	 that	of	 the	adult	DC	(Fig	4.36B).			
I	went	on	to	look	at	the	individual	DC	subsets,	all	of	which	expressed	AldefluorTM	in	the	adult	(Fig	4.37B).	 	The	highest	proportion	of	AldefluorTM+	cells	was	amongst	the	CD103+CD11b+	DC	subset	in	the	adult,	but	the	highest	level	of	expression	was	by	the	CD103+CD11b-	DC.		Although	AldefluorTM+	cells	were	detectable	amongst	most	of	the	DC	 subsets	 present	 at	D1,	 the	 levels	were	 lower	 than	 those	 in	 the	 equivalent	 adult	
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subsets	and	CD103-CD11b-	DC	contained	no	AldefluorTM+	cells.		By	D7	the	proportion	of	AldefluorTM+	cells	amongst	CD103+CD11b-	and	CD103-CD11b-	DC	had	reached	that	of	the	adult,	when	the	levels	were	also	almost	equivalent.		By	contrast	the	proportion	of	 AldefluorTM+	 cells	 amongst	 CD103+CD11b+	 and	 CD103-CD11b+	 DC	 actually	 fell	between	D1	and	D7	and	the	levels	of	RALDH	in	these	subsets	remained	significantly	below	the	adult	levels	(Fig	4.37).		These	data	indicate	that	RA	production	takes	some	time	 to	 develop	 after	 birth,	 even	 when	 the	 principal	 RA	 producing	 subsets	 have	already	begun	to	accumulate.			
4.5.2 Age dependent development of effector T cells in small intestinal 
lamina propria 
I	next	went	on	to	investigate	whether	the	changes	in	DC	composition	and	function	in	neonates	correlated	with	CD4+	effector	T	cell	development,	as	different	DC	subsets	in	the	 intestine	are	able	to	polarise	naïve	CD4+	T	cells	differently	(Cerovic	et	al.,	2013;	Coombes	 et	 al.,	 2007;	 Sun	 et	 al.,	 2007).	 	 To	 do	 this,	 I	 isolated	 SI	 LP	 leukocytes,	stimulated	them	with	PMA	and	ionomycin	for	4.5	hours	and	assessed	their	expression	of	IL-17,	IFNγ	and	FoxP3	by	intracellular	staining.		In	these	experiments	I	identified	T	cells	using	CD5	instead	of	CD3,	as	CD3	can	be	internalised	from	the	T	cell	membrane	after	activation	(Yamane	et	al.,	1991).		CD5+	B	cells	were	excluded	using	B220	and	the	remaining	CD5+	CD4+	T	cells	analysed	(Fig	4.38A).		Positive	intracellular	staining	for	Treg,	 Th1	 and	 Th17	 cells	 was	 determined	 by	 comparing	 with	 appropriate	 isotype	controls	(Fig	4.38B).			The	time	course	started	at	D7,	as	I	was	unable	to	isolate	enough	SI	LP	leukocytes	for	the	PMA/ionomycin	restimulation	from	D1	mice.			
The	frequency	of	CD4+	T	cells	amongst	total	CD45+	leukocytes	decreased	significantly	between	D7	(~30%)	and	D21	(~20%)	and	again	from	D21	to	D42	(~10%),	before	the	frequency	stabilised	in	8-10	week	old	adults.		Although	the	absolute	numbers	of	CD4+	T	cells	did	not	change	significantly	over	the	time	course,	there	was	a	slight	increase	in	their	number	at	8-10	weeks,	which	was	not	significant	due	to	the	variability	between	individual	results	(Fig	4.38A;	lower	panel).			
FoxP3+	 Treg	 cells	 increased	 significantly	 in	 proportion	 from	 D7	 (~4%)	 until	 D42	(~14%),	at	which	point	they	were	similar	to	those	in	the	8-10	week	old	adult	(~15%).		
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There	 was	 also	 a	 general	 trend	 for	 the	 frequency	 of	 both	 Th1	 and	 Th17	 cells	 to	increase	 as	 the	 mice	 matured	 to	 adulthood,	 although	 from	 D21	 onwards	 Th1	 and	Th17	cells	made	up	a	significantly	lower	proportion	of	CD4+	T	cells.		The	numbers	of	FoxP3+	Tregs	also	increased	significantly	from	D7	(~0.6	x104)	to	~6	x104	at	D42	and	to	~10	x104	 in	adults.	 	The	Th1	and	Th17	cells	gradually	 increased	 in	number	with	time,	but	remained	significantly	less	abundant	than	FoxP3+	Tregs	from	D21	onwards	(Fig	4.38B).			
4.6 Summary	
The	results	of	this	chapter	show	that	DC	are	present	in	the	intestine	from	before	birth,	but	 the	 composition	 of	 the	 population	 changes	markedly	 from	 then	 until	 adult	 life,	particularly	 in	 the	 neonatal	 period.	 	 Thus,	 although	 CD103+CD11b+	 DC	 were	 the	predominant	population	 in	 the	adult	SI	LP,	 this	pattern	did	not	become	established	until	around	28	days	after	birth	and	these	DC	were	rare	in	the	neonatal	SI	LP	until	D5.		The	appearance	of	CD103+CD11b+	DC	was	preceded	by	the	presence	of	a	substantial	number	of	CD103-CD11b+	DC,	which	then	fell	towards	adult	levels.		CD103+CD11b-	DC	were	 the	predominant	subset	 in	embryonic	SI	LP,	but	 their	 frequency	 fell	markedly	after	 birth,	 before	 a	 second	 expansion	 after	 D7	which	meant	 that	 they	 became	 the	second	most	abundant	DC	subset	in	the	SI	LP	thereafter.			
The	development	of	CD103+CD11b+	DC	in	the	CLP	was	slower	than	in	the	SI	LP	and	this	 subset	 never	 reached	 the	 same	 proportions	 as	 in	 the	 SI	 LP	 and	 did	 not	 really	become	established	until	D14,	a	week	later	than	in	the	SI	LP.		However,	as	in	the	SI	LP,	the	 increase	 in	 colonic	 CD103+CD11b+	 DC	 frequency	 coincided	 with	 a	 decrease	 in	CD103-CD11b+	DC.			
The	development	of	migratory	DC	subsets	in	MLN	mirrored	that	of	the	lamina	propria	of	 the	 intestine,	 resembling	 the	 SI	 LP	 in	 particular.	 	 However	 the	 expansion	 in	 the	proportion	of	CD103+CD11b+	DC	was	more	dramatic	than	in	either	the	SI	LP	or	CLP	and	it	was	delayed	when	compared	to	the	lamina	propria.		In	parallel,	the	contraction	of	 the	 CD103-CD11b+	 DC	 population	 was	 also	 more	 evident	 in	 MLN,	 whereas	CD103+CD11b-	DC	increased	relatively	gradually	as	the	mice	matured.			
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The	resident	compartment	of	MLN	DC	was	used	as	an	example	of	blood	derived	DC	in	secondary	lymphoid	organs.		As	expected,	CD103+CD11b+	DC	were	missing	from	this	population	 and	 the	 much	 greater	 proportion	 of	 CD103-CD11b+	 DC	 accumulated	progressively	from	birth	until	D28.		These	changes	were	paralleled	by	contraction	in	the	proportion	of	CD103+CD11b-	DC	that	predominated	at	birth.		I	also	used	the	lung	as	 a	 non-intestinal	 mucosal	 tissue,	 where	 again	 CD103+CD11b+	 DC	 were	 almost	absent.	 	As	with	resident	MLN	DC,	 there	was	an	 increase	 in	CD103-CD11b+	DC	from	D3	up	until	D28	in	both	proportion	and	absolute	number,	whilst	the	CD103+CD11b-	DC	initially	dropped	in	proportion	from	D1	to	D3,	and	then	increased	and	stabilised	from	D5	to	D28.		Although	there	were	similarities	between	the	resident	MLN	DC	and	the	 lung	 DC,	 there	 were	 subtle	 differences	 in	 the	 dynamics	 of	 the	 DC	 subsets,	probably	reflecting	differences	in	the	local	environment.			
Because	I	was	concerned	that	the	 increasing	size	of	 the	tissues	during	development	might	confound	interpretation	of	the	results,	I	also	calculated	the	number	of	cells	per	gram	of	 tissue.	 	This	showed	that	although	the	absolute	numbers	of	DC	populations	increased	progressively	with	time,	their	density	in	the	LP	did	not	change	as	markedly,	apart	 from	a	 transient	 expansion	 at	D14.	 	 This	 increase	 in	density	 at	D14	was	 also	seen	amongst	migratory	and	resident	MLN	DC,	and	a	similar	pattern	was	seen	in	the	lung,	except	that	the	early	transient	expansion	occurred	at	D7	as	opposed	to	D14.			
An	additional	feature	that	changed	as	DC	developed	in	the	SI	LP	and	CLP	was	that	the	level	of	CD103	expression	increased	progressively	on	both	subsets	of	CD103+	DC	as	the	mice	matured,	especially	on	CD103+CD11b-	DC.		However,	this	was	not	seen	with	CD103+CD11b-	DC	 in	 the	MLN	or	 lung,	suggesting	there	may	be	a	 local	 factor	 in	 the	intestine	that	influences	the	expression	of	CD103.			
These	 changes	 in	 CD103	 expression	 and	 the	 apparently	 reciprocal	 behaviour	 of	CD103+CD11b+	 and	 CD103-CD11b+	 DC	 led	 me	 to	 explore	 the	 development	 of	 the	CD103+CD11b+	lineage	in	more	detail,	and	specifically	to	examine	how	these	subsets	might	be	related.		To	do	this	I	exploited	microarray	data	generated	in	the	lab	that	had	identified	 CD101	 and	 Trem-1	 as	 markers	 that	 were	 differentially	 upregulated	between	 CD103+CD11b+	 and	 CD103-CD11b+	 DC.	 	 Flow	 cytometric	 analysis	 of	 adult	tissues	confirmed	this	by	showing	that	CD103+CD11b+	and	CD103-CD11b+	DC	in	the	
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SI	LP	and	migratory	sMLN	expressed	CD101	and	Trem-1,	whereas	no	resident	MLN	DC	 expressed	 Trem-1	 and	 only	 a	 few	 CD103-CD11b+	DC	 in	 the	 intestine	 expressed	CD101.		Interestingly,	the	expression	of	both	Trem-1	and	CD101	was	different	in	the	CLP	and	cMLN,	where	there	was	little	or	no	expression	of	Trem-1	by	CD103-CD11b+	or	 CD103-CD11b+	 DC.	 	 This	was	 also	 true	 of	 Trem-1	 expression	 by	 DC	 in	 all	 other	tissues	and	 therefore	appeared	 to	be	a	 specific	 feature	of	 intestinal	DC,	particularly	those	 in	 the	SI.	 	However,	CD101	was	expressed	by	DC	 in	other	 tissues	such	as	 the	spleen,	liver,	kidney	and	lung	where	it	was	confined	mostly	to	the	CD103-CD11b+	DC,	as	well	as	to	the	rare	CD103+CD11b+	DC	found	in	the	lung.	PLN	and	heart	DC	did	not	express	CD101.			
These	 results	 indicated	 that	 Trem-1	 and	 CD101	 were	 selective	 markers	 of	CD103+CD11b+	DC	developing	from	CD103-CD11b+	DC.		Therefore	I	went	on	to	look	at	the	 effects	 of	 ageing	 on	 CD101	 and	 Trem-1	 expression	 by	 intestinal	 DC.	 	 These	experiments	showed	that	CD101	and	Trem-1	expression	by	CD103+CD11b+	or	CD103-CD11b+	 DC	 in	 SI	 LP	 and	 migratory	 MLN	 generally	 increased	 with	 age.	 	 However,	despite	the	absence	of	Trem-1	expression	in	the	adult	CLP,	a	transient	population	of	CD101+Trem-1+	cells	was	present	amongst	CD103+CD11b+	DC	in	the	CLP	at	D14.		The	lack	of	expression	of	CD101	and	Trem-1	by	CD103+CD11b-	and	CD103-CD11b-	DC	in	SI	LP,	CLP	and	MLN	did	not	change	with	age.			
Taken	 together,	 these	 results	 suggest	 that	development	of	CD103+CD11b+	DC	could	be	 related	 to	 the	 CD103+CD11b-	 DC,	 evidenced	 by	 their	 reciprocal	 increase	 and	decrease,	respectively.		Furthermore,	increasing	levels	in	the	co-expression	of	CD101	and	Trem-1	amongst	CD103+CD11b+	DC,	compared	to	the	more	dynamic	expression	in	CD103-CD11b+	DC	could	indicate	a	shared	maturation	pathway	in	these	DC	subsets.			
Lastly,	 I	 investigated	 if	 these	 phenotypic	 changes	 with	 age	 in	 intestinal	 DC	 were	associated	 with	 any	 functional	 differences.	 	 To	 address	 this,	 I	 first	 assessed	 RA	production	 by	 the	 various	 subsets	 from	 the	 SI	 LP	 at	 different	 ages,	 and	 found	 that	although	RALDH	activity	was	present	 in	most	DC	 subsets	 at	birth,	 the	 frequency	of	positive	DC	and	 the	 levels	of	expression	 increased	 thereafter.	 	This	 took	 longest	 for	CD103+CD11b+	 and	 CD103-CD11b+	 DC,	 which	 only	 acquired	 adult	 levels	 after	 D7,	
 
 
 
114 
whereas	the	CD103+CD11b-	and	CD103-CD11b-	DC	subsets	had	already	reached	adult	levels	by	D7.			
Next	 I	 examined	 for	 the	presence	of	 differentiated	CD4+	T	 in	 the	mucosa,	 as	 this	 is	known	to	reflect	the	activity	of	different	intestinal	DC	subsets.		These	results	showed	that	the	proportion	of	total	CD4+	T	cells	amongst	CD45+	leukocytes	reduced	with	age,	while	 the	absolute	numbers	of	T	cells	did	not	vary	greatly	 from	D7	until	adulthood.	FoxP3+	Tregs	were	always	the	most	abundant	CD4+	T	cell	population,	while	Th1	and	Th17	 cells	 were	 fairly	 similar	 in	 frequency	 and	 number,	 both	 to	 each	 other	 and	throughout	development.			
Overall	 the	 results	 in	 this	 chapter	 show	 that	 the	 distinctive	 composition	 of	 the	intestinal	DC	compartment	takes	some	time	to	develop	after	birth	and	that	this	occurs	differently	 in	 the	 different	 parts	 of	 the	 gut.	 	 In	 addition,	 these	 dynamic	 changes	particularly	 affected	 the	 development	 of	 the	 intestine	 specific	 CD103+CD11b+	 DC.		These	 changes	 reflect	 the	 complex	 maturation	 process	 involving	 a	 number	 of	different	 phenotypic	 changes,	 rather	 than	 just	 the	 acquisition	 of	 CD103,	 and	 are	associated	with	functional	maturation	as	shown	by	the	production	of	RA.		Following	on	 from	 these	 results	 in	 the	next	 chapter	 I	went	on	 to	 look	at	how	age	effected	DC	transcriptional	and	growth	factor	receptors	along	with	CD101	and	Trem-1	expression	in	SIRPα	mt	and	CCR2-/-	mice.		I	also	looked	at	the	role	of	Trem-1	in	DC	development.				
Figure 4.1: Identification of dendritic cells in small intestinal lamina propria 
at different ages 
A SI LP cells were isolated from embryonic D18 (E18) WT mice by enzymatic digestion, 
and after identifying single cells based on FSC-A and FSC-H, mononuclear phagocytes 
(MP) were identified amongst live 7AAD- CD45+ leukocytes as MHC II+ CD11c+.  B After 
exclusion of B220+ CD11c+ plasmacytoid DC (pDC), conventional DC were identified as 
CD11c+ CD64- (or F4/80-), while Mφ were CD11c+ CD64+ (top panels).  The DC were then 
subdivided into four populations based on expression of CD103 and CD11b (bottom 
panels).  The graphs show representative data from mice aged E18, D1 after birth, 8-10 
week old adults and one-year old aged mice.   
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Figure 4.2: Effects of age on dendritic cells in small intestinal lamina propria 
SI LP cells were isolated from WT mice, and live MHC II+ CD11c+ B220- CD64- leukocytes 
were analysed for the expression of CD103 and CD11b from E18 to one year of age.  
Frequency (left panels) and absolute numbers (right panels) of A CD103+CD11b+ B 
CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC. Each dot represents an 
individual mouse and the results are derived from at least 10 different litters. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 4.3: Identification of dendritic cells in colonic lamina propria at 
different ages 
A CLP cells were isolated from embryonic D18 (E18) WT mice by enzymatic digestion 
and after identifying single cells based on FSC-A and FSC-H, mononuclear phagocytes 
(MP) were identified amongst live 7AAD- CD45+ leukocytes as MHC II+ CD11c+.  B After 
exclusion of B220+ CD11c+ plasmacytoid DC (pDC), conventional DC were identified as 
CD11c+ CD64- (or F4/80-), while Mφ were CD11c+ CD64+ (top panels).  The DC were then 
subdivided into four populations based on expression of CD103 and CD11b (bottom 
panels).  The graphs show representative data from mice aged E18, D1 after birth, 8-10 
week old adults and one-year old aged mice.  
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Figure 4.4: Effects of age on dendritic cells in colonic lamina propria 
CLP cells were isolated from WT mice, and live MHC II+ CD11c+ B220- CD64- leukocytes 
were analysed for the expression of CD103 and CD11b from E18 to one year of age.  
Frequency (left panels) and absolute numbers (right panels) of A CD103+CD11b+ B 
CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC. Each dot represents an 
individual mouse and the results are derived from at least 10 different litters. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 4.5: Identification of dendritic cells in MLN at different ages 
A MLN cells were isolated from WT MLN by enzymatic digestion, and after identifying 
single cells based on FSC-A and FSC-H, migratory DC were identified amongst live 
7AAD- CD45+ leukocytes as MHC IIhi CD11c+ and resident DC were identified as MHC IIint 
CD11c+.  B Migratory conventional DC or C Resident conventional DC were identified as 
CD11c+ B220- CD64- and assessed for the expression CD103 and CD11b.  The DC were 
then subdivided into four populations based on expression of CD103 and CD11b.  The 
graphs show representative data from mice aged D1 after birth, 8-10 week old adults and 
one-year old aged mice.  
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Figure 4.6: Effects of age on migratory dendritic cells in MLN 
MLN cells were isolated from WT mice and live MHC IIhi CD11c+ B220- CD64- leukocytes 
were analysed for the expression of CD103 and CD11b from D1 to one year of age.  
Frequency (left panels) and absolute numbers (right panels) of A CD103+CD11b+ B 
CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC. Each dot represents an 
individual mouse and the results are derived from at least 10 different litters. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 4.7: Effects of age on resident dendritic cells in MLN 
MLN cells were isolated from WT mice and live MHC IIint CD11c+ B220- CD64- leukocytes 
were analysed for the expression of CD103 and CD11b from D1 to one year of age.  
Frequency (left panels) and absolute numbers (right panels) of A CD103+CD11b+ B 
CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC. Each dot represents an 
individual mouse and the results are derived from at least 10 different litters. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 4.8: Effects of age on the composition of intestinal dendritic cell 
populations 
Frequencies of CD103 and CD11b based DC subsets in A SI LP, B CLP, C migratory MLN 
compartment and D resident MLN compartment from E18 until adulthood.  The data are 
pooled from at least ten experiments with at least n=3 animals per group of mice per time 
point.   
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Figure 4.9: Effects of age on the density of intestinal dendritic cell populations  
A Weights of SI, colon and MLN from D1 until adulthood.  The frequencies of CD103 and 
CD11b based DC subsets expressed per gram of tissue were then assessed in B SI LP, C 
CLP, D migratory MLN compartment and E resident MLN compartment. The data are pooled 
from at least five experiments in total with at least n=3 animals per group of mice per time 
point.   
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Figure 4.10: Identification of dendritic cells in the lung at different ages 
A Lung cells were isolated from D1 WT mice by enzymatic digestion, and after identifying 
single cells based on FSC-A and FSC-H, mononuclear phagocytes (MP) were identified 
amongst live 7AAD- CD45+ leukocytes as MHC II+ CD11c+.  B After exclusion of B220+ 
CD11c+ plasmacytoid DC (pDC), conventional DC were identified as CD11c+ CD64-, while 
Mφ were CD11c+ CD64+ (top panels).  The DC were then subdivided into four populations 
based on expression of CD103 and CD11b (bottom panels).  The graphs show 
representative data from mice aged E18, D1 after birth, 8-10 week old adults and one-year 
old aged mice.   
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Figure 4.11: Effects of age on dendritic cells in the lung 
Lung cells were isolated from WT mice and live MHC II+ CD11c+ B220- CD64- leukocytes 
were analysed for the expression of CD103 and CD11b from D1 to 8-10 week old adults.  
Frequency (left panels) and absolute numbers (right panels) of A CD103+CD11b+ B 
CD103-CD11b+ C CD103+CD11b- and D CD103-CD11b- DC. Each dot represents an 
individual mouse and the results are derived from at least 10 different litters. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 Student’s t-test.   
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Figure 4.12: Effects of age on composition of lung dendritic cells 
A Frequencies of CD103 and CD11b based DC subsets in the lung. B Weights of lungs and 
frequencies of CD103 and CD11b based DC subsets expressed per gram of tissue.  The 
data are pooled from at least ten experiments with at least n=3 animals per group of mice 
per time point.   
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Figure 4.13: Effects of age on CD103 expression by intestinal dendritic cell 
subsets 
Levels of CD103 on CD103+CD11b+ and CD103+CD11b- DC from A SI LP, B CLP, 
C migratory MLN compartment and D resident MLN compartment.  The results shown are 
the differences in mean fluorescence intensity (ΔMFI) between the CD103-CD11b- DC and 
the CD103 expressing DC subset. The data are pooled from at least ten experiments with at 
least n=3 animals per group of mice per time point. *p<0.05, ***p<0.001, ****p<0.0001, 
Student’s t-test.   
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Figure 4.14: Gene expression profiles of mononuclear phagocyte subsets 
Expression profiles were established using Mouse GeneChip 1.0 ST arrays (Affymetrix). 
Array data was analysed using Genespring 13.0 GX software, normalised using RMA16. 
A MP subsets were clustered according to expression levels of all genes/entities nmφ, 
nCD103+CD11b-, nCD103-CD11b-, nCD103+CD11b+, nCD103-CD11b+. B Volcano plot 
showing expression levels of all entities in CD103+CD11b+ compared to CD103-CD11b+ DC. 
Genes satisfying a FC cut off of 2 and a corrected p value cut off of 0.05 shown in red, 
annotated genes outlined in black.  C Annotated heatmap displaying the relative signalling 
intensities of the 25 entities more highly expressed in CD103+CD11b+ compared to CD103-
CD11b+ DC. Data was kindly generated by Charlotte Scott and analysed by Carolyn 
Thomson, University of Glasgow.   
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Figure 4.15: Expression of Trem-1 and CD101 by small intestinal dendritic 
cells 
Cells were isolated from the SI LP of adult mice and conventional DC identified as single, 
live, CD45+ MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the four 
DC populations based on CD11b and CD103 expression, together with the levels of 
CD101 and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 
by each subset with gates set based on appropriate isotype controls.  C Frequencies of 
each subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 
- 6 mice/group.  Results are pooled from two experiments.   
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Figure 4.16: Expression of Trem-1 and CD101 by migratory small intestinal 
MLN dendritic cells 
Cells were isolated from the sMLN of adult mice and migratory conventional DC identified 
as single, live, CD45+ MHC IIhi CD11c+ CD64- B220- cells.  A Representative analysis 
shows the four DC populations based on CD11b and CD103 expression, together with 
the levels of CD101 and Trem-1 amongst each of the DC subsets. B Co-expression of 
CD101 and Trem-1 by each subset with gates set based on appropriate isotype controls.  
C Frequencies of each subset expressing CD101 and/ or Trem-1, with the data 
representing the mean of 4 mice/group.  Results are from one experiment.   
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Figure 4.17: Expression of Trem-1 and CD101 by resident small intestinal 
MLN dendritic cells 
Cells were isolated from the sMLN of adult mice and resident conventional DC identified 
as single, live, CD45+ MHC IIint CD11c+ CD64- B220- cells.  A Representative analysis 
shows the four DC populations based on CD11b and CD103 expression, and the levels 
of CD101 and Trem-1 amongst each of the DC subsets.  B Co-expression of CD101 and 
Trem-1 by each subset with gates set based on isotype controls.  C Frequencies of each 
subset expressing CD101 and Trem-1 with the data representing the mean of 4 mice/
group.  
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Figure 4.18: Expression of Trem-1 and CD101 by colonic dendritic cells 
Cells were isolated from the CLP of adult mice and conventional DC identified as single, 
live, CD45+ MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the four 
DC populations based on CD11b and CD103 expression, together with the levels of 
CD101 and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 
by each subset with gates set based on appropriate isotype controls.  C Frequencies of 
each subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 
- 6 mice/group.  Results are pooled from two experiments.   
21 45 
7 23 
19 0.9 
11 68 
1 1 
61 36 
0.4 1 
98 1 
0.2 5 
94 0.8 
CD103+CD11b+
CD103+CD11b-
CD103-CD11b+
CD103-CD11b-
CD101-Trem1+
CD101+Trem1+
CD101+Trem1-
CD101-Trem1-
133 
CD11b 
C
D
10
3 
CD101 
Tr
em
-1
 
CD101 Trem-1 
CD103+CD11b+	 CD103-CD11b+	 CD103+CD11b-	 CD103-CD11b-	
Figure 4.19: Expression of Trem-1 and CD101 by migratory colonic MLN 
dendritic cells 
Cells were isolated from the cMLN of adult mice and migratory DC identified as single, 
live, CD45+ MHC IIhi CD11c+ CD64- B220- cells. A Representative analysis shows the four 
DC populations based on CD11b and CD103 expression, together with the levels of 
CD101 and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 
by each subset with gates set based on appropriate isotype controls.  C Frequencies of 
each subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 
- 6 mice/group.  Results are pooled from two experiments.   
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Figure 4.20: Expression of Trem-1 and CD101 by resident colonic MLN 
dendritic cells 
Cells were isolated from the cMLN of adult mice and resident DC identified as single, live, 
CD45+ MHC IIint CD11c+ CD64- B220- cells. A Representative analysis shows the four DC 
populations based on CD11b and CD103 expression, together with the levels of CD101 
and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each 
subset with gates set based on appropriate isotype controls.  C Frequencies of each 
subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 
mice/group.  Results are pooled from two experiments.   
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Figure 4.21: Expression of Trem-1 and CD101 by migratory peripheral LN 
dendritic cells 
Cells were isolated from the PLN of adult mice and migratory DC identified as single, live, 
CD45+ MHC IIhi CD11c+ CD64- B220- cells. A Representative analysis shows the four DC 
populations based on CD11b and CD103 expression, together with the levels of CD101 
and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each 
subset with gates set based on appropriate isotype controls.  C Frequencies of each 
subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 
mice/group.  Results are pooled from two experiments.   
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Figure 4.22: Expression of Trem-1 and CD101 by resident peripheral LN 
dendritic cells 
Cells were isolated from the PLN of adult mice and resident DC identified as single, live, 
CD45+ MHC IIint CD11c+ CD64- B220- cells. A Representative analysis shows the DC 
populations based on CD11b and CD103 expression, together with the levels of CD101 
and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each 
subset with gates set based on appropriate isotype controls.  C Frequencies of each 
subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 
mice/group.  Results are pooled from two experiments.   
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Figure 4.23: Expression of Trem-1 and CD101 by spleen dendritic cells 
Cells were isolated from the spleen of adult mice and DC identified as single, live, CD45+ 
MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the DC populations 
based on CD11b and CD103 expression, together with the levels of CD101 and Trem-1 
on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each subset with 
gates set based on appropriate isotype controls.  C Frequencies of each subset 
expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 mice/
group.  Results are pooled from two experiments.   
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Figure 4.24: Expression of Trem-1 and CD101 by liver dendritic cells 
Cells were isolated from the liver of adult mice and DC identified as single, live, CD45+ 
MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the DC populations 
based on CD11b and CD103 expression, together with the levels of CD101 and Trem-1 
on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each subset with 
gates set based on appropriate isotype controls.  C Frequencies of each subset 
expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 mice/
group.  Results are pooled from two experiments.   
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Figure 4.25: Expression of Trem-1 and CD101 by kidney dendritic cells 
Cells were isolated from the kidney of adult mice and DC identified as single, live, CD45+ 
MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the DC populations 
based on CD11b and CD103 expression, together with the levels of CD101 and Trem-1 
on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each subset with 
gates set based on appropriate isotype controls.  C Frequencies of each subset 
expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 mice/
group.  Results are pooled from two experiments.   
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Figure 4.26: Expression of Trem-1 and CD101 by heart dendritic cells 
Cells were isolated from the heart of adult mice and DC identified as single, live, CD45+ 
MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the DC populations 
based on CD11b and CD103 expression, together with the levels of CD101 and Trem-1 
on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each subset with 
gates set based on appropriate isotype controls.  C Frequencies of each subset 
expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 mice/
group.  Results are pooled from two experiments.   
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Figure 4.27: Expression of Trem-1 and CD101 by lung dendritic cells 
Cells were isolated from the lung of adult mice and DC identified as single, live, CD45+ 
MHC II+ CD11c+ CD64- B220- cells. A Representative analysis shows the four DC 
populations based on CD11b and CD103 expression, together with the levels of CD101 
and Trem-1 on each of the DC subsets.  B Co-expression of CD101 and Trem-1 by each 
subset with gates set based on appropriate isotype controls.  C Frequencies of each 
subset expressing CD101 and/ or Trem-1, with the data representing the mean of 4 - 6 
mice/group.  Results are pooled from two experiments.   
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Figure 4.28: CD101 and Trem-1 expression by small intestinal dendritic cells 
during development 
Cells were isolated from SI LP.  Live CD11c+ MHC II+ CD64- leukocytes were analysed for 
the expression of CD103 and CD11b from D1 to adulthood (8-10 weeks). 
A Representative analysis shows the four DC populations based on CD11b and CD103 
expression at D1, D14 and on adults.  Co-expression of CD101 and Trem-1 at each time 
point, with gates set based on isotype controls by B CD103+CD11b+, C CD103-CD11b+, D 
CD103+CD11b- and E CD103-CD11b-. Data are representative of one experiment at each 
time point with n=4-8 mice/group.   
CD11b 
C
D
10
3 
D1	 D14	 ADULT	
Gated: Live CD45+ MHC II+ CD11c+ CD64-	
A 
B 
C 
D 
E 
10 19 
16 47 
28 35 
10 22 
40 24 
10 20 
25 4 
34 37 
76 0.7 
1 22 
88 3 
2 8 
15 8 
41 37 
25 2 
18 55 
17 10 
48 25 
0 1 
98 1 
2 3 
93 2 
1 5 
92 1 
1 7 
87 5 
0 2 
93 5 
0 9 
90 1 
143 
A 
B 
Gated: Live CD45+ MHC II+ CD11c+ CD64-	
D 
Figure 4.29: Expression of Trem-1 and CD101 by small intestinal dendritic 
cells during development  
Schematic depiction of the distribution of CD101+Trem-1+ (white), CD101-Trem-1+ (black), 
CD101+Trem-1- (light grey) and CD101-Trem-1- (dark grey) cells amongst each DC 
subset in the SI LP from mice at D1, D14 and in adults. A CD103+CD11b+, B CD103-
CD11b+, C CD103+CD11b- and D CD103-CD11b- DC. Data are means of one experiment 
at each time point with n=4-8 mice/group.   
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Figure 4.30: Expression of Trem-1 and CD101 by colonic dendritic cells 
during development  
Cells were isolated from CLP. Live CD11c+ MHC II+ CD64- leukocytes were analysed for 
the expression of CD103 and CD11b from D1 to adulthood (8-10 weeks). 
A Representative analysis shows the four DC populations based on CD11b and CD103 
expression at D1, D14 and on adults.  Co-expression of CD101 and Trem-1 at each time 
point, with gates set based on isotype controls by B CD103+CD11b+, C CD103-CD11b+, D 
CD103+CD11b- and E CD103-CD11b-. Data are representative of one experiment at each 
time point with n=4-8 mice/group.  
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Figure 4.31: Expression of Trem-1 and CD101 by colonic dendritic cells 
during development  
Schematic depiction of the distribution of CD101+Trem-1+ (white), CD101-Trem-1+ (black), 
CD101+Trem-1- (light grey) and CD101-Trem-1- (dark grey) cells amongst each DC 
subset in the CLP from mice at D1, D14 and in adults. A CD103+CD11b+, B CD103-
CD11b+, C CD103+CD11b- and D CD103-CD11b- DC. Data are means of one experiment 
at each time point with n=4-8 mice/group.   
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Figure 4.32: Expression of Trem-1 and CD101 by migratory MLN dendritic 
cells during development  
Cells were isolated from MLN and live CD11c+ MHC Iihi B220- CD64- migratory DC were 
were analysed for the expression of CD103 and CD11b from D1 to adulthood (8-10 
weeks). A Representative analysis shows the four DC populations based on CD11b and 
CD103 expression at D1, D14 and on adults.  Co-expression of CD101 and Trem-1 at 
each time point, with gates set based on isotype controls by B CD103+CD11b+, C CD103-
CD11b+, D CD103+CD11b- and E CD103-CD11b-. Data are representative of one 
experiment at each time point with n=4-8 mice/group.  
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Figure 4.33: Expression of Trem-1 and CD101 by migratory MLN dendritic 
cells during development  
Schematic depiction of the distribution of CD101+Trem-1+ (white), CD101-Trem-1+ (black), 
CD101+Trem-1- (light grey) and CD101-Trem-1- (dark grey) cells amongst each DC 
subset in the migratory MLN compartment from mice at D1, D14 and in adults. A 
CD103+CD11b+, B CD103-CD11b+, C CD103+CD11b- and D CD103-CD11b- DC. Data are 
means of one experiment at each time point with n=4-8 mice/group.   
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Figure 4.34: Expression of Trem-1 and CD101 by resident MLN dendritic 
cells during development  
Cells were isolated from MLN.  Live CD11c+ MHC IIInt CD64- resident DC were were 
analysed for the expression of CD103 and CD11b from D1 to adulthood (8-10 weeks). 
A Representative analysis shows the four DC populations based on CD11b and CD103 
expression at D1, D14 and on adults.  Co-expression of CD101 and Trem-1 at each time 
point, with gates set based on isotype controls by B CD103+CD11b+, C CD103-CD11b+, D 
CD103+CD11b- and E CD103-CD11b-. Data are representative of one experiment at each 
time point with n=4-8 mice/group.  
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Figure 4.35: Expression of Trem-1 and CD101 by resident MLN dendritic 
cells during development  
Schematic depiction of the distribution of CD101+Trem-1+ (white), CD101-Trem-1+ (black), 
CD101+Trem-1- (light grey) and CD101-Trem-1- (dark grey) cells amongst each DC 
subset in the resident MLN compartment from mice at D1, D14 and in adults. A 
CD103+CD11b+, B CD103-CD11b+, C CD103+CD11b- and D CD103-CD11b- DC. Data are 
means of one experiment at each time point with n=4-8 mice/group.   
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Figure 4.36: Effects of age on retinoic acid production by dendritic cells 
from small intestinal lamina propria 
Total SI LP cells were incubated with the fluorescent ALDH substrate ALDEFLUORTM in 
the presence or absence of the ALDH inhibitor diethylaminobenzoaldehyde (DEAB) and 
stained for flow cytometry.  A Representative FACS plots showing total MHC II+ CD11c+ 
CD64- B220- DC at D1, D7 and 8-10 week old adults (top panels), together with 
histograms showing ALDEFLUORTM fluorescence in the presence (grey line) or absence 
(black line) of DEAB (bottom panels). B Frequency of ALDEFLUORTM+ DC amongst total 
DC or Δ Mean fluorescence intensity (MFI) for ALDEFLUORTM activity (MFI in absence of 
DEAB – MFI in presence of DEAB) for total DC. Data are representative of one 
experiment for each time point with n=2-3 (D7) or n=4 (D14). **p<0.01, ***p<0.001. 
Student’s t-test.  
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Figure 4.37: Effects of age on retinoic acid production by dendritic cells 
subsets from small intestinal lamina propria 
Total SI LP cells were incubated with the fluorescent ALDH substrate ALDEFLUORTM in 
the presence or absence of the ALDH inhibitor diethylaminobenzoaldehyde (DEAB) and 
subsequently stained for flow cytometry.  A Representative FACS plots showing DC 
subsets at D1, D7 and 8-10 week old adults. B Histograms of results from D1 (top 
panels) or D7 (bottom panels), each compared with adults, showing ALDEFLUORTM 
fluorescence by DC subsets in the presence (grey line) or absence (coloured) of DEAB.  
C Frequency of ALDEFLUORTM+ amongst total DC or Δ Mean fluorescence intensity 
(MFI) for ALDEFLUORTM activity (MFI in absence of DEAB – MFI in presence of DEAB) 
for DC subsets. Data are representative of one experiment for each time point with n=2-3 
(D7) or n=4 (D14). *p<0.05,  **p<0.01, ***p<0.001. Student’s t-test.  
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Figure 4.38: Effects of age on CD4+ T cells in small intestinal lamina propria 
Total SI LP cells were incubated for 4.5 hours with PMA, ionomycin, brefeldin and 
monensin before analysis of CD4+ T cells by intracellular staining.  A Gating strategy for 
identifying CD4+ T cells as live B220- CD5+ CD8- cells in SI LP of 8-10 week adult mice.   
B Frequencies amongst total CD45+ leukocytes (left) and absolute numbers (right) of 
CD4+ T cells.  C Intracellular expression of FoxP3, INFγ  and IL-17 assessed by flow 
cytometry using appropriate antibodies with gates set on isotype controls. D Frequencies 
and absolute numbers of Treg, Th1 and Th17 cells amongst CD4+ T cells isolated from 
mice at D7, D21, D42 or 8-10 week adults.  Data are from a single experiment with n=4-5 
mice/group. ***p<0.001, ****p<0.0001 Student’s t-test.   
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5 Chapter	5	
Characterisation	of	intestinal	factors	involved	in	DC	
development	from	neonates	to	adults	
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5.1 Introduction	
Having	 shown	 in	 previous	 chapters	 that	 the	 defect	 in	 CD103+CD11b+	 DC	 in	 the	intestine	of	SIRPα	mt	mice	resolved	with	age,	 I	 then	went	on	to	 investigate	how	DC	subsets	developed	in	WT	mice	from	embryonic	life	until	one	year	of	age.		This	showed	that	unlike	 the	other	DC	 subsets,	 CD103+CD11b+	DC	were	not	present	 at	 birth,	 and	that	they	took	some	time	to	reach	normal	numbers.		I	also	discovered	that	CD101	and	Trem-1	 expression	 could	 be	 used	 to	 dissect	 DC	 development	 in	 more	 detail,	 with	Trem-1	 being	 largely	 restricted	 to	 CD103+CD11b+	DC	 and	 some	 CD103-CD11b+	DC.		Using	 these	 markers	 confirmed	 that	 the	 slow	 appearance	 of	 CD103+CD11b+	 DC	reflected	 a	 delayed	 developmental	 programme	 rather	 than	 simply	 a	 lack	 of	upregulation	of	CD103.		
In	 this	 chapter,	 I	 used	CD101	 and	Trem-1	 to	 explore	 the	 ontogeny	 of	 intestinal	DC	subsets	 in	 CCR2-/-	 and	 SIRPα	mt	mice,	 both	 of	which	 have	 selective	 defects	 in	 one	particular	group	of	DC	(Persson	et	al.,	2013b;	Scott	et	al.,	2014b;	2014a).	 	To	extend	these	studies,	I	also	examined	the	expression	of	different	DC	growth	factor	receptors	on	DC	subsets	from	mice	of	different	ages,	and	I	investigated	whether	Trem-1	played	any	role	in	DC	development.		Lastly,	I	examined	the	role	of	the	microbiota	in	driving	the	differentiation	of	intestinal	DC	subsets.			
5.2 Effects	of	age	on	expression	of	DC	growth	factor	receptors	
Having	 established	 the	pattern	of	 development	 of	 the	DC	 subsets	 in	 the	 intestine,	 I	wanted	 to	 try	 and	 understand	 some	 of	 the	 factors	 that	 might	 regulate	 these	 age	related	processes.	 	GM-CSFR	(CSF-2R),	 IRF-4	and	TGFβR	(our	unpublished	findings)	are	 all	 required	 for	 the	 development	 of	 CD103+CD11b+	 DC	 in	 the	 intestine,	 as	 is	retinoic	 acid	 receptor	α	 (RARα)	 (Agace	 and	 Persson,	 2012;	 Bogunovic	 et	 al.,	 2009;	Persson	 et	 al.,	 2013b).	 	 Therefore	 I	 thought	 it	 would	 be	 of	 interest	 to	 determine	whether	 the	expression	of	 these	receptors	might	correlate	with	 the	development	of	the	DC	subsets	in	the	neonatal	period.		To	do	this	I	performed	qPCR	analysis	of	FACS	purified	DC	subsets	from	D4,	D14,	D21	and	8	week	old	SI	LP	(Fig	5.1).			
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There	were	no	significant	differences	in	Csfra1	between	any	of	the	DC	subsets	at	any	time	 point,	 although	 overall	 the	 levels	 were	 usually	 lower	 in	 the	 CD103-CD11b+	subset	compared	with	the	others.	 	These	patterns	also	did	not	change	with	age	(Fig	5.2A).	 	 Irf4	 expression	 also	 showed	 few	 significant	 effects	 on	 subsets	 or	 time,	although	Irf4	mRNA	was	higher	in	CD103-CD11b-	DC	at	D4	than	in	any	other	subset,	when	it	was	also	significantly	increased	compared	with	the	same	subset	at	older	ages.		Additionally,	 at	 D14	 there	 was	 a	 transient	 but	 significant	 increase	 in	 Irf4	 mRNA	expression	amongst	CD103+CD11b-	DC	compared	with	CD103-CD11b+	DC	(Fig	5.2B).		Analysis	of	Tgfbr1	mRNA	expression	also	showed	few	consistent	differences	between	the	 subsets	 at	 different	 times,	 except	 on	D14	 of	 age,	when	 there	were	 significantly	greater	 levels	 of	 mRNA	 in	 CD103+CD11b-	 and	 CD103-CD11b-	 DC	 compared	 with	CD103-CD11b+	DC.	 	D14	CD103+CD11b+	DC	also	expressed	more	Tgfbr1	mRNA	than	CD103+CD11b-	DC	on	D4	and	D21,	as	well	as	in	adults.		In	general,	the	levels	of	Tgfbr1	were	 highest	 in	 all	 subsets	 on	 D14	 (Fig	 5.2C).	 	 Expression	 of	Rara	 mRNA	 showed	considerable	 variability	 between	 samples	 and	 the	 levels	 were	 generally	 low.		However,	CD103+CD11b-	DC	expressed	significantly	more	Rara	on	D4	compared	with	the	other	three	subsets	and	this	remained	the	general	trend	throughout	development	until	 adulthood,	 when	 CD103+CD11b+	 DC	 expressed	 similar	 amounts	 to	CD103+CD11b-	DC	in	the	adult	intestine	(Fig	5.2D).			
Overall,	these	data	showed	few	consistent	differences	between	the	transcript	levels	of	key	 receptors	 and	 transcription	 factors	during	 the	development	of	 the	different	DC	subsets	and	did	not	provide	clear	evidence	for	individual	pathways	in	this	process.			
5.3 Postnatal	development	of	intestinal	DC	in	SIRPα 	mt	mice	
Due	to	the	defect	in	individual	DC	subsets	that	has	been	described	in	adulthood,	I	next	went	on	 to	examine	DC	development	 in	SIRPα	mt	mice.	 	As	 I	 showed	 in	Chapter	3,	adult	mice	that	 lack	SIRPα	signalling	have	a	selective	defect	 in	CD103+CD11b+	DC.	 	 I	was	therefore	interested	in	examining	whether	this	defect	was	present	from	early	on	in	 life.	 	Furthermore,	 since	carrying	out	 that	 initial	work,	 I	had	validated	 the	use	of	CD101	 and	 Trem-1	 as	 tools	 for	 dissecting	 the	 lineage	 of	 CD103+CD11b+	DC	 in	WT	
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neonatal	mice.		This	enabled	me	to	examine	further	and	in	greater	depth	the	natural	defect	in	CD103+CD11b+	DC	that	occurs	in	SIRPα	mt	mice.			
5.3.1 CD103 and CD11b expression 
The	selective	defect	 in	the	proportion	and	absolute	number	of	CD103+CD11b+	DC	 in	SIRPα	mt	SI	was	already	clear	by	D7	of	age,	and	 indeed,	 it	was	relatively	greater	at	this	 stage	 than	 I	had	 found	 in	adults.	 	As	a	 result	 there	were	negligible	numbers	of	these	DC	 in	 SIRPα	mt	mice	 at	 this	 age	 (Fig	 5.3A).	 	 As	 I	 had	 found	 in	WT	mice,	 the	frequency	and	numbers	of	CD103+CD11b+	DC	were	rising	towards	the	levels	observed	in	adult	 SI	LP	by	D14,	but	 the	 significant	deficit	 in	SIRPα	mt	mice	was	 still	present	(Fig	5.3B).			
Interestingly	 the	 proportion	 of	 CD103-CD11b+	 DC	 was	 higher	 in	 SIRPα	 mt	 SI	 LP	compared	 with	 WT	 (~24%	 vs	 ~18%)	 on	 D7,	 unlike	 what	 I	 had	 found	 in	 adults.		However,	the	absolute	numbers	of	CD103-CD11b+	DC	were	reduced	in	the	SIRPα	mt	compared	 with	 the	 WT	 at	 this	 early	 time	 point	 (Fig	 5.3A),	 and	 by	 D14	 both	 the	frequency	and	number	of	 this	 subset	were	 similar	 in	SIRPα	mt	and	WT	SI	LP.	 	The	frequency	of	CD103+CD11b-	DC	was	not	significantly	different	between	WT	and	SIRPα	mt	mice	on	D7	of	age,	although	the	absolute	numbers	were	reduced	amongst	SIRPα	mt	mice.	 	As	 I	had	 found	 in	adults,	by	D14	the	proportion	of	CD103+CD11b-	DC	was	increased	in	SIRPα	mt	mice	compared	with	WT	mice,	although	the	absolute	numbers	were	 not	 different	 (Fig	 5.3B).	 	 The	 proportion	 CD103-CD11b-	 DC	 was	 increased	significantly	in	D7	SIRPα	mt	mice	compared	with	WT	mice,	but	the	absolute	numbers	were	significantly	lower	(Fig	5.3A)	and	these	differences	had	disappeared	by	D14	(Fig	5.3B).			
There	were	no	differences	between	migratory	DC	subsets	in	the	MLN	of	SIRPα	mt	and	WT	mice	at	D7,	perhaps	reflecting	the	very	low	number	of	these	cells	at	this	time	(Fig	5.4A).		However,	by	D14	the	proportions	of	all	subsets	resembled	the	pattern	seen	in	their	adult	counterparts,	with	reduced	CD103+CD11b+	and	increased	CD103+CD11b-	DC	 in	 the	 SIRPα	 mt	mice;	 there	was	 also	 now	 a	marked	 reduction	 in	 the	 absolute	numbers	of	all	migratory	DC	subsets	present	in	the	MLN	of	SIRPα	mt	mice	compared	
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with	WT	at	D14	(Fig	5.4B).		There	were	no	differences	in	the	frequency	or	number	of	the	 different	 resident	 DC	 subsets	 present	 in	 the	 MLN	 at	 D7.	 	 However,	 as	 I	 had	observed	 in	 adult	mice,	 the	 frequencies	 of	 CD103-CD11b+	and	 of	 CD103+CD11b-	DC	showed	 trends	 toward	 being	 decreased	 and	 increased	 respectively	 in	 SIRPα	 mt	neonatal	 mice	 (Fig	 5.5A;	 Fig	 3.3B).	 	 By	 D14,	 there	 were	 reduced	 proportions	 of	CD103-CD11b+	DC	and	increased	proportions	of	CD103+CD11b-	DC	amongst	resident	MLN	 DC,	 but	 again	 the	 numbers	 of	 all	 resident	 DC	 subsets	 were	 now	 markedly	reduced	in	SIRPα	mt	MLN,	as	was	the	case	in	adults	(Fig	5.5B;	Fig	3.3C).			
5.3.2 CD101 and Trem-1 expression 
I	next	used	CD101	and	Trem-1	to	ascertain	whether	the	reduction	in	CD103+CD11b+	DC	 in	 the	SIRPα	mt	 intestine	was	simply	due	 to	 the	 lack	of	CD103	up-regulation.	 	 I	first	analysed	CD101	and	Trem-1	expression	by	total	CD11b+	DC	in	D7	neonate	and	8	week	 old	 adult	 SI	 LP,	 as	 this	 could	 be	 where	 those	 DC	 might	 be	 (Fig.	 5.6A).	 	 As	expected,	 the	 frequency	 of	 total	 CD11b+	 DC	was	 reduced	 significantly	 in	 SIRPα	 mt	mice	at	both	time	points,	reflecting	the	usual	predominance	of	CD103+CD11b+	DC	in	the	intestine	of	WT	mice.		The	proportion	of	total	CD11b+	DC	also	did	not	increase	as	much	from	D7	into	adulthood	in	the	SIRPα	mt	SI	LP,	as	it	did	in	WT	mice	(Fig	5.6B).		In	 parallel,	 SIRPα	 mt	 SI	 LP	 had	 a	 significantly	 lower	 proportion	 of	 CD11b+	 DC	expressing	CD101	compared	with	WT	 intestines	 at	 both	D7	 and	 in	 adults,	 although	interestingly,	in	both	strains	there	were	greater	proportions	of	CD11b+	DC	expressing	CD101	in	D7	mice	than	in	adults.		A	similar	pattern	was	seen	with	Trem-1	expression	amongst	 total	 CD11b+	 DC,	 where	 a	 significantly	 fewer	 proportion	 of	 these	 cells	expressed	 Trem-1	 in	 both	 neonatal	 and	 adult	 SIRPα	 mt	 SI	 LP	 compared	 with	WT	controls.	 	 However	 unlike	 CD101,	 the	 proportion	 of	 CD11b+	DC	 expressing	 Trem-1	increased	with	age	in	both	WT	and	SIRPα	mt	mice	(Fig	5.6C).			
I	 went	 on	 to	 investigate	 the	 expression	 of	 CD101	 and	 Trem-1	 by	 the	 individual	subsets	 of	 CD11b+	 DC	 in	WT	 and	 SIRPα	 mt	mice.	 	 As	 both	 subsets	 predominantly	lacked	CD101	and	TREM1	expression	in	adult	mice,	the	expression	of	these	markers	on	 CD103+CD11b-	 and	 CD103-CD11b-	DC	was	 not	 assessed	 in	 this	 experiment	 (Fig.	4.33).	 	As	I	had	found	in	these	previous	experiments,	the	majority	of	CD103+CD11b+	
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DC	in	WT	adult	SI	LP	expressed	both	CD101	and	Trem-1,	whereas	WT	CD103-CD11b+	DC	were	more	heterogeneous,	with	~22%	and	~14%	expressing	CD101	and	Trem-1	respectively.	 	 There	 was	 a	 small	 but	 significant	 decrease	 in	 the	 proportion	 of	CD103+CD11b+	 DC	 that	 co-expressed	 CD101	 and	 Trem-1	 in	 adult	 SIRPα	 mt	 mice	compared	with	the	WT	subset,	although	most	of	the	remainder	expressed	CD101	or	Trem-1	alone	(Fig	5.7B).	 	As	 in	WT	mice,	CD103-CD11b+	DC	in	SIRPα	mt	mice	were	heterogeneous	 for	 the	expression	of	CD101	and	Trem-1,	although	again	 there	were	significantly	fewer	in	proportion	expressing	both	CD101	and	Trem-1	compared	with	controls	 (~14%	 vs	 ~4%).	 	 There	were	 no	 differences	 in	 the	 proportion	 of	 CD103-CD11b+	DC	expressing	CD101	or	Trem-1	alone,	but	the	proportion	of	CD101-Trem-1-	DC	was	significantly	higher	in	SIRPα	mt	mice	compared	with	controls	(Fig	5.7B).		The	differences	between	WT	and	SIRPα	mt	SI	LP	DC	were	even	more	striking	on	D7	than	in	 adults,	 with	 much	 greater	 differences	 in	 the	 frequency	 of	 CD101+Trem-1+	 DC	amongst	both	CD103+CD11b+	(~35%)	and	CD103-CD11b+	(~4%)	DC	compared	with	~69%	and	14%	in	WT	mice	of	the	same	age	(Fig.	5.7A).	
Thus	lack	of	signalling	through	SIRPα	appears	to	have	an	even	more	profound	effect	on	DC	development	early	in	life	than	it	does	in	adults,	and	this	is	not	simply	due	to	the	lack	of	acquisition	of	CD103	on	CD103+CD11b+	DC.	 	Rather	 it	affects	a	wide	ranging	developmental	pathway,	as	indicated	by	reduced	acquisition	of	CD101	and	Trem-1.		
5.4 Role	of	CCR2	in	the	development	of	CD11b+	DC	
I	 next	 examined	 intestinal	 DC	 in	 CCR2-/-	 mice,	 which	 are	 known	 to	 have	 reduced	frequency	and	numbers	of	CD103-CD11b+	DC	in	the	intestine	(Scott	et	al.,	2014a).	 	 I	did	not	have	access	to	neonatal	CCR2-\-	mice,	as	they	were	bred	at	a	different	facility.	I	was	therefore	only	able	to	analyse	adults	of	this	strain.		In	contrast	to	what	had	been	shown	previously	in	the	lab,	there	were	no	significant	differences	in	the	frequency	of	total	CD11b+	DC	or	of	 the	 individual	DC	subsets	 in	CCR2-/-	mice	compared	with	age	matched	WT	 controls,	 although	 there	 was	 a	 trend	 towards	 a	 reduction	 in	 CD103-CD11b+	 DC	 in	 the	 SI	 LP	 (Fig	 5.8A-B).	 	 There	 were	 also	 no	 significant	 differences	between	CCR2-/-	and	WT	mice	in	the	proportion	of	total	CD11b+	DC	expressing	CD101.		
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However	a	significantly	greater	proportion	of	CD11b+	DC	expressed	Trem-1	in	CCR2-/-	mice	compared	with	WT	controls	(Fig	5.8C).			
When	the	CD103+CD11b+	and	CD103-CD11b+	DC	subsets	were	analysed	individually,	I	found	 that	 the	 large	 majority	 of	 CD103+CD11b+	 DC	 were	 CD101+Trem-1+	 in	 both	CCR2-/-	 and	 WT	 SI	 LP,	 although	 there	 was	 a	 small	 but	 significant	 increase	 in	 the	proportion	of	these	DC	expressing	both	CD101	and	Trem-1	in	CCR2-/-	mice	compared	with	WT	mice.		CD103-CD11b+	DC	were	heterogeneous	for	CD101	and	Trem-1	in	both	strains,	and	there	were	no	significant	differences	between	them	in	the	expression	of	these	markers	(Fig	5.9A).		As	was	shown	previously	in	the	laboratory,	a	small	subset	of	 CD103-CD11b+	DC	 in	WT	 SI	 LP	 expressed	 CCR2,	 and	 interestingly,	 these	 did	 not	express	either	CD101	or	Trem-1	(Fig	5.9B).			
5.5 Effects	of	Trem-1	on	intestinal	DC	development	
So	 far,	 I	 have	 shown	 that	 intestinal	 DC	 subsets	 develop	 gradually	 over	 time,	particularly	 the	CD103+CD11b+	DC	 (Chapter	4).	 	Moreover,	 this	development	 is	not	simply	due	to	the	upregulation	of	CD103,	commonly	used	to	define	the	four	intestinal	DC	subsets,	but	reflects	a	more	complex	programme	involving	the	acquisition	of	other	molecules	including	CD101	and	Trem-1.		
As	 Trem-1	 seemed	 to	 be	 particularly	 associated	with	 the	 CD103+CD11b+	 lineage,	 I	decided	 to	 investigate	whether	Trem-1	 itself	played	any	role	 in	 the	development	of	DC	in	the	SI	LP.		To	do	this	I	collaborated	with	Professor	Christoph	Mueller’s	group	at	the	University	of	Bern,	where	 they	had	generated	Trem-1-/-	mice.	 	As	a	preliminary	step,	I	was	sent	flow	cytometry	data	from	SI	LP	digests	they	had	carried	out	on	Trem-1-/-	 and	 Trem-1+/+	 (WT)	 littermate	 mice,	 and	 I	 analysed	 the	 results	 using	 the	strategies	 I	 had	 applied	 to	my	 own	 animals.	 Unfortunately,	 there	was	 a	 significant	amount	of	 cell	death	 in	all	 of	 the	 samples,	 and	 I	 thought	 it	 sensible	only	 to	analyse	those	that	had	greater	than	50%	viability,	which	was	one	WT	and	two	Trem-1-/-	mice.			
In	these	samples	I	was	able	to	identify	the	four	subsets	of	cDC	based	on	CD11b	and	CD103	expression	in	both	WT	and	Trem-1-/-	SI	LP.		However,	the	relative	frequencies	of	 the	subsets	present	 in	 the	WT	SI	LP	were	different	 from	those	that	 I,	and	others,	
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had	 observed	 in	 the	 SI	 LP	 of	 Glasgow	mice,	with	 only	~20%	 of	 the	 total	 DC	 being	CD103+CD11b+,	compared	with	the	~40%	that	I	reported	previously	(Fig	5.10A).	 	In	parallel,	the	proportion	of	CD103+CD11b-	DC	was	much	higher	than	what	myself,	and	others,	have	reported.		Although	the	low	number	of	mice	makes	it	impossible	to	come	to	 any	 precise	 conclusion,	 the	 frequency	 of	 CD103+CD11b+	 DC	 appeared	 to	 be	increased	 in	 Trem-1-/-	 mice	 compared	 with	 their	 WT	 control,	 with	 a	 reciprocal	decrease	in	CD103+CD11b-	DC.		The	proportions	of	CD103-CD11b+	and	CD103-CD11-	DC	 were	 identical	 in	 the	 two	 strains	 (Fig	 5.10B).	 	 I	 was	 not	 able	 to	 generate	 any	absolute	 numbers	 in	 this	 experiment,	 as	 no	 total	 cell	 counts	 had	 been	 carried	 out	when	 the	 tissues	 were	 harvested.	 	 In	 addition,	 the	 host	 group	 had	 not	 stained	 for	CD101	or	Trem-1,	or	taken	other	tissues	for	more	detailed	comparison.			
Although	this	analysis	was	inconclusive,	there	appeared	to	be	some	evidence	that	the	absence	 of	 Trem-1	 might	 influence	 DC	 development	 in	 the	 intestine.	 	 Therefore,	 I	decided	 to	 investigate	 further	 by	 obtaining	 BM	 from	 the	 Mueller	 group	 and	generating	 competitive	 BM	 chimeras.	 CD45.2/CD45.1	 WT	 recipients	 were	reconstituted	with	a	90:10	mix	of	CD45.2+	WT	and	CD45.1+	WT	(WT:WT)	BM	cells	or	with	a	85:15	mix	of	CD45.2+	Trem-1-/-	and	CD45.1+	WT	(Trem-1-/-:WT)	BM	cells	(Fig.	5.11).		In	each	case,	my	intention	had	been	to	set	up	50:50	chimeras,	but	the	CD45.1+	WT	 BM	 cells	 appeared	 to	 have	 undergone	 selective	 death	 during	 the	 preparation	process.	 	 This	 was	 only	 highlighted	when	 I	 assessed	 the	 levels	 of	 chimerism	 eight	weeks	 after	 reconstitution.	 To	 standardise	 the	 analysis	 of	 chimerism,	 I	 used	 CD19+	blood	B	cells	as	these	do	not	express	Trem-1	and	therefore	should	not	be	affected	by	its	absence	(Fig	5.12A).		Consistent	with	the	ratio	I	had	used	to	reconstitute,	the	level	of	chimerism	in	WT:WT	chimeras	was	~90:10.	However,	despite	reconstituting	with	a	85:15	ratio,	by	8	weeks	the	level	of	chimerism	in	Trem-1-/-:WT	chimeras	was	~94:6	(Fig	5.12B).	These	ratios	were	then	used	to	normalise	 the	values	obtained	 from	the	other	 cell	 types.	 	 In	 comparison	 to	 B	 cells,	 Ly6Chi	monocytes	 and	 neutrophils	 from	CD45.2	WT	BM	appeared	to	reconstitute	recipients	more	efficiently	than	their	CD45.1	WT	 counterparts,	 with	 normalised	 ratios	 of	 ~4	 and	 ~2.5	 respectively,	 perhaps	reflecting	 the	 viability	 of	 the	 original	 inoculum	 as	 mentioned	 above	 (Fig	 5.12B).		However,	 CD45.2	 Trem-1-/-	 BM	 was	 markedly	 less	 efficient	 than	 its	 CD45.1	 WT	counterpart	 in	 reconstituting	 these	myeloid	 cells	 (especially	 neutrophils,	which	 are	
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uniformly	Trem-1+	 in	WT	mice),	while	only	a	small	proportion	of	Ly6Chi	monocytes	are	normally	Trem-1+	(Fig	5.12A).			
DC	 in	 the	 SI	 LP	 behaved	 more	 like	 blood	 neutrophils	 than	 B	 cells,	 showing	 a	CD45.2:CD45.1	 ratio	 of	~2	 in	WT:WT	 chimeras.	 Interestingly,	 CD45.2	Trem-1-/-	 BM	was	 less	 capable	 of	 generating	 all	 DC	 subsets	 than	 the	WT	 BM,	 giving	 ratios	 even	lower	than	those	of	blood	B	cells	under	the	same	conditions.		However,	this	affected	all	DC	subsets	equally	 in	both	 types	of	chimera,	 indicating	 that	 the	effects	were	not	related	to	the	levels	of	Trem-1	expressed	by	the	different	DC	subsets.		Unfortunately,	problems	 with	 the	 digestion	 process	 meant	 I	 only	 had	 two	 WT:WT	 chimeras	 to	analyse	 in	 this	 experiment,	 and	 therefore	 it	 was	 not	 possible	 to	 assess	 statistical	significance	 between	 the	 cell	 populations	 present	 in	 the	 SI	 LP	 of	 the	 WT:WT	 and	Trem-1-/-:WT	chimeras	(Fig	5.13B).		I	was	also	unable	to	obtain	more	Trem-1-/-	BM	to	repeat	these	studies	in	the	time	remaining	to	me.			
Monocytes	entering	the	LP	also	express	Trem-1	(Bouchon	et	al.,	2000).		Therefore,	to	extend	 these	 findings,	 I	 also	 examined	 the	 monocyte/mφ	 continuum	 in	 the	 SI	 LP.		These	cells	were	 identified	as	 live,	side	scatterlo,	CD11b+	B220-	and	CD64int-hi.	 	They	were	then	subsetted	based	on	the	expression	of	MHC	II	and	Ly6C	(Fig	5.14A;	(Bain	et	al.,	2013)).		According	to	this	strategy,	P1	is	made	up	of	Ly6Chi	MHC	II-	monocytes	that	are	newly	arrived	from	the	blood,	whilst	P2	are	Ly6Chi	MHC	II+	cells	transitioning	into	mφ.	The	Ly6C-	MHC	II+	mature	mφ	can	then	be	further	differentiated	into	P3	and	P4	based	 on	 the	 level	 of	 CX3CR1	 expression	 (Bain	 et	 al.,	 2013;	 Tamoutounour	 et	 al.,	2013).		Consistent	with	recent	results	from	the	laboratory,	showing	that	intestinal	mφ	are	 derived	 by	 continuous	 replenishment	 from	 circulating	 monocytes,	 all	 the	 mφ	lineage	 populations	 behaved	 more	 like	 blood	 Ly6Chi	 monocytes	 than	 B	 cells	 in	WT:WT	 chimeras,	 showing	 a	 CD45.2:CD45.1	 ratio	 of	~2.5	 for	 Ly6Chi	 P1	monocytes	and	slightly	lower	levels	as	the	cells	progressed	through	P2	to	P3/P4	(Fig	5.14B&C).		Again	 as	 I	 found	 with	 blood	 monocytes,	 the	 ratios	 for	 reconstitution	 of	 intestinal	mφ were	reduced	in	Trem-1-/-:WT	chimeras.		
I	also	examined	the	colon	of	these	competitive	chimeras,	where	again	the	DC	subsets	in	WT:WT	chimeras	were	reconstituted	preferentially	by	CD45.2+	BM	(Fig	5.15A&B).	Ranging	from	~3-5,	the	CD45.2:CD45.1	ratios	were	higher	than	those	in	the	SI	LP	(Fig	
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5.15B).		In	the	Trem-1-/-:WT	chimeras,	the	DC	subsets	again	showed	an	even	greater	defect	in	reconstitution	by	Trem-1-/-	BM	and,	like	the	SI	LP,	this	was	less	efficient	than	blood	B	cells	(Fig	5.15B).		Although	there	were	too	few	samples	to	perform	statistical	analysis,	it	appeared	that	in	WT:WT	chimeras	there	was	a	trend	towards	CD45.2+	BM	being	better	able	to	generate	CD103-CD11b+	DC	than	CD103+CD11b+	DC.		As	in	the	SI	LP,	 there	 were	 no	 observable	 differences	 between	 the	 DC	 subsets	 in	 any	 of	 the	chimeras	(Fig	5.15A-B).		Analysis	of	monocytes	and	mφ	in	the	colon	showed	the	same	patterns	 of	 reconstitution	 as	 in	 the	 SI	 LP	where	 the	 ratios	 for	 reconstitution	were	lower	in	Trem-1-/-:WT	chimeras	compared	to	WT:WT	chimeras	(Fig	5.16A-B).			
Next	 I	analysed	the	reconstitution	of	DC	subsets	 in	both	the	resident	and	migratory	compartments	of	the	MLN	of	the	chimeric	mice.		As	in	the	SI	LP	and	CLP,	CD45.2+	WT	BM	contributed	to	migratory	DC	populations	to	a	greater	extent	than	in	blood	B	cells,	while	CD45.2+	Trem-1-/-	BM	was	less	efficient	than	the	equivalent	WT	BM	(Fig	5.17A-B).	 	 Although	 there	 were	 insufficient	 samples	 to	 carry	 out	 statistical	 analysis,	 it	appeared	that	CD45.2+	WT	BM	was	better	able	to	generate	migratory	CD103-CD11b+	DC	than	CD103+CD11b+	DC,	with	CD45.2:CD45.1	ratios	of	~4	and	~2	respectively	(Fig	5.17B).		This	pattern	was	more	similar	to	that	seen	in	the	CLP	than	in	the	SI	LP.		The	resident	 compartment	 of	 MLN	 DC	 behaved	 differently	 to	 other	 DC	 populations,	 as	reconstitution	 by	 CD45.2+	 BM	 appeared	 better	 than	 that	 of	 B	 cells,	 regardless	 of	whether	it	was	of	WT	or	Trem-1-/-	origin	(Fig	5.18A-B).		However,	the	relative	defect	in	 reconstitution	 by	 Trem-1-/-	 BM	 remained	 apparent,	 with	 the	 most	 striking	difference	being	in	the	CD103-CD11b+	DC	subset,	where	the	CD45.2:CD45.1	ratio	was	~34	(Fig	5.18B).	 	However,	 it	should	be	pointed	out	that	this	result	 is	from	just	one	animal	and	therefore	could	be	an	anomaly.		Overall,	these	data	show	that	the	lack	of	Trem-1	 expression	 on	 haematopoietic	 cells	 causes	 a	 reduction	 in	 the	 ability	 of	leukocytes	to	reconstitute	irradiated	chimeras,	regardless	of	whether	or	not	that	cell	type	expresses	Trem-1	or	not.	 	However	this	applies	equally	to	all	DC	subsets	in	the	mucosa	and	migratory	DC	in	the	MLN,	and	there	was	no	evidence	that	Trem-1	played	a	selective	role	in	the	development	of	individual	subsets.			
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5.6 The	influence	of	microbiota	on	intestinal	DC		
The	results	of	preceding	experiments	showed	that	intestinal	DC	populations	changed	markedly	 during	 the	 neonatal	 period,	 and	 in	 some	 cases	 also	 with	 ageing.	 	 One	hypothesis	 I	 considered	 to	 explain	 these	 effects	 was	 that	 the	 acquisition	 of	 the	microbiota	may	 be	 responsible.	 	 To	 test	 this,	 I	 looked	 at	 intestinal	 DC	 in	 antibiotic	treated	and	germ-free	adult	mice.			
5.6.1 The effects of antibiotic treatment on intestinal DC 
Eight-week	old	WT	mice	were	treated	with	an	antibiotic	cocktail	containing	1	mg/ml	Cefoxitin,	Gentamicin,	Metronidazol,	and	Vancomycin,	previously	reported	to	deplete	the	microbiota	sufficiently	to	impair	DC	function	within	1-2	weeks	(Diefenbach	et	al.,	2012).	 	 Mice	 were	 administered	 antibiotics	 orally	 in	 drinking	 water	 containing	artificial	 sweetener,	 or	maintained	 on	normal	 drinking	water	 containing	 sweetener	for	two	weeks.	 	Although	I	did	not	have	access	to	facilities	that	would	have	allowed	me	 to	confirm	directly	 that	 the	antibiotic	protocol	had	reduced	 the	microbiota,	 this	appeared	to	be	the	case,	as	the	treated	mice	had	markedly	enlarged	caeca	compared	with	controls	(data	not	shown).		However,	neither	the	frequency	nor	the	numbers	of	any	of	 the	DC	subsets	 in	 the	SI	LP	were	affected	by	 treatment	with	antibiotics	 (Fig.	5.19A-B).	 	 Similar	 results	were	 found	when	 I	examined	 the	CLP,	apart	 from	a	small	but	 significant	 reduction	 in	 the	 frequency	 of	 CD103+CD11b-	 DC	 in	 the	 antibiotic	treated	mice	(Fig.	5.20).	 	 In	contrast	to	these	findings	on	DC,	there	was	a	significant	reduction	 in	 the	 proportion	 of	 FoxP3+	Tregs	 in	 the	 SI	 LP	 of	 antibiotic	 treated	mice,	although	the	populations	of	Th17	and	Th1	cells	were	unaffected	(Fig.	5.19C).		
Consistent	with	the	findings	in	the	SI	LP	and	CLP,	antibiotic	treatment	had	little	effect	on	migratory	DC	in	MLN,	where	the	only	significant	change	was	a	reduced	frequency	CD103-CD11b-	 DC	 (Fig	 5.21).	 	 By	 contrast,	 although	 the	 relative	 frequencies	 of	 the	various	subsets	of	resident	DC	in	the	MLN	were	not	affected	by	antibiotic	treatment,	the	 absolute	 numbers	 of	 CD103+CD11b-	 and	 CD103-CD11b-	 DC	 were	 significantly	reduced	in	these	mice,	and	there	was	also	a	trend	toward	reduced	numbers	of	CD103-CD11b+	DC	(Fig.	5.22).				
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5.6.2 The effects of a germ free environment on DC development 
As	 the	administration	of	antibiotics	 to	mice	with	an	 intact	microbiota	had	very	 few	significant	 effects	 on	 intestinal	 DC,	 I	 decided	 to	 examine	 whether	 longer	 term	 or	complete	absence	of	microbiota	might	have	more	influence.		To	do	this,	I	exploited	a	collaboration	 with	 the	 Institute	 of	 Food	 Research	 in	 Norwich	 where	 there	 was	 a	germ-free	colony.		Unfortunately,	at	the	time	of	my	visit	it	was	found	that	the	‘facility	barrier’	 had	 recently	been	breached,	meaning	 the	germ-free	 status	of	 the	mice	was	unclear.	 	 Despite	 this,	 I	 decided	 to	 proceed	 with	 the	 experiment,	 and	 subsequent	analysis	revealed	that	the	animals	had	a	greater	diversity	of	bacterial	species	at	both	the	family	and	genus	level,	but	fewer	copy	numbers	of	those	bacteria	when	compared	with	SPF	controls	(Fig	5.23).		In	the	SPF	mice,	it	appeared	there	was	a	predominance	of	 Lachnospiraceae,	 which	 was	 not	 present	 in	 the	 GF	 mice	 (Fig	 5.23A).	 	 As	 in	antibiotic	treated	mice,	there	were	no	differences	in	the	relative	frequencies	of	the	DC	subsets	 in	the	SI	LP	between	GF	and	conventional	mice,	although	there	was	a	slight	reduction	in	the	number	of	CD103-CD11b-	DC	in	GF	animals	(Fig	5.24A).		In	the	CLP,	the	only	significant	changes	in	germ-free	mice	was	an	increased	proportion	of	CD103-CD11b+	 DC	 and	 a	 reduced	 frequency	 of	 CD103+CD11b-	 DC,	 together	 with	 a	 slight	increase	 in	 the	 CD103-CD11b-	 DC	 (Fig.	 5.24B).	 	 There	 were	 no	 differences	 in	 the	proportions	 or	 numbers	 of	 DC	 subsets	 amongst	 the	 migratory	 or	 resident	compartments	of	MLN	between	germ-free	and	conventional	mice	(Fig	5.25).		
5.7 Summary	
In	 this	 chapter	 I	 attempted	 to	 investigate	 the	 factors	 that	 might	 drive	 the	differentiation	of	intestinal	DC	subsets	during	development,	with	particular	regard	to	the	CD103+CD11b+	DC	subset.	 	First	 I	 examined	 the	expression	of	 factors	known	 to	influence	DC	development,	but	found	few	consistent	differences	in	the	levels	of	mRNA	for	the	genes	encoding	CSF2-Rα1,	IRF4,	TGFβR	and	RARα	amongst	the	DC	subsets	at	different	 times.	 	 Although	 these	 results	 could	 suggest	 that	 responsiveness	 to	 these	factors	may	already	be	 imprinted	from	birth,	 the	data	were	highly	variable	and	this	needs	to	be	repeated.	 	Next	I	 investigated	whether	the	selective	effects	of	the	SIRPα	mutation	 on	 CD103+CD11b+	 DC	were	 already	manifest	 during	 the	 first	 and	 second	
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weeks	 of	 life.	 	 This	 appeared	 to	 be	 the	 case	 and	 indeed,	 the	 defect	 was	 more	pronounced	in	the	SI	LP	at	D7	of	age	than	at	D14	or	in	adults.		Furthermore,	there	was	a	 defect	 in	 the	numbers	 of	 all	DC	 subsets	 at	D7,	 perhaps	 suggesting	 that	 there	 is	 a	generalised	delay	in	DC	development	in	these	mice.		None	of	these	features	were	seen	amongst	migratory	DC	MLN	at	D7,	perhaps	due	to	the	very	low	number	of	these	cells	at	this	age,	but	the	selective	defect	in	CD103+CD11b+	DC	and	concomitant	increase	in	CD103+CD11b-	DC	frequency	were	present	by	D14.		The	generalised	reduction	of	DC	numbers	seen	in	adults	was	also	now	present	at	this	time.		The	frequency	of	CD103-CD11b+	 DC	 was	 decreased	 amongst	 resident	 MLN	 DC	 by	 D14,	 when	 there	 was	 a	reciprocal	increase	in	CD103+CD11b-	DC.		At	this	time,	there	were	also	fewer	resident	DC	of	all	subsets.	 	The	expression	of	both	CD101	and	Trem-1	was	reduced	amongst	total	 CD11b+	DC	 from	 SI	 LP	 of	 SIRPα	mt	mice	 at	 both	D7	 and	D14,	 as	was	 the	 co-expression	 of	 CD101	 and	Trem-1	by	CD103+CD11b+	 and	CD103-CD11b+	DC.	 	 These	changes	did	not	resolve	with	age.			
I	next	extended	previous	findings	in	the	laboratory,	which	had	revealed	that	a	subset	of	CD103-CD11b+	DC	was	absent	in	CCR2-/-	mice,	by	showing	that	the	absence	of	these	cells	did	not	affect	the	proportion	of	CD11b+	DC	that	expressed	CD101.	 	By	contrast	Trem-1	expression	was	increased	on	CD103-CD11b-	DC	in	CCR2-/-	mice,	as	was	the	co-expression	of	CD101	and	Trem-1	amongst	CD103+CD11b+	DC	in	these	animals.		This	may	reflect	 the	absence	of	a	CCR2+	subset	of	 these	DC,	which	 I	 found	 to	 lack	either	marker.	 	Thus	 the	CCR2-dependent	DC	population	does	not	 appear	 to	overlap	with	those	that	go	on	to	express	CD101	or	Trem-1.			
In	 the	 previous	 chapter,	 I	 demonstrated	 that	 Trem-1	 expression	 was	 a	 selective	feature	of	CD103+CD11b+	DC	and	I	therefore	examined	whether	Trem-1	had	a	direct	role	 in	 the	development	of	 these	 cells.	 	The	 limited	experiments	 that	were	possible	from	analysis	of	cells	isolated	by	collaborators	in	Bern	revealed	few	if	any	effects	on	intestinal	DC.	Nor	were	 there	selective	effects	on	any	DC	subset	when	Trem-1-/-	BM	was	 used	 to	 generate	 competitive	 chimeras.	 	 However,	 Trem-1-/-	 BM	 showed	 a	generalised	 defect	 in	 the	 ability	 to	 generate	 all	 leukocytes	 in	 the	 mucosa	 and	migratory	MLN,	but	not	in	resident	MLN	DC.	 	Lastly,	I	tested	the	hypothesis	that	the	microbiota	might	 be	 involved	 in	 shaping	 the	 intestinal	 DC	 subsets,	 but	 analysis	 of	
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both	antibiotic	 treated	animals	and	germ-free	mice	showed	that	 the	microbiota	had	little	effect	on	the	DC	populations	present	in	the	intestine.			
Together,	 these	 results	 show	 that	 the	 specific	 acquisition	 of	 CD103+CD11b+	 DC	appears	 not	 to	 be	 dependent	 on	 the	 specific	 upregulation	 of	 genes	 encoding	 CSF2-Rα1,	 IRF4,	 TGFβR	 and	 RARα, nor	 on	 the	 expression	 of	 Trem-1.	 	 Furthermore,	bacterial	 load	 in	 the	 intestinal	mucosa	does	not	 seem	 to	be	 the	 sole	 reason	 for	 the	presence	of	CD103+CD11b+	DC.	 	These	data	 show	 that	CD103+CD11b+	DC	 lineage	 is	complicated	and	 is	 likely	 to	be	a	 combination	of	different	 factors	 including	age	and	environment.				
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Figure 5.1: Purification of small intestinal DC subsets by FACS  
SI LP cells were isolated from WT mice at 8 weeks of age and DC identified as live 
(7-AAD−) CD11c+ MHC II+ B220− CD64− cells.  A Representative dot plot showing the 
expression of CD11b and CD103 by DC from adult mice and the frequency of each 
subset as a proportion of total cells.  B Representative plots showing the proportion 
of each cell type as a percentage after sorting. Data are representative of at least 10 
independent experiments with 2-7 mice pooled per experiment.  
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Figure 5.2: Expression of transcriptional and growth factor receptors by 
small intestinal DC subsets at different ages  
A-D. SI LP DC were FACS-purified from wild type mice aged D4, D14, D21 or 8 week old 
adult as described in Fig. 5.1 and analysed by qRT-PCR for the expression of mRNA for 
(A) Csf2ra1, (B) Irf4, (C) Tgfbr1 and (D) Rara. Results shown are relative to TATA binding 
protein (TBP) using the 2-ΔΔct method with adult CD103+CD11b+ DC set to 1. Data are 
from a single experiment with cells pooled from 2-7 mice per time point with n=3 
biological replicates per group.  * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 within a 
time point. ^^ p<0.01, ^^^ p<0.001 across different time points,  Two-way ANOVA with 
Bonferroni post-test.   
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Figure 5.3: Development of small intestinal DC subsets in SIRPα mt mice  
SI LP cells were isolated from WT and SIRPα mt mice and live MHC II+ CD11c+ B220- 
CD64- DC were analysed for the expression of CD103 and CD11b. Frequencies amongst 
total DC (left panels) and absolute numbers (right panels) were analysed at A D7 and B 
D14.  Data are from one experiment with 3-5 animals per group. *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001 Student’s t test.   
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Figure 5.4: Development of migratory DC subsets in the MLN of SIRPα mt 
mice  
MLN cells were isolated from WT and SIRPα mt mice and live MHC IIhi CD11c+ B220- 
CD64- migratory DC were analysed for the expression of CD103 and CD11b. 
Frequencies amongst total migratory DC (left panels) and absolute numbers (right 
panels) were analysed at A D7 and B D14.  Data are from one experiment with 3-5 
animals per group. *p<0.05, **p<0.01, Student’s t test.   
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Figure 5.5: Development of resident DC subsets in the MLN of SIRPα mt mice  
MLN cells were isolated from WT and SIRPα mt mice and live MHC IIint CD11c+ B220- 
CD64- resident DC were analysed for the expression of CD103 and CD11b. Frequencies 
amongst resident DC (left panels) and absolute numbers (right panels) were analysed at 
A D7 and B D14.  Data are from one experiment with 3-5 animals per group. *p<0.05, 
**p<0.01, Student’s t test.   
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A Gated: Live CD45+ MHC II+ CD11c+ B220- CD64-	
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Figure 5.6: Expression of CD101 and Trem-1 by small intestinal DC from 
SIRPα mt mice at different ages 
SI LP cells were isolated from D7 or 8 week old adult WT and SIRPα mt mice and DC 
identified as single, live CD45+ CD11c+ MHC II+ CD64- leukocytes.  A Representative dot 
plots showing the expression of CD11b and CD103 on DC in adult WT mice (left panel), 
together with the expression of CD101 and Trem-1 by total CD11b+ DC (right panel).  
B Frequency and absolute numbers of total CD11b+ DC amongst total DC.  C Frequency 
of CD101+ (left panel) or Trem-1+ (right panel) cells amongst total CD11b+ DC.  Data are 
from a single experiment with n=4-5. ***p<0.001, ^p<0.05, ^^p<0.01, ^^^p<0.001, 
^^^^p<0.000,1  Student’s t test.  
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Figure 5.7: Expression of CD101 and Trem-1 by small intestinal DC from 
SIRPα mt mice at different ages 
SI LP cells were isolated from D7 or 8 week old adult WT and SIRPα mt mice and DC 
identified as single, live CD45+ CD11c+ MHC II+ CD64- leukocytes.  The pie-charts 
represent the proportions of cells expressing CD101 and Trem-1 amongst CD103+CD11b
+ (red) or CD103-CD11b+(green) DC and the frequencies of those that are 
CD101+Trem-1+ (far right panel) for A adults and B D7 mice. Data are from a single 
experiment with n=4-5. ***p<0.001, Student’s t test.  
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Figure 5.8: CD101 and Trem-1 expression by small intestinal DC from CCR2-/- 
mice 
SI LP cells were isolated from 8 week old adult WT and CCR2-/- mice and DC identified 
as single, live CD45+ CD11c+ MHC II+ B220- CD64- leukocytes.  A Representative dot 
plots showing the expression of CD11b and CD103 on total DC (left panel).  
B Frequencies amongst total DC and absolute numbers of DC subsets or total CD11b+ 
DC amongst total DC.  C Frequency of CD101+ or Trem-1+ DC amongst total CD11b+ 
DC.  Data are from a single experiment with n=4-5. *p<0.05, Student’s t test.  
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Figure 5.9: CD101 and Trem-1 expression by small intestinal DC from CCR2-/- 
mice 
SI LP cells were isolated from 8-10 week old adult WT and CCR2-/- mice and DC 
identified as live CD45+ CD11c+ MHC II+ B220- CD64- leukocytes. A Pie-charts 
representing the proportions of cells expressing CD101 and Trem-1 amongst 
CD103+CD11b+ (red) or CD103-CD11b+ (green) DC and the frequencies of those that are 
CD101+Trem-1+ (far right panel).  B Representative dot plots of WT (top panels) or 
CCR2-/- (bottom panels) CD103-CD11b+ DC showing expression of CCR2 vs. Trem-1 or 
CD101. Data are from a single experiment with n=4-5. **p<0.01, Student’s t test. 
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Figure 5.10: CD11b and CD103 expression by small intestinal DC from 
Trem-1-/- mice 
SI LP cells were isolated from 8-10 week old adult WT and Trem-1-/- mice and DC 
identified as live CD45+ CD11c+ MHC II+ B220- CD64- leukocytes.  A Representative dot 
plots showing expression of CD11b and CD103 on DC. B Replicate data showing 
frequency of the four DC subsets amongst total DC. Data are from a single experiment 
with n=1-2.   
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Figure 5.11: Generation of WT:WT or Trem-1-/-:WT competitive BM chimeras  
A Mixed WT:WT or Trem-1-/-:WT BM chimeras were generated by lethally irradiating 
CD45.1+CD45.2+ WT recipient mice and reconstituting with an approximately 90:10 mix 
of CD45.2+ WT and CD45.1+ WT or CD45.2+ Trem-1-/-and CD45.1+ WT BM respectively. 
B CD45.1 and CD45.2 expression by the BM precursors used to reconstitute irradiated 
recipients.  
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Figure 5.12: Chimerism of leukocyte populations in the blood of WT:WT or 
WT:Trem-1-/- competitive BM chimeras 
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed in blood 8 weeks after reconstitution. A Trem-1 expression and 
B proportion of CD45.1+ cells (WT) and CD45.2+ cells (WT or Trem-1-/-) amongst B cells, 
Ly6Chi monocytes and neutrophils from WT:WT chimeras (top panels) or WT:Trem-1-/- 
chimeras (bottom panels). C Ratio of CD45.2:CD45.1 derived cells in WT:WT and 
WT:Trem-1-/- chimeras normalised to peripheral blood B cells in the same mice.  Data are 
from a single experiment with n=2-4 mice/group.  
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Figure 5.13: DC in the small intestine lamina propria of WT:WT or 
WT:Trem-1-/- competitive BM chimeras  
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed 8 weeks after reconstitution. CD11b and CD103 defined 
subsets amongst live MHC II+ CD11c+ CD64- DC in SI LP were analysed for CD45.1 and 
CD45.2 expression and A the proportion of CD45.1+ cells (WT) and CD45.2+ cells (WT or 
Trem-1-/-) amongst DC subsets from WT:WT chimeras (top panels) or WT:Trem-1-/- 
chimeras (bottom panels) are shown. B Ratio of CD45.2:CD45.1 derived cells in WT:WT 
and WT:Trem-1-/- chimeras normalised to peripheral blood B cells in the same mice.  Data 
are from a single experiment with n=2-4 mice/group.  
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Figure 5.14: Monocytes and macrophages in the small intestinal lamina 
proporia of WT:WT or WT:Trem-1-/- competitive BM chimeras  
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed 8 weeks after reconstitution. A Monocyte/mφ  subsets amongst 
live MHC II+ CD11c+ MP in SI LP were analysed for CD45.1 and CD45.2 expression and 
B the proportion of CD45.1+ cells (WT) and CD45.2+ cells (WT or Trem-1-/-) amongst MP 
subsets from WT:WT chimeras (top panels) or WT:Trem-1-/- chimeras (bottom panels) are 
shown. C Ratio of CD45.2:CD45.1 derived cells in WT:WT and WT:Trem-1-/- chimeras 
normalised to peripheral blood B cells in the same mice.  Data are from a single 
experiment with n=2-4 mice/group.  
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Figure 5.15: DC in the colonic lamina propria of WT:WT or WT:Trem-1-/- 
competitive BM chimeras  
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed 8 weeks after reconstitution. CD11b and CD103 defined 
subsets amongst live MHC II+ CD11c+ CD64- DC in CLP were analysed for CD45.1 and 
CD45.2 expression and A proportion of CD45.1+ cells (WT) and CD45.2+ cells (WT or 
Trem-1-/-) amongst DC subsets from WT:WT chimeras (top panels) or WT:Trem-1-/- 
chimeras (bottom panels) are shown. B Ratio of CD45.2:CD45.1 derived cells in WT:WT 
and WT:Trem-1-/- chimeras normalised to peripheral blood B cells in the same mice.  Data 
are from a single experiment with n=2-4 mice/group.  
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Figure 5.16: Monocytes and macrophages in the colonic lamina propria of 
WT:WT or WT:Trem-1-/- competitive BM chimeras  
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed 8 weeks after reconstitution. A Monocyte/mφ  subsets amongst 
live MHC II+ CD11c+ MP in CLP were analysed for CD45.1 and CD45.2 expression and B 
the proportion of CD45.1+ cells (WT) and CD45.2+ cells (WT or Trem-1-/-) amongst MP 
subsets from WT:WT chimeras (top panels) or WT:Trem-1-/- chimeras (bottom panels) are 
shown. C Ratio of CD45.2:CD45.1 derived cells in WT:WT and WT:Trem-1-/- chimeras 
normalised to peripheral blood B cells in the same mice.  Data are from a single 
experiment with n=2-4 mice/group.  
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Figure 5.17: Migratory DC in the mesenteric lymph node of WT:WT or 
WT:Trem-1-/- competitive BM chimeras  
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed 8 weeks after reconstitution. CD11b and CD103 defined 
subsets amongst migratory live MHC IIhi CD11c+ CD64- DC in MLN were analysed for 
CD45.1 and CD45.2 expression and A the proportion of CD45.1+ cells (WT) and CD45.2+ 
cells (WT or Trem-1-/-) amongst DC subsets from WT:WT chimeras (top panels) or 
WT:Trem-1-/- chimeras (bottom panels) are shown. B Ratio of CD45.2:CD45.1 derived 
cells in WT:WT and WT:Trem-1-/- chimeras normalised to peripheral blood B cells in the 
same mice.  Data are from a single experiment with n=2-4 mice/group.  
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Figure 5.18: Resident DC in the MLN of WT:WT or WT:Trem-1-/- competitive 
BM chimeras  
Mixed WT:WT or WT:Trem-1-/- BM chimeras were generated as described in Figure 5.11 
and chimerism assessed 8 weeks after reconstitution. CD11b and CD103 defined 
subsets amongst resident live MHC IIint CD11c+ CD64- DC in MLN were analysed for 
CD45.1 and CD45.2 expression and A the proportion of CD45.1+ cells (WT) and CD45.2+ 
cells (WT or Trem-1-/-) amongst DC subsets from WT:WT chimeras (top panels) or 
WT:Trem-1-/- chimeras (bottom panels) are shown. B Ratio of CD45.2:CD45.1 derived 
cells in WT:WT and WT:Trem-1-/- chimeras normalised to peripheral blood B cells in the 
same mice.  Data are from a single experiment with n=2-4 mice/group.  
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Figure 5.19: Effects of antibiotics on DC and T cells in the small intestinal 
lamina propria 
SI LP cells were isolated from adult WT mice treated with 1 mg/ml Cefoxitin, 1 mg/ml 
Gentamicin, 1 mg/ml Metronidazol, and 1 mg/ml Vancomycin in the drinking water for two 
weeks (Abx) or from controls given plain water with sweetener, and DC identified as 
single live (7-AAD-) CD45+ CD11c+ MHC II+ B220- CD64- cells.  A Representative dot 
plots showing the expression of CD11b and CD103 by DC from control and antibiotic 
treated mice.  B Frequencies amongst total DC (left) and absolute number (right) of DC 
subsets.  C Expression of FoxP3, Il-17 and IFNγ by B220-CD3+CD4+ T cells assessed by 
intracellular cytokine staining. The results shown are frequencies (left) and absolute 
numbers (right) of Treg, Th17 and Th1 cells.  Data are from a single experiment with 
n=4-5. *p<0.05 Student’s t test. 
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Figure 5.20: Effects of antibiotics on DC in colonic lamina propria 
CLP cells were isolated from adult WT mice treated with 1 mg/ml Cefoxitin, 1 mg/ml 
Gentamicin, 1 mg/ml Metronidazol, and 1 mg/ml Vancomycin in the drinking water for two 
weeks (Abx) or from controls given plain water with sweetener, and DC identified as 
single live (7-AAD-) CD45+ CD11c+ MHC II+ B220- CD64- cells.  A Representative dot 
plots showing the expression of CD11b and CD103 by DC from control and antibiotic 
treated mice.  B Frequencies amongst total DC (left) and absolute number (right) of DC 
subsets. Data are from a single experiment with n=4-5. *p<0.05, Student’s t test.   
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Figure 5.21: Effects of antibiotics on migratory DC in MLN 
MLN cells were isolated from adult WT mice treated with 1 mg/ml Cefoxitin, 1 mg/ml 
Gentamicin, 1 mg/ml Metronidazol, and 1 mg/ml Vancomycin in the drinking water for two 
weeks (Abx) or from controls given plain water with sweetener, and migratory DC 
identified as single live (7-AAD-) CD45+ CD11c+ MHC IIhi B220- CD64- cells.  A 
Representative dot plots showing the expression of CD11b and CD103 by migratory DC 
from control and antibiotic treated mice.  B Frequencies amongst total migratory DC (left) 
and absolute number (right) of DC subsets. Data are from a single experiment with 
n=4-5. *p<0.05, Student’s t test.   
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Gated: Live CD45+ MHC Iiint CD11c+ B220- CD64-	
Figure 5.22: Effects of antibiotics on resident DC in MLN 
MLN cells were isolated from adult WT mice treated with 1 mg/ml Cefoxitin, 1 mg/ml 
Gentamicin, 1 mg/ml Metronidazol, and 1 mg/ml Vancomycin in the drinking water for two 
weeks (Abx) or from controls given plain water with sweetener, and resident DC identified 
as single live (7-AAD-) CD11c+ MHC IIint B220- CD64- cells.  A Representative dot plots 
showing the expression of CD11b and CD103 by resident DC from control and antibiotic 
treated mice.  B Frequencies amongst total resident DC (left) and absolute number (right) 
of DC subsets. Data are from a single experiment with n=4-5. **p<0.01, Student’s t test.   
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Figure 5.23: 16s analysis of Germ Free and SPF caeca 
Caecal contents were taken for 16s analysis from GF animals used in experiments 
alongside SPF mice housed at the facility in Norwich.  The taxonomy profile is shown as 
the number of reads for the specific bacterial sequence at A family and B genus level.  
With thanks to Lindsay Hall and Suparna Mitra at IFR, Norwich for providing me with 
these data.   
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Figure 5.24: Intestinal DC subsets in germ free mice 
Cells were isolated from adult conventional or germ free mice and DC identified as live 
(7-AAD-) CD45+ CD11c+ MHC II+ B220- CD64- cells.  Frequencies amongst total DC (left) 
and absolute number (right) of DC subsets from A SI LP or B CLP.  Data are from a 
single experiment with n=2-6.  *p<0.05, **p<0.01, Student’s t test.   
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Figure 5.25:  Intestinal DC subsets in the mesenteric lymph nodes of germ 
free mice 
Cells were isolated from adult WT or germ free mice, and DC identified as live (7-AAD-) 
CD11c+ MHC II+ B220- CD64- cells.  Frequencies amongst total migratory or resident DC 
(left) and absolute number (right) of DC subsets from A MHC IIhi migratory or B MHC IIint 
resident DC.  Data are from a single experiment with n=3.   
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General	Discussion	
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6.1 Introduction		
The	 constant	 pressure	 on	 the	 intestinal	 immune	 system	 to	 induce	 tolerance	 to	harmless	antigens	from	commensal	bacteria	and	dietary	constituents,	or	to	mount	an	active	immune	response	against	harmful	pathogens	leads	to	great	complexity.		DC	are	the	 link	 between	 the	 ‘outside’	 luminal	 world	 and	 the	 ‘inside’	 adaptive	 immune	response.		Until	recently,	the	distinctions	between	DC	and	mφ,	the	other	main	antigen	presenting	 cell	 in	 the	 intestine,	 have	 been	 largely	 ignored,	 leading	 to	misunderstanding	 of	 their	 exact	 roles	 in	 the	 intestinal	 immune	 system.	 	 The	main	differences	between	the	two	cell	types	is	that	DC	migrate	to	the	MLN	and	can	induce	an	 adaptive	 immune	 response	 by	 presenting	 antigen	 to	 naïve	 T	 cells,	 whereas	mφ	remain	 sessile	 in	 the	 LP,	 scavenging	 pathogens	 and	 damaged	 cells	 as	 well	 as	maintaining	 epithelial	 barrier	 integrity	 (Cerovic	 et	 al.,	 2014a).	 	With	 the	 increasing	clarity	of	the	differences	between	these	two	cell	types,	the	main	aim	of	my	thesis	was	to	analyse	the	different	subsets	of	DC	in	the	intestine,	paying	particular	attention	to	how	 the	 populations	 changed	 from	 birth	 into	 adulthood	 and	 trying	 to	 understand	some	of	the	pathways	involved	in	their	development.			
When	 I	 began	 my	 PhD,	 it	 had	 recently	 been	 shown	 that	 MHC	 II	 and	 CD11c	 were	insufficient	 to	 distinguish	 between	DC	 and	mφ	 in	 the	 intestinal	 LP,	with	 additional	markers	such	as	CD64	being	required	(Bain	et	al.,	2013;	Tamoutounour	et	al.,	2012).			Work	 by	 a	 number	 of	 groups,	 including	 a	 previous	 PhD	 student	 in	 the	 laboratory,	Charlotte	 Scott,	 exploited	 these	 insights	 to	 develop	 rigorous	 gating	 strategies	 that	showed	 there	 were	 four	 genuine	 subsets	 of	 DC	 in	 the	 intestine	 based	 on	 the	expression	 of	 CD11b	 and	 CD103.	 	 This	 had	 revealed	 that	 the	 CD103+	 population	previously	thought	to	be	homogeneous,	contained	both	CD11b+	and	CD11b-	subsets.		In	 addition,	 presence	of	 genuine	CD103-	 subsets,	 previously	 included	with	mφ,	was	established	(Cerovic	et	al.,	2014a;	Denning	et	al.,	2011;	Schlitzer	et	al.,	2013;	Scott	et	al.,	2011).			
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6.2 The	DC	landscape	changes	with	age	
In	chapter	4,	I	showed	how	the	intestinal	DC	subsets	changed	relative	to	one	another	from	 birth	 into	 adulthood,	 something	 that	 had	 not	 previously	 been	 explored.	 	 The	most	interesting	finding	was	that	although	DC	were	present	in	the	SI	LP	before	birth,	CD103+CD11b+	DC	were	rare	at	birth,	and	their	numbers	only	slowly	increased	with	age	until	they	became	the	most	dominant	population	by	D28.		Interestingly,	although	~10%	 of	 CD103+CD11b+	 DC	 were	 seen	 among	 the	 migratory	 DC	 at	 D1,	 their	proportions	 did	 not	 increase	 further	 until	D14,	 around	 the	 time	 that	mice	 begin	 to	ingest	solid	 food	to	supplement	 their	main	milk	diet.	 	 In	contrast,	 the	proportion	of	CD103-CD11b+	DC	increased	earlier	and	then	fell	as	the	proportion	of	CD103+CD11b+	DC	 increased,	 suggesting	 a	 reciprocal	 relationship	 between	 the	 subsets.	 	 These	changes	were	mirrored	amongst	the	migratory	DC	in	the	MLN	although	were	delayed	in	this	tissue,	consistent	with	the	need	for	DC	to	enter	from	afferent	lymph.		The	same	pattern	was	observed	in	the	CLP,	though	CD103+CD11b+	DC	are	less	frequent	in	this	site.	 	 In	 contrast	 to	 this	 pattern	 amongst	 CD11b+	 subsets,	 CD103+CD11b-	 DC	were	already	abundant	in	both	the	SI	LP	and	CLP	before	birth	and	although	their	absolute	numbers	increased,	their	proportions	behaved	independently	of	other	subsets.		
There	have	been	 few	 studies	 applying	modern	methodology	 to	 investigate	how	 the	immune	 system	 develops	 in	 the	 neonatal	 intestine	 at	 the	 cellular	 level.	 	 A	 recent	detailed	 report	 showed	 that	 there	 was	 defective	 activation	 of	 CD4+	 T	 cells	 in	 the	intestine	 early	 in	 life,	 partially	 as	 a	 result	 of	 an	 active	 suppression	 mechanism.		Although	these	authors	speculated	that	these	features	might	be	related	to	defects	in	antigen	presentation,	 they	showed	 that	 the	numbers	of	DC	and	mφ	did	not	 seem	to	change	after	birth.		Although	this	contrasts	with	my	own	work,	Torow	et	al.	measured	cell	numbers	as	a	proportion	of	total	CD45+	cells,	of	which	DC	and	mφ	make	up	a	very	small	 proportion.	 	 Thus	 they	 had	 failed	 to	 observe	 subtle	 changes	 in	 these	populations,	especially	in	DC	subsets	(Torow	et	al.,	2015).			
The	processes	responsible	for	driving	the	appearance	of	DC	in	the	neonatal	intestine	remain	 to	 be	 defined,	 as	 do	 the	 mechanisms	 involved	 in	 the	 development	 of	 the	different	subsets.	 	Many	factors	change	in	the	immune	system	and	intestine	early	in	
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life,	including	the	colonisation	of	the	microbiota,	presence	of	breast	milk,	changes	in	the	diet	at	weaning,	structural	maturation	of	the	mucosa,	hormones	etc.		Perhaps	the	most	obvious	one	is	the	rapid	exposure	to	microbes	which	occurs	at	birth	due	to	the	maternal	 vaginal	 and	 faecal	 microbiotas	 (Francino,	 2014).	 	 The	 subsequent	establishment	 and	 diversification	 of	 the	 microbiota	 may	 be	 one	 way	 in	 which	 DC	differentiation	 can	 be	 influenced	 in	 the	 intestine	 during	 this	 time,	 although	 my	experiment	 with	 antibiotics	 in	 adults	 might	 argue	 against	 this	 (see	 below).	 	 The	question	 then	 arises	 of	 how	 DC	 are	 already	 present	 in	 the	 LP	 and	 migratory	compartment	 in	 the	 MLN	 at	 birth	 or	 just	 after.	 	 The	 likelihood	 that	 bacteria	 are	present	 in	utero	 (Francino,	2014)	 is	one	possibility,	alternatively	 is	that	constitutive	migration	 of	 DC	 carrying	 self	 antigen	 from	 the	 embryonic	 intestine	 leads	 to	 their	presence	in	the	MLN	from	early	in	life	(Huang	et	al.,	2000).			
Another	hypothesis	 for	 the	differential	 appearance	of	DC	 subsets	 in	 the	 intestine	 is	that	each	may	have	a	distinct	precursor	whose	development	and	or	emigration	from	the	 BM	 occurs	 at	 different	 times.	 	 Although	 all	 cDC	 originate	 from	 a	 common	precursor,	 recent	 evidence	 suggests	 there	 may	 be	 specific	 precursors	 already	committed	to	the	cDC1	or	cDC2	lineage	(Schlitzer	et	al.,	2015;	Zeng	et	al.,	2012).		This	could	explain	the	differential	appearance	of	DC	subsets	as	they	would	likely	be	under	the	 control	 of	 different	 external	 factors	 promoting	 their	 differentiation	 at	 different	times.		To	test	this,	single	cell	analysis	of	individual	DC	subsets	and	precursors	could	be	 performed	 to	 assess	 if	 there	 are	 common	 transcriptional	 clusters	 between	 the	different	gut	DC	susbets.		
As	I	wasn’t	able	to	analyse	pre-DC	in	this	way,	I	examined	whether	the	expression	of	genes	 involved	 in	 DC	 development	 might	 correlate	 with	 the	 appearance	 of	 the	different	subsets	after	birth.		CSF-2	is	required	for	the	development	of	CD103+CD11b-	DC	 in	 tissues	 apart	 from	 the	 intestine,	 and	 for	 the	 development	 of	 intestinal	CD103+CD11b+	DC	(Greter	et	al.,	2012).	 	Although	my	results	suggested	there	might	be	a	trend	towards	a	decrease	in	Csf2ra	expression	by	all	DC	subsets	as	the	mice	aged,	these	differences	were	not	significant,	and	in	general,	there	was	no	obvious	pattern	of	change	in	Csf2ra	expression	between	the	DC	subsets	over	time.		
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CD103+CD11b+	DC	have	a	selective	requirement	 for	 IRF4	signalling	 in	development,	with	 both	 CD11b+	 DC	 subsets	 expressing	 high	 levels	 of	 IRF4	 protein	 in	 adults	(Persson	 et	 al.,	 2013b).	 	 However,	 the	 only	 significant	 difference	 I	 found	 was	 that	CD103+CD11b-	DC	expressed	significantly	more	Irf4	 than	CD103-CD11b+	DC	on	D14.		The	 reasons	 for	 this	 discrepancy	 are	 not	 clear.	 	Tgfbr1	 expression	 was	 studied	 as	recent	 work	 in	 our	 laboratory	 has	 shown	 that	 CD11c-Cre.Tgfbr1fl/fl	 mice	 lacked	CD103+CD11b+	DC	selectively,	but	had	an	increased	proportion	of	CD103-CD11b+	DC,	suggesting	that	TGFβ	might	control	the	transition	between	these	subsets.	 	TGFβ	has	previously	been	shown	to	be	important	on	splenic	cDC	function,	but	not	required	for	their	development	(Laouar	et	al.,	2005;	Strobl	and	Knapp,	1999).		On	the	other	hand,	Langerhans	 cells,	 (which,	 although	 not	 strictly	 DC,	 share	 some	 of	 their	 functional	properties)	 do	 require	 TGFβ	 for	 their	 development	 (Zahner	 et	 al.,	 2011).	 	 I	hypothesised	that	 increased	 levels	of	Tgfbr1	in	CD103-CD11b+	DC	might	accompany	the	 expansion	of	 CD103+CD11b+	DC	 around	D14.	 	 There	was	 indeed	 an	 increase	 in	transcription	 of	Tgfbr1	 at	 D14,	 but	 this	was	 only	 significant	 for	 CD103-CD11b+	DC,	with	a	small	increase	in	CD103+CD11b+	DC.			
Lastly,	I	examined	the	expression	of	Rara.		Intestinal	CD103+	DC	not	only	produce	RA,	but	 RA	 can	 promote	 the	 development	 of	 CD103+CD11b+	 DC	 (Agace	 and	 Persson,	2012).	 	 Unexpectedly	 however,	 the	 only	 population	 I	 found	 to	 express	 significant	levels	of	Rara	were	CD103+CD11b-	DC	and	this	was	seen	at	all	time	points.		Although	it	is	possible	that	one	of	the	other	receptors	for	RA	might	have	allowed	discrimination	between	the	subsets,	it	has	been	reported	that	RARα	is	the	most	highly	expressed	in	intestinal	 CD103+	DC,	 followed	by	RARγ while	RARβ is	 barely	 detectable	 (Jaensson-Gyllenbäck	 et	 al.,	 2011).	 	 Therefore	 it	 seems	 likely	 that	 RARα	 should	 have	 been	 a	useful	 marker.	 	 Together,	 these	 analyses	 of	 gene	 expression	 on	 the	 different	 DC	subsets	 at	 different	 ages	 are	 largely	 inconclusive	 and	were	 subject	 to	 considerable	variability.	 	This	may	reflect	 the	difficulties	 I	had	 in	sorting	suitable	numbers	of	 the	DC	 subsets	 from	 neonatal	 intestine	 and	 unfortunately,	 for	 this	 reason	 I	 was	 also	unable	to	repeat	these	experiments,	though	it	would	be	worth	pursuing.				
These	molecules	were	measured	at	the	mRNA	level	due	to	low	cell	numbers	and	lack	of	 robust	 antibodies	 to	 some	 of	 these	molecules,	 though	 it	would	 be	 interesting	 to	
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understand	 how	 these	 genes	 are	 regulated	 in	 the	 production	 of	 protein	 at	 the	different	ages.		To	extend	these	findings	further,	other	genes	such	as	Irf8	(involved	in	CD103+CD11b-DC	 differentiation	 (Luda	 et	 al.,	 2016))	 as	 well	 as	 CCR9	 and	 α4β7,	reported	to	be	present	on	the	intestine	specific	pre-DC	(Zeng	et	al.,	2012)	should	be	analysed.		Other	receptors	that	could	also	change	with	age	are	the	TLRs,	differentially	expressed	amongst	the	DC	subsets	and	thought	to	provide	the	DC	subsets	with	their	specific	 ability	 to	 prime	 naïve	 T	 cells	 with	 different	 effector	 responses.	 	 Co-stimulatory	molecules	as	well	would	help	to	determine	the	functional	capacity	of	the	DC	in	neonates	and	how	these	might	change	with	age.		To	complement	these	findings,	I	would	measure	vitamin	A,	retinol,	RA	and	CSF-2	in	the	mucosa	itself	as	it	might	be	that	in	lieu	of	changes	in	the	receptors	on	DC	subsets,	the	developmental	patterns	of	the	DC	subsets	arise	from	the	availability	of	the	factors	themselves.	
There	 were	 also	 changes	 in	 the	 relative	 numbers	 of	 DC	 subsets	 amongst	 blood	derived	resident	MLN	DC,	although	the	populations	are	less	complex	than	in	the	LP,	with	 CD103+CD11b+	 DC	 essentially	 being	 almost	 absent,	 apart	 from	 a	 few	contaminants	from	the	migratory	compartment.		As	in	the	LP,	CD103+CD11b-	DC	were	the	 most	 prevalent	 subset	 amongst	 resident	 MLN	 DC	 at	 birth,	 although	 from	 D3	onwards	 the	CD103-CD11b+	subset	 took	over.	 	Together	 these	results	could	suggest	that	CD103+CD11b-	DC	are	the	first	to	develop	from	blood	derived	precursors,	or	that	these	 are	 the	 first	 to	 seed	 secondary	 lymphoid	 organs,	where	 they	 account	 for	 the	majority	of	DC	in	T	cell	areas	(Houston	et	al.,	2015).		Indeed,	I	was	unable	to	remove	ILF	from	the	colon	in	any	mice	or	PP	in	the	neonatal	mice.		I	also	analysed	DC	in	the	lung	as	an	example	of	a	mucosal	tissue	other	than	the	intestine.		My	results	confirmed	that	 there	were	very	 few	CD103+CD11b+	DC	 in	 the	 lungs	at	any	 time,	 though	on	D1	there	made	 up	~3.6%.	 	However,	 this	may	 simply	 reflect	 the	 very	 low	numbers	 of	total	DC	in	the	neonatal	lung	and	equating	to	one	cell	in	a	gate	making	up	a	significant	frequency.	 	 In	 contrast	 to	 the	 intestine	 and	 MLN,	 CD103+CD11b-	 DC	 made	 up	 the	greatest	 proportion	 of	 DC	 at	 most	 time	 points	 in	 the	 lung,	 confirming	 a	 previous	report	(Ruckwardt	et	al.,	2014),	while	CD103-CD11b+	DC	proportions	increased	also	increased	with	 age.	 	 The	 differences	 between	 the	 lung	 and	 LP	 could	 be	 due	 to	 the	different	functions	the	organs	perform	and/or	to	their	distinct	microbiota	(Barfod	et	al.,	2013;	Segal	and	Blaser,	2014).		CD103+CD11b-	DC	cross-present	antigen	to	CD8+	T	
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cells,	and	are	therefore	well	adapted	in	responding	to	viral	pathogens.		They	also	have	a	unique	capacity	to	transport	apoptotic	cells	to	the	draining	LN	(del	Rio	et	al.,	2007;	Desch	et	al.,	2011;	Ginhoux	et	al.,	2009a).		It	is	possible	that	due	to	the	lungs’	constant	exposure	 to	 viral	 antigen	 there	 is	 a	 requirement	 for	 CD103+CD11b-	 DC	 to	 be	 the	dominant	 population	 here,	 while	 in	 the	 intestine	 there	 is	 a	 strong	 pressure	 on	generating	Th1	and	Th17	responses	towards	the	various	antigen,	performed	more	by	CD103-CD11b+	DC	(Cerovic	et	al.,	2013;	Scott	et	al.,	2014a).			
6.2.1 The role of the microbiota in DC development  
As	noted	above,	the	expansion	of	DC	in	neonatal	intestine	occurred	at	the	time	when	the	microbiota	 is	 becoming	 established,	 and	 given	 the	marked	 effects	 that	 bacteria	and	 their	products	have	on	DC	 (Francino,	2014;	 Ivanov	et	al.,	2009;	 Janelsins	et	al.,	2014;	Ng	et	al.,	2010),	it	seemed	feasible	that	these	might	influence	the	differentiation	of	the	DC	subsets.		In	parallel,	the	developing	DC	populations	would	be	important	for	ensuring	that	the	neonatal	immune	system	begins	to	make	appropriate	responses	to	these	new	arrivals.	 	Although	I	was	not	able	to	explore	the	relationship	between	the	microbiota	 and	 DC	 in	 the	 neonatal	 intestine,	 I	 did	 attempt	 to	 address	 the	 issue	 by	investigating	the	effects	of	antibiotic	treatment	in	adult	mice.		It	was	evident	that	the	antibiotics	 had	 been	 effective,	 as	 shown	 by	 the	 enlarged	 caeca	 of	 treated	 mice,	however	all	DC	subsets	were	unaffected	in	SI	LP,	CLP	and	MLN,	apart	from	a	decrease	in	the	proportion	of	CD103+CD11b-	DC	in	the	CLP.		However,	this	was	not	reflected	in	a	 difference	 in	 cell	 number	 on	 this	 population,	 and	 as	 this	 experiment	 was	 only	carried	out	 in	one	cohort	of	mice,	 it	would	be	 important	to	repeat	 it.	 	 If	repeated,	 it	would	 also	 be	 important	 to	 address	 how	 effective	 this	 antibiotic	 regime	 was,	 by	performing	16s	RNA	sequencing	of	the	microbiome	in	faecal	and	intestinal	samples	as	this	might	also	highlight	a	role	for	individual	species	as	well	as	relative	abundance.		
As	 I	was	somewhat	surprised	by	the	apparent	 lack	of	effect	of	 the	antibiotic	regime	and	I	could	not	be	sure	of	how	effective	the	depletion	of	 the	microbiota	had	been,	 I	went	on	to	plan	experiments	in	adult	GF	mice.	 	Unfortunately,	due	to	the	recent	and	unintended	 recolonisation	 of	 these	 mice,	 it	 was	 difficult	 to	 draw	 any	 confident	conclusions	 from	 these	 experiments.	 	 However,	 sequencing	 of	 the	microbiome	 did	indicate	the	‘GF’	animals	had	a	greater	diversity	of	bacterial	species	at	both	the	family	
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and	genus	level,	but	fewer	copy	numbers	of	those	bacteria	when	compared	with	SPF	controls.		This	was	consistent	recent	colonisation	where	many	bacterial	species	were	competing	 for	 a	 niche	 in	 the	 intestine.	 	 The	 results	 did	 corroborate	my	 findings	 in	antibiotic	 treated	 mice,	 as	 there	 were	 no	 consistent	 differences	 amongst	 the	 DC	subsets	 in	 the	 SI	 LP	 and	 MLN,	 compared	 with	 conventional	 mice,	 although	 the	proportion	of	CD103+CD11b-	DC	was	decreased	in	the	CLP	of	GF	mice.		Together	these	experiments	 indicate	 that	 although	 the	 microbiota	 might	 play	 some	 role	 in	 the	differentiation	of	individual	DC	subsets	in	the	intestine	its	presence	is	not	an	absolute	requirement.	 	 Indeed	other	studies	 in	GF	animals	have	also	shown	DC	do	not	 show	altered	activation	markers	(Walton	et	al.,	2006),	nor	does	their	migration	to	the	MLN	change	after	treatment	with	broad	spectrum	antibiotics	or	in	GF	animals,	although	it	is	dependent	on	MyD88	signalling	(Hagerbrand	et	al.,	2015).		It	would	be	important	to	repeat	 these	 experiments	 to	 extend	 these	 findings	 while	 analysis	 of	 neonatal	 GF	intestines	would	provide	evidence	as	to	whether	DC	are	impacted	by	the	microbiota	during	development.		Although	previous	GF	studies	have	highlighted	that	absence	of	the	 intestinal	 microbiota	 has	 little	 impact	 on	 DC	 subsets	 proportions	 and	 their	migration,	there	is	evidence	that	intestinal	organisms	can	influence	DC.		In	particular,	SFB	have	been	shown	to	promote	CD103+CD11b+	DC	to	produce	 Il-23	and	generate	Th17	cells	(Goto	et	al.,	2014;	Ivanov	et	al.,	2009).		This	kind	of	relationship	between	individual	bacterial	species	and	DC	subsets	might	regulate	how	DC	subsets	develop	in	the	LP.		Re-colonisation	of	specific	bacterial	species	might	allow	this	to	be	tested.			
As	 my	 experiments	 suggested	 there	 might	 be	 little	 effect	 of	 the	 microbiota	 on	 DC	subsets,	another	local	factor	might	be	involved	in	their	development	in	the	neonatal	period.	 	The	diet	 is	 the	other	major	factor	that	changes	around	the	time	I	 found	the	biggest	shifts	in	DC	populations.		Mice	consume	their	mother’s	milk	only	for	the	first	two	weeks	of	 life,	after	which	they	supplement	milk	by	nibbling	solid	food	that	falls	from	 the	 feeders.	 	 In	our	animal	 facility,	mice	are	 fully	weaned	and	separated	 from	their	mothers	at	21	days	of	age,	though	in	the	future,	to	test	the	impact	of	weaning	on	DC	 populations,	 it	 could	 be	 delayed	 and	 compared	 with	 those	 weaned	 at	 D21.		Although	my	data	showed	a	mostly	gradual	increase	in	the	proportions	and	numbers	of	DC	subsets	after	birth,	as	assessed	per	intestine,	calculating	the	density	of	cells	per	gram	of	 tissue	 indicated	that	 the	peak	 increases	 in	cellularity,	occurred	 in	 the	SI	LP	
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and	CLP	at	D14.		This	could	suggest	that	the	expansion	of	DC	numbers	may	be	driven	by	the	introduction	of	new	materials	into	the	diet.		Again	this	would	seem	a	sensible	strategy	to	allow	the	immune	system	to	deal	with	novel	food	proteins.			
The	 CD103+CD11b+	 DC	 subset	 was	 the	 one	 whose	 numbers	 were	 particularly	 age	dependent,	and	one	component	of	the	diet	which	could	influence	the	development	of	these	cells	is	vitamin	A.		A	number	of	studies	have	shown	that	retinoic	acid	promotes	the	 differentiation	 of	 CD103+CD11b+	DC,	 and	 the	 only	 source	 of	 RA	 in	mammals	 is	metabolism	 of	 vitamin	 A	 from	 the	 diet	 (Klebanoff	 et	 al.,	 2013;	 Zeng	 et	 al.,	 2016).		However,	 vitamin	 A	 is	 known	 to	 cross	 the	 placenta	 and	 plays	 a	 crucial	 role	 in	embryonic	 development	 and	 is	 also	 present	 in	 maternal	 milk	 (Davila	 et	 al.,	 1985;	Green	et	al.,	2001).		Therefore,	the	newborn	mouse	clearly	already	has	a	source	of	RA	that	 could	 drive	 the	 development	 of	 CD103+CD11b+	 DC,	 yet	 these	 DC	 are	 absent	before	 birth,	 suggesting	 that	 additional	 factors	 may	 be	 involved,	 either	 alone	 or	together	 with	 RA	 and	 that	 these	 do	 not	 become	 available	 until	 after	 birth	 and	especially	at	the	time	of	weaning.			
Other	factors	that	infants	receive	from	maternal	milk	are	IgG	(Israel	et	al.,	1995)	and	IgA	 (Tourneur	 and	 Chassin,	 2013).	 	 The	 role	 of	 maternally	 derived	 IgG	 is	 in	 the	prevention	of	perinatal	infection,	but	also	modulates	the	developing	immune	system	by	 inducing	 tolerance	 towards	 dietary	 and	 commensal	 proteins.	 	 IgA	 has	 a	 similar	role,	but	is	specific	to	mucosal	sites	and	is	thought	to	act	as	immunological	‘fly	paper’	by	 promoting	 and	 stabilising	 the	 biofilm	 produced	 by	 bacteria	 (Macpherson	 et	 al.,	2001;	 2008).	 	 As	 there	 are	 no	 recent	 studies	 describing	 how	 the	 levels	 of	 these	immunoglobulins	directly	affect	DC	in	the	neonate	it	would	be	interesting	to	see	if	any	of	the	changes	correlate	with	the	changes	in	DC	populations	I	have	described.			
6.2.2 Functional maturation of intestinal DC 
The	low	numbers	of	DC	obtained	from	neonatal	intestine	meant	that	it	was	difficult	to	carry	 out	 functional	 assessments	 of	 the	 developing	 populations	 directly.		Furthermore,	 previous	 work	 in	 our	 laboratory	 has	 shown	 that	 flow	 cytometric	analysis	 of	 conventional	 activation	 markers	 such	 as	 CD80,	 CD86	 and	 CCR7	 is	unreliable.	 	 However,	 one	marker	 that	 did	 appear	 to	 change	with	 age	was	 CD103,	
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whose	 expression	 increased	 over	 time,	 especially	 amongst	 the	 CD103+CD11b+	population.		Although	the	function	of	CD103	remains	unclear	its	ligand	E-cadherin	is	expressed	on	epithelial	cells	in	the	intestine,	and	this	interaction	has	been	suggested	to	maintain	 the	 survival	 and	 positioning	 of	 CD103	 expressing	 DC	 and	 CD8+	 T	 cells	(Strauch	et	al.,	2001).		Interestingly,	CD103+CD11b+	DC	always	express	lower	levels	of	CD103	 than	CD103+CD11b-	DC	and	 it	 is	 tempting	 to	 speculate	 that	 this	 could	mean	CD103+CD11b-	 DC	 reside	 closer	 to	 the	 epithelium	 than	 CD103+CD11b+	 DC.	 	 By	extrapolation	the	lower	expression	of	CD103	on	neonatal	DC	could	therefore	indicate	that	DC	in	infant	mucosa	do	not	interact	as	closely	with	the	epithelium	as	their	adult	counterparts.	 	 Immunofluorescence	 staining	 of	 intestinal	 tissue	 sections	 would	 be	required	to	test	these	ideas	directly	and	to	my	knowledge	this	has	not	been	studied,	perhaps	 because	 of	 the	 number	 of	 parameters	 that	 would	 be	 required	 to	 identify	different	DC	subsets	precisely.		
The	one	functional	parameter	that	 I	did	assess	was	the	ability	of	DC	to	produce	RA,	using	the	AldefluorTM	assay.		These	studies	showed	that	fewer	of	all	the	neonatal	DC	subsets	produced	RA	compared	with	adults	and	the	levels	of	ALDH	activity	were	also	lower.	 	However,	both	parameters	 increased	with	age,	with	adult	 levels	matched	by	CD103+CD11b-	 and	 CD103-CD11b-	 DC	 by	 D7,	 whilst	 both	 CD103+CD11b+	 and	CD103+CD11b+	DC	were	significantly	 lower	than	their	adult	counterparts.	 	Together	with	the	expression	of	CD103,	these	results	suggest	that	not	only	do	the	populations	take	some	time	to	establish	after	birth,	but	their	functional	capacity	also	takes	time	to	mature.		The	low	production	of	RA	by	neonatal	DC	would	suggest	that	there	might	be	deficiencies	in	the	induction	of	the	gut	homing	molecules	CCR9	and	α4β7	on	T	cells	(Jaensson-Gyllenbäck	 et	 al.,	 2011).	 	 Furthermore,	 work	 carried	 out	 while	 I	 was	writing	my	thesis	also	showed	that	neonatal	 intestinal	CD103+	DC	were	 less	able	 to	produce	 RA	 and	 went	 on	 to	 show	 that	 this	 restricted	 oral	 tolerance	 in	 neonates	(Turfkruyer	et	al.,	2015).		Until	about	three	weeks	of	age	there	are	few	T	cells	present	in	the	intestine,	as	they	have	not	yet	exited	the	thymus,	thus	this	defect	on	D1	and	D7	may	not	be	of	practical	significance.	 	However,	 it	clearly	would	be	important	for	the	RA	generating	capacity	of	the	DC	to	keep	up	with	the	increasing	amount	of	antigen	in	the	developing	intestine	so	that	appropriate	T	cell	responses	can	be	generated	in	the	mucosa.	 	 The	 acquisition	 of	 RA	 production	 could	 reflect	 intrinsic	 changes	 in	 DC	 as	
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they	mature	or	the	levels	of	vitamin	A	in	the	diet.	 	An	additional	factor	could	be	the	presence	 of	 ligands	 for	 peroxisome	 proliferator-activated	 receptor	 (PPAR)γ,	 which	induce	vitamin	A	metabolising	activity	 in	human	monocyte-derived	DC	(Szatmari	et	al.,	 2006)	 and	 expression	 of	 Aldh1a2	 in	 murine	 splenic	 DC	 (Housley	 et	 al.,	 2009).		Natural	 PPARγ	 ligands,	 such	 as	 polyunsaturated	 fatty	 acids	 are	 present	 in	 the	 gut,	however	 are	 only	 reported	 at	 low	 levels,	 with	 weak	 binding	 affinities.	 	 Another	PPARγ ligand	is	linoleic	acid	found	in	the	diet	or	synthesised	by	commensal	bacteria	(Dubuquoy	et	al.,	2006;	Kelly	et	al.,	2003)	therefore	 it	would	be	interesting	to	see	if	these	ligands	are	available	in	neonatal	intestine	to	begin	imprinting	of	RA	metabolism	in	DC.		Additional	studies	to	investigate	whether	neonatal	DC	have	the	same	capacity	to	present	antigen	to	T	cells	and	how	the	T	cells	become	polarised	would	further	our	understanding	as	to	how	functional	neonatal	DC	are.		I	did	attempt	to	carry	out	DC-T	cell	co-cultures	using	DC	isolated	from	neonatal	SI	LP,	but	the	small	number	of	cells	and	 the	 lack	of	 viability	 from	 these	 cultures	did	not	 allow	me	 to	obtain	any	 results	from	these	experiments.		In	the	absence	of	these	co-cultures	working,	I	did	take	whole	SI	LP	digests	from	D7,	D21,	D42	and	adults	to	look	at	the	cytokine	production	by	the	T	cells	present.		I	would	have	predicted	a	significant	increase	in	Th17	cells,	in	line	with	the	published	data	describing	them	as	being	most	abundant	in	the	SI	LP	compared	to	Tregs	 (Denning	 et	 al.,	 2011)	 and	 to	 be	 reliant	 on	 the	 presence	 of	 functional	CD103+CD11b+	DC	(Persson	et	al.,	2013b;	Scott	et	al.,	2014b;	Welty	et	al.,	2013)	which	increase	with	 age.	 	However,	my	 findings	would	 suggest	 that	 although	 there	was	 a	trend	 in	 the	 increase	of	Th17	cells,	 these	were	never	greater	 than	 the	 frequency	or	numbers	of	Tregs.	 	This	would	lead	me	to	conclude	that	in	these	experiments,	IL-17	and	 IFNγ	 cytokine	 staining	 may	 have	 not	 worked	 properly,	 and	 the	 transcription	factor	staining	for	FoxP3+	Tregs	was	favoured.		These	experiments	would	need	to	be	repeated	and	perhaps	staining	for	the	transcription	factors,	RORγt	and	GATA3	would	help	to	distinguish	Th17	and	Th1	cells	respectively.		 
6.3 Trem-1	and	CD101	as	markers	of	DC	differentiation		
CD101	and	Trem-1	were	markers	 identified	in	a	microarray	performed	on	SI	LP	DC	subsets	by	a	previous	PhD	student,	as	being	highly	upregulated	in	CD103+CD11b+	DC	compared	with	 CD103-CD11b+	 DC.	 	 They	 have	 been	 subsequently	 proved	 useful	 in	
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dissecting	the	relationship	between	these	subsets	in	mice	lacking	TGFβR	signalling	on	DC	and	therefore	I	studied	their	expression	by	DC	at	different	ages	to	try	and	explore	the	delayed	differentiation	of	CD103+CD11b+	DC	 in	more	detail.	 	 I	 first	 investigated	their	expression	by	DC	subsets	in	different	tissues	from	adult	mice.		This	showed	that	most	CD103+CD11b+	DC	in	the	SI	LP	expressed	both	molecules,	as	did	this	subset	in	the	migratory	compartment	of	the	SI	draining	MLN	(sMLN).		No	DC	population	in	any	other	 adult	 tissue	 showed	 this	 pattern	 of	 co-expression,	 even	 in	 the	 CLP	 or	 its	draining	 cMLN,	 where	 only	 small	 numbers	 of	 the	 rarer	 CD103+CD11b+	 DC	 subset	were	 CD101+Trem-1+.	 	 Trem-1	 expression	 in	 particular	 was	 highly	 restricted	 to	intestinal	DC,	being	found	mostly	on	the	SI	LP	CD103+CD11b+	DC.		CD101	expression	was	 found	 more	 widely	 on	 a	 proportion	 of	 CD11b+	 DC	 in	 many	 tissues	 including	CD103-CD11b+	DC	in	SI	LP	and	CLP.			
While	 I	was	 finishing	my	 PhD,	 other	workers	 also	 reported	 that	 CD101	 expression	was	a	marker	of	intestinal	cDC2	and	that	this	is	dependent	on	vitamin	A	(Zeng	et	al.,	2016).	 	 However,	 in	 contrast	 to	 my	 studies,	 Zeng	 et	 al.	 did	 not	 observe	 CD101	expression	on	CD103-CD11b+	DC,	 although	 their	 gating	 strategy	did	not	distinguish	mφ	from	DC	and	as	mφ	comprise	the	majority	of	this	population	and	are	CD101-,	they	could	have	missed	the	small	subset	of	bona	fide	DC	that	were	CD101+.		Interestingly,	the	 proportion	 of	 CD11b+	 DC	 that	 expressed	 CD101	 varied	 considerably	 between	tissues,	being	high	in	resident	intestinal	DC,	spleen,	lung	and	kidney	but	low	or	absent	in	 skin	 draining	 LN	 and	 heart.	 	 The	 reasons	 for	 these	 differences	 are	 unknown,	although	it	would	be	interesting	to	examine	how	this	correlates	with	the	levels	of	RA	in	each	tissue,	or	if	it	is	dependent	on	vitamin	A.	
The	 role	 of	 CD101	 on	 intestinal	 DC	 is	 also	 unclear,	 although	 it	 has	 been	 shown	 to	inhibit	T	cell	activation	when	ligated	on	human	DC	(Bouloc	et	al.,	2000;	Soares	et	al.,	1998).	 	However,	 as	 it	 appeared	 to	define	particular	 stages	 in	 the	differentiation	of	the	 CD11b+	 lineage	 in	 the	 intestine,	 I	 went	 on	 to	 assess	 the	 levels	 of	 Trem-1	 and	CD101	on	intestinal	and	MLN	DC	subsets	during	neonatal	 life.	 	These	data	generally	confirmed	 that	 the	 subset-restricted	 patterns	 of	 expression	 were	 consistent	throughout	 life.	 	 However,	 co-expression	 of	 Trem-1	 and	 CD101	 increased	with	 age	amongst	 CD103+CD11b+	 DC,	 and	 was	 variable	 on	 CD103-CD11b+	 DC	 in	 SI	 LP	 and	migratory	 MLN	 DC,	 but	 not	 in	 the	 CLP,	 where	 the	 relative	 expression	 actually	
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decreased	on	both	CD103+CD11b+	and	CD103-CD11b+	DC	with	age.		The	expression	of	CD101	alone	reduced	amongst	CD103+CD11b+	DC	with	age	in	the	SI	LP	but	increased	in	the	CLP	most	likely	due	to	the	absence	of	Trem-1	expression	in	the	latter.		However,	in	both	DC	compartments	of	 the	MLN	there	were	no	distinct	expression	patterns	of	these	 molecules	 alone.	 	 This	 suggests	 that	 the	 difference	 between	 SI	 and	 colon	 in	expression	 of	 CD101	 and	 Trem-1	 may	 be	 due	 to	 a	 local	 factor	 that	 inhibits	 their	expression	 by	 CD103+CD11b+	 and	 CD103-CD11b+	 DC	 in	 the	 CLP.	 	 Whether	 these	markers	are	expressed	on	pre-DC	and	why	they	are	not	expressed	on	all	intestinal	DC	subsets	has	yet	to	be	determined.		
Trem-1	expression	by	cDC	has	not	been	reported	previously	and	it	was	believed	that	it	was	restricted	 to	blood	monocytes	and	neutrophils,	where	 it	appeared	to	amplify	inflammatory	 responses	by	modulating	TLR	 signalling	 (Bouchon	et	 al.,	 2001;	 2000;	Gibot	et	al.,	2004).		Via	its	ability	to	recognise	multimerised	PGLYRP1	on	neutrophils,	it	has	recently	been	shown	that	cytokine	production	by	human	neutrophils	and	mφ	is	enhanced	(Read	et	al.,	2015).	 	 In	 the	 intestine,	Trem-1	expression	has	been	studied	mostly	 in	 the	 context	 of	 inflammation	 where	 it	 is	 expressed	 on	 monocytes	 and	inflammatory	 mφ,	 but	 is	 absent	 on	 steady	 state	 mφ,	 possibly	 in	 response	 to	 the	microbiota	(Schenk	et	al.,	2005).		Its	role	in	inflammation	is	supported	by	the	findings	that	 Trem-1-/-	mice	 are	 less	 susceptible	 to	 experimental	 colitis	 and	 produce	 lower	amounts	 of	 cytokines	 in	 response	 to	 Leishmania	 infection	 (Weber	 et	 al.,	 2014).		According	 to	 the	 Immgenn	database,	 other	myeloid	 cells	 express	Trem-1	 in	 resting	mice,	although	it	has	been	reported	to	be	expressed	by	Langerhans	cells	and	BM	DC	under	hypoxic	conditions	(Bosco	et	al.,	2010;	Pierobon	et	al.,	2016).		As	the	intestine	is	likely	to	be	a	hypoxic	environment	compared	with	other	organs,	this	could	perhaps	explain	 the	 presence	 of	 Trem-1	 in	 the	 gut.	 	 However,	 this	 does	 not	 explain	 why	expression	is	absent	from	the	colon,	which	may	be	more	hypoxic	than	the	SI,	nor	why	it	is	so	restricted	to	a	single	subset	of	DC.		Similarly,	its	function	on	CD103+CD11b+	DC	is	unknown.	 	This	suggests	again,	 that	a	 local	 factor	specific	 to	 the	SI	such	as	RA	or	TGFβ	 may	 be	 involved	 in	 the	 imprinting	 of	 Trem-1	 on	 CD103+CD11b+	 DC.		Interestingly	 however,	 the	 absence	 of	 CD103+CD11b+	 DC	 in	 vivo	 leads	 to	 defective	Th17	responses	(Denning	et	al.,	2007;	Persson	et	al.,	2013b;	Scott	et	al.,	2014b;	Welty	et	al.,	2013)	and	could	 suggest	 that	Trem-1	might	be	 involved	 in	 the	 recognition	of	
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specific	microbes.		This	could	be	explored	by	challenging	Trem-1-/-	mice	with	known	Th17	driving	bacteria	such	as	Citrobacter	rodentium	or	SFB	to	see	if	there	is	a	defect	in	Th17	production	in	the	absence	of	Trem-1	signalling.			
6.4 Role	of	SIRPα 	and	CCR2	on	intestinal	DC	
SIRPα	is	expressed	by	all	CD11b+	DC	in	mice	and	is	now	considered	to	be	a	definitive	marker	of	the	cDC2	lineage	in	all	species	(Guilliams	et	al.,	2014;	Persson	et	al.,	2013a).		Although	 its	 exact	 function	 on	 DC	 is	 unknown,	 the	 cytoplasmic	 domain	 of	 SIRPα	contains	an	ITIM	motif	and	it	has	been	shown	to	have	inhibitory	effects	on	mφ	when	triggered	by	 its	ubiquitously	expressed	 ligand	CD47	(Barclay,	2009;	Matozaki	et	al.,	2009;	 Tsai	 et	 al.,	 2010).	 	 When	 I	 began	my	 PhD,	 the	 previous	 PhD	 student	 in	 the	laboratory	had	found	that	mice	with	a	mutation	in	the	signalling	domain	of	SIRPα	had	a	 selective	 reduction	 in	 intestinal	 CD103+CD11b+	 DC.	 This	 was	 associated	 with	 a	defect	 in	 the	 generation	 of	 local	 Th17	 cells,	 leading	 to	 increased	 susceptibility	 to	infection	by	Citrobacter	rodentium,	whereas	oral	tolerance	could	be	induced	normally	by	feeding	protein	antigen	(Scott	et	al.,	2014b).		Importantly	the	defect	in	DC	reflected	lack	of	signalling	via	SIRPα,	as	it	was	replicated	in	CD47KO	mice	and	the	initial	aim	of	my	 PhD	was	 to	 study	 SIRPα	 signalling	 in	 intestinal	 DC.	 	 However	 I	 was	 unable	 to	obtain	sufficient	numbers	of	DC	to	identify	signalling	molecules	by	Western	blotting	and	I	therefore	decided	to	try	and	explore	the	phenotype	of	SIPRα	mt	mice	in	more	detail	 in	 vivo.	 After	 confirming	 the	 reduced	 frequency	 and	 number	 of	 intestinal	CD103+CD11b+	DC,	I	went	on	to	show	that	this	defect	was	already	present	from	D7	of	life.		
How	age	affects	DC	development	in	SIRPα	mt	mice	has	not	been	examined	previously.		Rather	 than	 the	 continuum	of	 ages	 analysed	 in	WT	 animals	 previously,	 I	 examined	what	 I	had	determined	as	key	ages	 from	the	WT	mice;	D7	when	CD103+CD11b+	DC	were	beginning	to	establish,	D14	when	weaning	begins,	4	weeks-	just	after	mice	have	been	separated	from	their	mother,	8	week	old	adults,	as	well	as	16	and	24	week	old	adults	 to	monitor	ageing.	 	 In	 the	SI	LP,	 I	 found	a	generalised	defect	amongst	all	DC	subsets	in	SIRPα	mt	mice	at	D7,	which	was	absent	at	other	time	points.		By	D14	there	was	a	significant	reduction	in	CD103+CD11b+	DC	frequency	that	remained	at	all	time	
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points	studied,	in	line	with	published	findings	in	adults	(Scott	et	al.,	2014b).		However	in	contrast	 to	 the	published	data,	 cell	numbers	were	not	reduced	 in	SIRPα	mt	mice	after	D14,	and	it	appeared	that	the	numbers	of	Th17	cells	in	SIRPα	mt	intestine	were	comparable	 to	 those	 in	 the	WT	 intestine	 of	 24	week	old	mice,	 contradictory	 to	 the	reduction	previously	shown	in	8-10	week	old	mice	(Scott	et	al.,	2014b).	
To	better	 interpret	 the	CD103+CD11b+	DC	defect	 in	 SIRPα	mt	mice,	 I	 looked	 at	 the	expression	 of	 CD101	 and	 Trem-1	 in	 D7	 and	 adult	 SI	 LP	 amongst	 total	 CD11b+	 DC,	CD103-CD11b+	DC	and	CD103+CD11b+	DC.	 	At	both	 time	points,	 I	 found	 that	CD101	and	Trem-1	expression	was	reduced	amongst	these	subsets	in	SIRPα	mt	mice,	albeit	to	a	 lesser	extent	 in	 the	adult.	 	Therefore	 it	 seems	 that	SIRPα	 signalling	 is	 required	not	only	for	the	generation	of	CD103+CD11b+	DC,	but	also	for	specific	developmental	processes	 within	 both	 CD103-CD11b+	 and	 CD103+CD11b+	 DC.	 	 My	 experiments	 in	SIRPα	mt	->	WT	and	WT	->	SIRPα	mt	BM	chimeras	did	not	help	discern	whether	the	defects	I	saw	were	as	a	result	of	hematopoietic	cell	SIRPα signalling,	as	the	frequency	of	CD103+CD11b+	DC	was	reduced	in	both	sets	of	chimeras	compared	to	what	I	saw	in	the	 intact	 WT	 mice.	 	 The	 only	 significant	 difference	 was	 a	 greater	 frequency	 of	CD103+CD11b-	 DC	 in	 SIRPα	 mt	 ->	 WT	 chimeras	 compared	 with	 WT	 ->	 SIRPα	 mt	chimeras,	similar	to	what	I	had	seen	in	the	intact	SIRPα	mt	mice.		Unfortunately	due	to	 lack	of	mice	and	 time,	 the	BM	chimera	experiment	did	not	 include	WT	 ->	WT	or	SIRPα	mt	->	SIRPα	mt	chimeras	as	controls,	meaning	it	was	not	possible	to	determine	if	 this	reflected	a	genuine	absence	of	the	selective	defect,	or	 if	 irradiation	had	had	a	generalised	effect	on	the	dynamics	of	DC	reconstitution	in	the	intestine.			
Amongst	migratory	MLN	DC,	there	were	no	significant	differences	in	the	DC	subsets	at	 D7,	 however	 by	 D14	 there	 was	 a	 significant	 reduction	 in	 the	 frequency	 of	CD103+CD11b+	DC	as	in	the	SI	LP,	and	general	lymphopaenia	observed	in	adult	MLN.		By	4	weeks	 there	was	also	 a	 reduction	 in	 the	proportion	of	 CD103-CD11b+	DC	 that	remained	until	 24	weeks	but	was	not	 seen	 in	 the	 SI	 LP.	 	 There	were	no	 significant	differences	 amongst	 any	 of	 the	migratory	MLN	DC	 in	BM	 chimeras.	 	 Together	with	what	I	reported	in	SI	LP	DC	subsets,	it	appears	that	in	the	neonate	there	is	a	defect	in	the	ability	for	all	DC	subsets	to	fill	the	intestinal	niche,	while	after	D14,	this	becomes	apparent	 only	 in	CD103+CD11b+	DC.	 	 Furthermore,	 the	CD103+CD11b+	DC	defect	 is	
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less	robust	as	the	mice	exceed	eight	weeks.		It	also	indicates	a	potential	for	defective	migration	 of	 SIRPα+	 DC	 from	 the	 SI	 LP	 to	 the	 MLN,	 which	 has	 previously	 been	reported	in	the	skin	and	lung	(Hagnerud	et	al.,	2006;	Raymond	et	al.,	2010;	2009;	Van	Vu	Quang	et	al.,	2006).	 	This	had	been	 investigated	by	collection	of	pseudo-afferent	lymph	 of	 the	MLN,	 by	 a	 previous	 PhD	 student,	 however	 there	 were	 no	 conclusive	results,	 in	 part	 due	 to	 the	 age	 of	 the	 canulated	 mice	 and	 variability	 in	 results	(Charlotte	Scott;	unpublished	data)	and	would	therefore	need	repeating	to	confirm	if	migration	is	affected	in	intestinal	homeostasis	of	SIRPα	mt	mice.			
Amongst	resident	MLN	DC	and	spleen	DC	there	was	a	consistent	reduction	in	CD11b+	DC	with	a	reciprocal	increase	in	CD103+	DC	frequency	in	SIPRα	mt	mice,	which	was	unaffected	by	the	age	of	the	mice.		In	the	BM	chimeras	the	same	defect	was	seen	in	the	spleen	 only,	 consistent	with	what	 has	 previously	 been	 reported	 (Saito	 et	 al.,	 2010;	Washio	 et	 al.,	 2015),	 while	 amongst	 resident	 MLN	 DC,	 all	 defects	 in	 SIRPα	 mt	 DC	reconstitution	were	lost.			Together	with	the	defect	amongst	all	intestinal	DC	subsets	at	 D7	 and	 in	 the	 MLN	 throughout	 life,	 these	 data	 suggest	 that	 there	 may	 be	 a	generalised	defect	in	the	homeostasis	of	DC	generated	from	SIRPα	mt	mice,	and	that	this	is	more	profound	in	younger	animals.		In	mice	that	lack	IRF4	signalling	in	CD11c+	cells,	there	too	were	reduced	numbers	of	total	MLN	DC,	although	this	was	a	result	of	a	selective	defect	 in	CD103+CD11b+	DC	and	CD103-CD11b+	DC	(Persson	et	al.,	2013b)	rather	than	all	the	DC	subsets	as	I	saw.		In	SIRPα	mt	mice,	it	would	appear	that	there	is	a	defect	in	pre-DC	development,	however	previous	work	has	shown	that	there	are	normal	numbers	of	pre-DC	in	the	BM	and	blood	in	SIRPα	mt	mice	(Saito	et	al.,	2010;	Scott	 et	 al.,	 2014b).	 	 It	 could	 also	 be	 that	 recruitment	 and	 extravasation	 into	 the	intestine	 is	 impaired	 in	 these	 precursors	 by	 lack	 of	 SIRPα	 signalling	 through	CD47	expressed	 on	 vascular	 endothelial	 cells.	 	 Indeed,	 there	 have	 been	 reports	 showing	that	 SIRPα	 –	 CD47	 signaling	 is	 required	 for	 monocytes	 to	 transmigrate	 across	cerebral	endothelium	(de	Vries	et	al.,	2002;	Myers	et	al.,	2011).		However	competitive	adoptive	transfer	of	SIRPα	mt	pre-DC	into	WT	hosts	generated	all	DC	subsets	in	the	intestine,	 with	 even	 a	 selective	 advantage	 to	 having	 the	 SIRPα	 mutation	 when	generating	 CD103+CD11b+	 DC	 (Scott	 et	 al.,	 2014b),	 although	 this	 indication	 that	SIRPα	may	normally	function	as	a	checkpoint	in	the	development	of	a	specific	subset	of	intestinal	DC	is	contradictory	to	previous	findings	in	the	spleen.	Here,	pre-DC	from	
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SIRPα	mt	mice	were	found	to	have	a	reduced	ability	to	generate	CD11b+	DC	compared	with	WT	pre-DC	(Saito	et	al.,	2010).	 	However	the	latter	looked	at	a	later	time	point	after	transfer,	meaning	that	the	homeostatic	levels	of	SIRPα	mt	DC	might	have	been	reached,	but	would	suggest	that	 further	clarification	on	this	matter	 is	required	with	perhaps	analysis	of	both	lymphoid	and	non-lymphoid	tissues	at	different	times	post	transfer.	 	 	The	accelerated	CD103+CD11b+	DC	development	in	the	SI	LP	of	SIRPα	mt	mice	correlated	with	 increased	apoptosis	 in	the	migratory	CD103+CD11b+	DC	in	the	MLN,	and	by	proxy	was	a	reflection	of	the	LP,	as	it	was	impossible	to	assess	whether	this	 also	 occurred	 in	 the	 SI	 LP	 due	 to	 cell	 death	 in	 these	 preparations	 (Scott	 et	 al.,	2014b).	 	 It	 would	 be	 interesting	 to	 see	 if	 Annexin	 V	 staining	 in	 neonate	 SI	 LP	 is	possible	as	 this	undergoes	a	shorter	digestion	protocol	and	 lead	 to	more	viable	DC.		Analysis	of	Annexin	V	staining	would	allow	cell	death	to	be	measured	during	murine	development	 to	 see	 if	 neonatal	 DC	 are	 more	 susceptible	 to	 death	 than	 their	 adult	counterparts.	 	 This	might	 help	 to	 explain	 the	 generalised	 defect	 seen	 in	 SIRPα	 mt	MLN	throughout	life,	and	the	defect	seen	in	D7	SI	LP.		
The	 reduction	 in	mφ	 that	 I	 observed	 in	 adult	 SIRPα	mt	 SI	 LP	would	 not	 be	wholly	surprising,	 as	 mφ express	 constitutively	 high	 levels	 of	 SIRPα,	although	 this	 is	contradictory	 to	 the	current	 literature,	 that	 shows	mφ	 are	unaffected	by	 the	 lack	of	SIRPα	 signalling	 (Scott	et	al.,	2014b;	Washio	et	al.,	2015).	 	As	 the	defect	 I	observed	was	 subtle,	 it	 may	 have	 been	missed	 in	 previous	 experiments	 using	 less	 stringent	gating	protocols,	 or	because	of	differences	 in	microbiota.	 	 If	 confirmed,	 it	would	be	interesting	 to	 determine	 if	 the	 reduced	 population	 of	 intestinal	 macrophages	reflected	defective	generation,	 recruitment	or	 local	differentiation	of	 the	monocytes	that	 are	 the	 precursors	 of	 resident	 macrophages	 in	 this	 tissue	 (Bain	 et	 al.,	 2014).		Alternatively,	 there	may	 be	 decreased	 survival	 of	 the	mature	macrophages,	 as	 has	been	suggested	for	DC.	
To	see	how	these	data	might	fit	in	to	homeostatic	DC	development,	I	looked	at	other	reports	that	showed	a	defect	in	CD103+CD11b+	DC	and	reduction	in	Th17	cells.		In	the	absence	 of	 Notch2	 or	 its	 receptor,	 the	 selective	 loss	 of	 CD103-CD11b+	 DC	 in	 the	intestine	and	CD11b+	DC	 in	 the	spleen	was	due	 to	a	defect	 in	development	and	not	migration	(Lewis	et	al.,	2011;	Satpathy	et	al.,	2013).		In	the	skin	of	IRF4-/-	mice	there	
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were	 similar	 numbers	 of	 CD11b+	 DC	 but	 these	 were	 reduced	 in	 the	 draining	 LN,	which	was	accounted	for	by	decreased	DC	migration	(Bajana	et	al.,	2012),	while	when	IRF4	is	absent	on	CD11c+	cells,	there	were	reduced	CD103+CD11b+	DC	in	the	intestine	and	MLN,	as	well	as	reduced	CD103-CD11b+	DC	in	the	MLN.	 	These	DC	had	reduced	survival	compared	to	WT	counterparts	(Persson	et	al.,	2013b).	 	In	the	context	of	my	findings	and	those	already	published	for	SIRPα	mt	(Scott	et	al.,	2014b)	it	would	seem	that	 development	 of	 CD103+CD11b+	DC	 is	 not	 affected	 in	 SIRPα	mt	mice,	 though	 it	does	seem	plausible	that	migration	might	be	affected	along	with	a	fundamental	defect	in	 generation	 of	 CD11b+	 DC	 in	 lymphoid	 tissues.	 	 When	 CD103+CD11b+	 DC	 are	diminished,	Th17	cells	are	reduced	in	all	these	models,	however	this	does	not	explain	why	 I	 apparently	observed	a	 resolution	 in	 this	phenotype.	 	 It	might	be	 that	 certain	strains	of	commensals	might	change	with	age	in	the	intestine	and	that	these	changes	could	impact	the	production	of	Th17.	 	SFB	are	one	such	family	of	bacteria	that	have	been	 shown	 to	 modulate	 Th17	 responses	 in	 the	 intestine,	 via	 CD103+CD11b+	 DC	(Ivanov	et	al.,	2009;	Schlitzer	et	al.,	2013).		Given	the	variability	in	some	of	the	results	and	 the	 known	 influence	 of	 the	 microbiota	 on	 local	 immune	 cells,	 it	 would	 be	important	to	take	faecal	or	caecal	samples	to	perform	16S	RNA	sequencing	in	future	experiments.	This	would	allow	direct	correlation	of	differences	 in	 the	microbiota	of	SIRPα	mt	and	WT	mice	with	their	DC	phenotypes	and	could	also	reveal	whether	the	selective	 reduction	 in	 CD103+CD11b+	 DC	 might	 shape	 the	 microbial	 populations.		However	 it	 is	 important	 to	 emphasise	 that	 all	 these	 data	 need	 to	 be	 confirmed,	preferably	 using	 cohorts	 of	 age	 matched	 littermates	 housed	 together	 to	 eliminate	potential	confounding	factors	caused	by	such	subtle	differences	in	microbiota.		This	is	particularly	important,	as	the	age-related	resolution	of	the	SIRPα mt	defect	seemed	to	occur	 only	 in	 the	 intestine	 and	 not	 in	 the	 spleen,	 suggesting	 that	 a	 local	 intestinal	factor	such	as	the	microbiota	might	be	involved.			
I	was	unable	to	reproduce	the	statistically	significant	defect	 in	a	subset	of	 intestinal	CD103-CD11b+	DC	in	CCR2-/-	mice	that	had	been	reported	previously	in	the	laboratory	(Scott	et	al.,	2014a).		This	could	be	due	to	a	number	of	reasons,	including	the	fact	that	I	may	not	have	used	enough	mice	to	observe	what	was	shown	to	be	a	subtle	change	in	DC	numbers.		However,	I	did	find	a	trend	towards	reduced	numbers	of	CD103-CD11b+	DC	 in	 CCR2-/-	 mice	 and	 also	 confirmed	 the	 earlier	 finding	 that	 a	 subset	 of	 this	
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population	expressed	CCR2	(Scott	et	al.,	2014a).	 	 I	went	on	to	use	the	expression	of	CD101	and	Trem-1	to	explore	the	suggestion	made	in	previous	experiments	that	the	CCR2+	CD103-CD11b+	DC	could	be	an	intermediary	subset	that	downregulates	CCR2	before	becoming	CD103+CD11b+	DC.	However	there	was	no	difference	in	CD101	and	Trem-1	expression	between	the	CCR2+	and	CCR2-	subsets	of	CD103-CD11b+	DC,	while	there	was	actually	a	 small	 increase	 in	 the	proportion	of	CD103+CD11b+	DC	 that	 co-expressed	CD101	and	Trem-1	 in	CCR2-/-	mice,	 indicating	 that	CCR2+	CD103-CD11b+	DC	 were	 not	 the	 cells	 expressing	 CD101	 and	 Trem-1	 that	 are	 predicted	 to	 be	 the	direct	precursors	of	CD103+CD11b+	DC.			
6.5 The	role	of	Trem-1	in	DC	development	
A	remarkable	finding	from	my	project	was	that	Trem-1	expression	by	DC	was	highly	restricted	to	the	SI	LP,	where	it	was	found	on	most	CD103+CD11b+	DC,	together	with	some	 CD103-CD11b+	 DC.	 Even	 more	 surprising	 was	 that	 this	 pattern	 was	 not	replicated	in	the	colon,	apart	from	a	very	small	proportion	of	these	subsets	showing	transient	expression	of	Trem-1	in	the	neonatal	period.	Having	identified	this	selective	expression,	I	decided	to	investigate	whether	Trem-1	was	involved	in	the	development	of	 CD103+CD11b+	 DC.	 Initially	 I	 analysed	 data	 from	 an	 experiment	 carried	 out	 on	Trem-1-/-	mice	in	Christoph	Mueller’s	group	at	the	University	of	Bern,	but	only	a	few	of	 the	 data	 points	were	 useable	 due	 to	 cell	 death	 and	 gating	 problems.	 This	made	interpretation	 very	 difficult,	 but	 those	 results	 I	 did	 obtain	 were	 consistent	 with	information	I	obtained	from	the	Bern	laboratory	suggesting	that	there	were	no	effects	of	 Trem-1	deficiency	 on	 any	 of	 the	DC	 subsets	 in	 the	 SI	 LP.	However	 an	 additional	complication	to	this	experiment	was	that	the	frequency	of	CD103+CD11b+	DC	in	the	WT	controls	from	Bern	appeared	to	be	far	lower	(~20%)	than	I	had	usually	seen	in	Glasgow	(~40%).	This	might	have	been	due	to	the	different	digestion	protocol	used	in	Bern,	 potentially	 leading	 to	 enhanced	 death	 of	 CD103+CD11b+	 DC,	 a	 subset	 I	 had	found	to	be	particularly	susceptible	to	dying	when	samples	had	been	over-digested.		It	 could	 also	 be	 that	 PP	may	not	 have	 been	 removed	by	 the	Bern	 group	 and	 as	 PP	contain	 a	 large	 proportion	 of	 CD103+CD11b-	 DC,	 this	 could	 have	 skewed	 the	 DC	proportions	obtained.			
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After	having	seen	that	the	pattern	of	Trem-1	expression	by	SI	LP	CD103-CD11b+	and	CD103+CD11b+	DC	was	established	 from	birth	onwards,	 I	hypothesised	that	Trem-1	could	be	 involved	 in	DC	maturation.	 	As	 it	was	not	 feasible	 to	 establish	a	 colony	of	Trem-1-/-	mice	in	Glasgow	and	I	was	unsure	of	the	protocols	used	by	the	Bern	group	to	 isolate	 and	 characterise	 LP	 DC,	 I	 decided	 to	 generate	 competitive	 chimeras	 in	Glasgow	using	BM	obtained	 from	Bern.	The	plan	was	 to	 reconstitute	 irradiated	WT	mice	with	 a	 50:50	mixture	 of	 CD45.2+	Trem-1-/-	 or	 CD45.2+	Trem-1+/+	 and	CD45.1+	WT	BM,	but	when	I	analysed	the	cell	populations	8	weeks	after	transfer,	I	found	that	there	 were	 fewer	 CD45.1+	 derived	 BM	 cells	 than	 I	 had	 calculated	 at	 the	 time	 of	transfer.	 The	 most	 likely	 explanation	 for	 this	 is	 that	 there	 had	 been	 selective	 cell	death	amongst	 the	CD45.1+	WT	BM	cells	which	 I	had	stored	 in	a	 fridge	door	 for	48	hours	 to	 mimic	 the	 time	 and	 movement	 which	 CD45.2+	 Trem-1-/-	 and	 Trem-1+/+	bones	would	have	experienced	during	their	transport	from	Bern.	It	appeared	that	the	conditions	 of	 storage	 in	Glasgow	may	have	 compromised	 viability	more	 than	 those	involved	 in	 the	 international	 transfer.	 Despite	 the	 BM	 mixtures	 not	 achieving	 the	anticipated	50:50	level,	the	mice	did	still	represent	competitive	chimeras,	as	10-15%	of	 the	 reconstituted	 BM	 was	 derived	 from	 the	 CD45.1	 WT	 source	 in	 each	 case.	However	 in	 the	 blood,	 monocytes	 and	 neutrophils	 reconstituted	 less	 readily	 from	Trem-1-/-	 BM	 than	WT	 BM,	 perhaps	 consistent	 with	 these	 cells	 expressing	 Trem-1	(Bouchon	et	al.,	2000;	Zangi	et	al.,	2012).	The	generation	of	monocytes	and	mφ	in	the	intestine	of	chimeric	mice	showed	a	similar	dependence	on	Trem-1,	which	could	be	explained	by	these	cells	being	derived	from	blood	monocytes	(Bain	et	al.,	2014;	2012).	More	surprisingly,	Trem-1-/-	BM	was	also	less	efficient	at	generating	all	DC	subsets	in	the	 tissues	 analysed,	 except	 for	 the	 resident	 CD103-CD11b+	 DC	 in	 the	 MLN.	 This	included	 DC	 from	 the	 SI	 LP	 of	 these	 animals,	 although	 the	 data	 from	 the	 intestine	were	again	difficult	to	interpret	due	to	a	low	number	of	viable	samples.	The	reasons	for	all	DC	subsets	to	be	affected	are	not	wholly	clear,	as	there	was	no	correlation	with	the	expression	of	Trem-1	by	the	different	subsets,	and	no	defects	had	been	observed	in	the	intact	Trem-1-/-	mice	from	Bern.		If	confirmed,	these	results	would	suggest	that	the	 defective	 generation	 of	 DC	 by	 Trem-1-/-	 BM	 in	 the	 chimeras	 is	 not	 due	 to	 an	intrinsic	 loss	 of	 Trem-1,	 but	 may	 reflect	 the	 loss	 of	 Trem-1	 on	 other	 cells.	 	 As	mentioned	 before,	 it	 has	 not	 been	 determined	 if	 Trem-1	 is	 expressed	 on	 BM	precursors	 cells	 such	as	monocytes,	HSC,	CMP	or	pre-DC	and	 thus	 there	 could	be	a	
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role	for	Trem-1	in	the	generation	of	the	correct	niche	required	to	generate	DC.		I	did	not	analyse	other	tissues	in	these	chimeras,	so	it	is	possible	that	a	DC	defect	might	be	present	 at	 other	 sites	 as	 a	 result	 of	 defective	 generation	 upstream	 in	 their	development.					
6.6 Concluding	remarks	
These	data	have	shown	how	intestinal	DC	subsets	develop	with	age.		More	specifically,	that	CD103+CD11b+	DC	are	not	present	at	birth	and	their	appearance	is	preceded	by	that	of	the	CD103-CD11b+	subset.	 	Other	evidence	suggests	these	subsets	are	related	to	 each	 other	 and	 that	 the	 CD103-CD11b+	DC	 is	 the	 intermediate	 precursor	 of	 the	CD103+CD11b+	DC,	with	this	differentiation	step	occurring	only	in	the	intestine.		The	expression	 of	 CD101	 and	 Trem-1	 on	 only	 a	 proportion	 of	 CD103-CD11b+	DC,	while	absent	on	the	other	DC	subsets,	might	indicate	those	CD103-CD11b+	DC	that	are	about	to	 become	 CD103+CD11b+	DC.	 	 Furthermore,	 the	microarray	 analysis	 which	 shows	only	a	limited	number	of	genes	different	between	these	two	CD11b+	subsets	and	the	close	clustering	of	these	two	subsets	when	compared	to	the	other	subsets	all	indicate	a	 relationship	 between	 them.	 Due	 to	 the	 specific	 nature	 of	 Trem-1	 on	 intestinal	CD11b+	DC,	 it	could	be	used	as	a	fate-mapping	gene	to	observe	how	the	DC	develop	from	 one	 subset	 to	 another,	 although	 it	 would	 be	 important	 to	 determine	 exactly	when	 Trem-1	 was	 switched	 on	 during	 DC	 development.	 	 Recent	 work	 in	 our	 own	laboratory	further	supports	a	developmental	relationship	between	the	two	subsets	of	CD11b+	DC	 in	 the	 intestine,	as	CD11c-cre-TGFβR1fl/fl	mice	 lack	CD103+CD11b+	DC	 in	the	intestine	but	have	a	reciprocal	increase	in	CD103-CD11b+	DC	and	normal	numbers	of	CD11b+	DC	expressing	CD101	(Drs	Jennifer	Montgomery	and	Calum	Bain,	Personal	Communication).		To	test	whether	it	is	indeed	CD101+	DC	from	the	CD103-CD11b+	DC,	this	 population	 of	 cells	 could	 be	 sorted	 and	 cultured	 in	 vitro	 with	 factors	 such	 as	retinoic	acid	and	accessed	if	CD103+CD11b+	DC	are	generated.	 	However,	these	sorts	of	 experiments	 are	 not	 without	 limitation	 as	 they	 involve	 isolations	 of	 very	 rare	populations	 of	 cells,	 but	 also	 in	 vitro	 cultures	 can	 never	 fully	 recapitulate	 in	 vivo	conditions	due	 to	 the	 lack	of	 local	 intestinal	 factors	 that	may	all	 be	 involved	 in	 the	maintenance	of	specific	cell	types.			
  
 
 
213 
The	highly	restricted	distribution	of	CD103+CD11b+	DC	 in	 the	SI	LP	and,	 to	a	 lesser	extent,	 in	 the	 colon	 could	 mean	 that	 this	 population	 is	 derived	 from	 a	 specific	precursor	 that	 is	 recruited	 selectively	 to	 the	mucosa,	 or	 that	 a	 common	 precursor	develops	 preferentially	 due	 to	 signals	 within	 the	 local	 environment.	 	 Recently	 a	population	of	gut-tropic	DC	progenitors	has	been	described,	suggesting	that	distinct	precursors	 may	 be	 involved	 in	 the	 generation	 of	 intestinal	 DC	 (Zeng	 et	 al.,	 2016;	2012).		However,	these	pre-mucosal	DCs	(pre-	μDCs)	were	also	capable	of	generating	splenic	DC	and	appeared	 to	generate	CD103+CD11b-	DC,	even	 in	 the	SI.	 	These	pre-μDC	expressed	 the	β7	 integrin	and	B220	and	 thus	exactly	how	 they	 relate	 classical	pre-DCs,	which	are	B220-	is	unclear.		On	balance,	it	is	likely	that	local	imprinting	is	the	mechanism	responsible	and	as	I	have	discussed	above,	this	could	include	factors	such	as	 the	 microbiota,	 diet	 or	 indeed	 host-derived	 signals	 generated	 by	 local	hematopoietic,	 epithelial,	 stromal	or	neural	 cells.	 	My	own,	and	other	 results	would	suggest	 that	 the	microbiota	 does	 not	 influence	 the	 development	 of	 the	 phenotypic	subsets	of	DC	in	the	intestine	(Hagerbrand	et	al.,	2015;	Walton	et	al.,	2006),	although	whether	their	function	is	altered	has	not	been	addressed.		Dietary	vitamin	A	has	been	shown	to	be	important	for	the	development	of	CD103+CD11b+	DC	and	for	their	ability	to	generate	RA	(Agace	and	Persson,	2012;	Coombes	et	al.,	2007).	 	This	may	reflect	a	defect	 in	 the	relevant	pre-cDC	(Zeng	et	al.,	2012),	but	 it	would	also	be	 important	 to	use	markers	such	as	CD101	and	Trem-1	to	analyse	whether	vitamin	A	also	controls	the	 local	differentiation	of	 this	 lineage.	 	 Interactions	with	a	number	of	 local	stromal	and	 haematopoietic	 cells	 have	 been	 reported	 to	 regulate	 the	 development	 of	CD103+CD11b+	and	other	intestinal	DC,	including	ILC3,	eosinophils	and	macrophages	(Cedric	Auffray	et	al.,	2009).		These	pathways	may	involve	mediators	such	as	Il-1,	GM-CSF	 or	 RA.	 	 The	 role	 of	 such	 cells	 and	 the	 stage	 at	 which	 they	 operate	 could	 be	assessed	by	co-culturing	them	or	their	soluble	products	with	pre-cDC	or	more	mature	DC	and	using	CD101,	Trem-1	and	other	markers	 to	determine	 the	nature	of	 the	DC	that	appear.	 	It	will	also	be	important	to	explore	if	these	local	factors	change	during	neonatal	 life	 in	 parallel	 with	 the	 dynamic	 maturation	 of	 the	 DC	 subsets	 and	 the	findings	 presented	 here	 should	 provide	 the	 basis	 for	more	 detailed	 studies	 of	 this	kind.	Finally	it	would	be	important	now	to	extend	these	experiments	in	the	mouse	by	exploring	whether	there	are	similar	processes	taking	place	in	the	human	DC	network	early	in	life,	and	if	differences	in	this	might	predict	later	susceptibility	to	disease.		
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